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Thesis Overview  
 
This thesis is presented in two volumes: the research (Volume One) and clinical 
(Volume Two) components. Volume One presents three research papers. The first paper 
is a systematic review exploring sensory modulation difficulties in rare genetic 
syndromes associated with Intellectual Disability (ID) and Autism Spectrum Disorder 
(ASD). The second is an empirical paper examining the behavioural phenotype in 
Pallister-Killian Syndrome (PKS). The third is a public dissemination report written to 
inform carers/parents of individuals with genetic syndromes with the results of the two 
papers.  
 
Volume two consists of five clinical practice reports (CPRs). CPR One presents 
two formulations (using behavioural and psychodynamic models) of a girl with anxiety 
and a specific phobia of vomiting in a Child and Adolescent Mental Health Service 
(CAMHS). CPR Two is a service evaluation determining if a neurodevelopmental 
pathway assessing ASD in young people met the standards of NICE guideline. CPR 
Three is an experimental functional analysis of a girl with Tuberculous Complex (TSC) 
who was displaying aggressive behaviour. CPR Four is the case study, including 
assessment, formulation and intervention of a woman with schizoaffective disorder who 
required a relapse prevention plan. The abstract of CPR 5 (an oral case presentation) is 
the assessment of a man with Mild Cognitive Impairment (MCI), low mood and 
Leukaemia.  
 
 
 
  
Acknowledgements 
 
I am thankful to Dr Chris Oliver for his guidance and support, your dedication 
and commitment to improving families well-being affected by genetic syndromes is 
inspirational. I am especially indebted to Dr Alice Welham for your supervision at every 
stage of my research, for giving guidance, offering feedback and statistical analysis. 
You more than demonstrated your serenity and patience. 
 
I would also like thank all the members of the Cerebra centre for making me feel 
welcome and offering support. Specifically, Stacey Bissell and Graham who’s 
knowledge of LimeSurvey was invaluable. I have learnt so much more about data 
coding that I ever imagined I would. I would also like to thank ClearLinks for 
proofreading my work. 
 
I am grateful to UNIQUE who allowed and supported me to recruit families 
from the support group. I am specifically, grateful to all of the parents who took the 
time to complete the online questionnaire. This research would not of been possible 
with you. Similarly, I appreciate all the other families who have taken part in previous 
research, allowing me to use comparison data.  
 
I feel lucky to have experienced working with so many encouraging clinical 
supervisors and had the opportunity to work with a range of clients. I feel Clinical 
Psychologists have such a privileged job to share so many emotional experiences with 
others.  
  
I am also thankful to my oldest and closest friends, for their encouragement and 
their never-ending ability to always put a smile on my face. I feel privileged to have 
grown up with so many beautiful, inspiring women. I am also thankful for the new 
friends I have made along the way, especially to Amy, Davey and Luke. You have 
challenged me to think about myself in new ways, yet managed to contain all of my 
anxieties. Thankyou for helping me develop into the clinician I am today.  
 
The generosity from my parents always exceeds my expectations, your love, 
time and driving ability (thanks for the lifts dad!) has been fundamental in my 
achievements. You always demonstrated the value of working hard. Because of you 
both, I am the person I am today. I am blessed to be part of my family- Thankyou to 
Nana, Paul, Tara and Emily.  
 
Finally, I would like to give special thanks to my partner, Jonathan, for making 
me happy each and every day. Thankyou for believing in me more than I believe in 
myself. I will try to remember the patience you showed at this time in years to come.  
 
This will be my final degree…I promise! 
 
 
 
 
 
 
 
 
  
Table of Contents 
 
Volume One- Research Component  
 
 Page 
CHAPTER 1: SENSORY SYMPTOMS IN RARE GENETIC 
SYNDROMES: A SYSTEMATIC REVIEW  
 
Abstract…………………………………………………………………………… 1 
Introduction……………………………………………………………………….. 2 
Rationale and Aim………………………………………………………………... 14 
Method……………………………………………………………………………. 16 
Results…………………………………………………………………………….. 24 
Discussion………………………………………………………………………… 64 
Conclusion………………………………………………………………………... 77 
References………………………………………………………………………… 82 
CHAPTER 2: EXPLORING THE BEHAVIOURAL PHENOTYPE OF 
PALLISTER-KILLIAN SYNDROME 
 
Abstract…………………………………………………………………………… 122 
Introduction……………………………………………………………………….. 123 
Aim……………………………………………………………………………….. 131 
Method……………………………………………………………………………. 134 
Results…………………………………………………………………………….. 150 
Discussion………………………………………………………………………… 170 
References………………………………………………………………………… 184 
CHAPTER 3: PUBLIC DISSEMINATION DOCUMENT  
Literature Review: Sensory Symptoms in Rare Genetic Syndromes…………….. 200 
Research Study: Exploring the Behavioural Phenotype of Pallister-Killian 
Syndrome…………………………………………………………………………. 
 
202 
References………………………………………………………………………… 205 
APPENDIX ONE: Criteria and Associated Features with ASD taken from 
Grzadzinski (2013)……………………………………………………………...... 
 
207 
APPENDIX TWO: The Percentage of ASD Symptomology in a Range of  
 Genetic Syndromes Associated with Intellectual Disability……………………... 208 
APPENDIX THREE: Explanation of the Development of the Quality 
Assessment Framework…………………………………………………………... 
 
209 
APPENDIX FOUR: Participant Invitation, Consent Forms, Information Sheets 
and Background Information Questionnaire……………………………………... 
 
214 
APPENDIX FIVE: Ethical Approval Letter…………………………………….. 237 
APPENDIX SIX: Assessments………………………………………………….. 241 
APPENDIX SEVEN: Health Difficulties in Individuals with Pallister-Killian 
Syndrome…………………………………………………………………………. 
 
256 
 
 
List of Figures 
 
Volume One-Research Component 
 
 Page 
CHAPTER 1: SENSORY SYMPTOMS IN RARE GENETIC 
SYNDROMES: A SYSTEMATIC REVIEW 
 
Figure 1.1. Dunn’s Model of Sensory Processing…………………………..... 5 
 
 
List of Tables 
 
Volume One-Research Component 
 Page 
CHAPTER 1: SENSORY SYMPTOMS IN RARE GENETIC 
SYNDROMES: A SYSTEMATIC REVIEW 
 
Table 1.1:The Search Process……………………………………………………. 18 
 Table 1.2. Inclusion and Exclusion Criteria…………………………………........ 23 
Table 1.3. Descriptions of the Genetic Syndromes……………………………….. 26 
Table 1.4. Descriptions of the Research Articles Included in the Review……....... 31 
Table 1.5. Descriptions of the Assessment Methods used by the Research 
Articles……………………………………………………………………………. 
 
47 
Table 1.6. The Quality Assessment Framework………………………………...... 57 
Table 1.7. Results of the Evaluation Criteria Applied to the Research Articles…. 60 
CHAPTER 2: EXPLORING THE BEHAVIOURAL PHENOTYPE OF 
PALLISTER-KILLIAN SYNDROME 
 
Table 2.1. Descriptions of Angelman Syndrome, Fragile X Syndrome and 
Cornelia de Lange Syndrome…………………………………………………….. 
 
133 
Table 2.2. Descriptions of the Individual participants with Pallister-Killian 
Syndrome…………………………………………………………………………. 
 
136 
Table 2.3: Demographic Characteristics and Statistical Analysis for 
Participants Group: Pallister-Killian Syndrome and Matched Angelman 
Syndrome………………………………………………………………………….. 
 
 
139 
Table 2.4. Demographic Characteristics and Statistical Analyses for 
Participants Groups: Pallister-Killian Syndrome, Non-Matched Angelman 
Syndrome, Fragile X Syndrome and Cornelia de Lange Syndrome……………… 
 
 
141 
Table 2.5. Descriptions of the Assessments, Including the Psychometric 
Properties…………………………………………………………………………. 
 
143 
Table 2.6. Number and Percentage of Individuals with Pallister-Killian 
Syndrome and Matched Individuals with Angelman Syndrome displaying 
Challenging Behaviour and Chi-Squared Analysis………………………………. 
 
 
151 
Table 2.7. Median (Inter Quartile Range) for Individuals with Pallister-Killian 
Syndrome and Matched Individuals with Angelman Syndrome Subscales of the 
Challenging Behaviour Severity Score, Mood, Interest and Pleasure 
Questionnaire, the Repetitive Behaviour Questionnaire, the Activity 
Questionnaire, and the Social Communication Questionnaire with Results for 
Mann-Whitney U Analysis………………………………………………………...  
 
 
 
 
 
154 
Table 2.8. Number and Percentage of Individuals with Pallister-Killian 
Syndrome and Matched Individuals with Angelman Syndrome meeting criteria 
 
 
 for ASD and Autism from the Social Communication Questionnaire and Chi-
Squared Analysis…………………………………………………………………. 
 
155 
Table 2.9. Median (Inter Quartile Range) for Individuals with Pallister-Killian 
Syndrome, Non-Matched Individuals with Angelman Syndrome, Cornelia de 
Lange Syndrome and Fragile X Syndrome Subscales of the Sociability in 
Intellectual Disabilities Questionnaire with Results for Kruskal-Wallis Analysis 
and Post Hoc Mann-Whitney U Analysis……………………………………….... 
 
 
 
 
157 
Table 2.10. Mean, Standard Deviation and Classification of Sensory 
Experiences in Individuals with Pallister-Killian Syndrome, and Non-Matched 
Individuals with Angelman Syndrome, Cornelia de Lange and Fragile X 
Syndrome………………………………………………………………………….. 
 
 
 
160 
Table 2.11. Number of Individuals with Pallister-Killian Syndrome, and Non-
Matched Individuals with Angelman Syndrome, Cornelia de Lange Syndrome 
and Fragile X Syndrome Scoring in the ‘Typical’ Range Category on the 
Sensory Experience Questionnaire with Results for the Chi-Squared Analysis….. 
 
 
 
1162 
Table 2.12. Median (Inter Quartile Range) for Individuals with Pallister-Killian 
Syndrome, Non-Matched Individuals with Angelman Syndrome, Cornelia de 
Lange Syndrome and Fragile X Syndrome Subscales of the Sensory Experience 
Questionnaire with Results for the Kruskal-Wallis Analysis and Post-Hoc Mann-
Whitney U Analysis……………………………………………………………….. 
 
 
 
 
165 
Table 2.13. Percentage displaying Classification, Median (Inter Quartile 
Range), for Individuals with Pallister-Killian Syndrome, and Non-Matched 
Individuals with Angelman Syndrome, Cornelia de Lange Syndrome and Fragile 
X Syndrome Subscales of the Hospital Anxiety and Depression Scale with 
Results for the Mann-Whitney U Analysis………………………………………... 
 
 
 
 
168 
Table 2.14. Summary Results and the Relative Comparisons of the Pallister-
Killian Syndrome Group to the Angelman Syndrome, Cornelia de Lange 
Syndrome and Fragile X Syndrome Groups……………………………………… 
 
 
169 
 
 
Volume Two- Clinical Component  
  
 Page 
CLINICAL PRACTICE REPORT 1: Psychological Models  
Abstract…………………………………………………………………………… 1 
Introduction……………………………………………………………………….. 2 
Assessment………………………………………………………………………... 2 
Formulation……………………………………………………………………….. 12 
Critique and Reflections………………………………………………………….. 29 
References………………………………………………………………………… 31 
CLINICAL PRACTICE REPORT 2: Service Evaluation  
Abstract…………………………………………………………………………… 35 
Introduction……………………………………………………………………….. 36 
Method……………………………………………………………………………. 39 
Results…………………………………………………………………………….. 42 
Discussion………………………………………………………………………… 59 
Reflections………………………………………………………………………... 74 
References………………………………………………………………………… 75 
CLINICAL PRACTICE REPORT 3: Single Case Experimental Design  
Abstract…………………………………………………………………………… 83 
Introduction……………………………………………………………………….. 85 
Assessment………………………………………………………………………... 88 
Results…………………………………………………………………………….. 92 
Functional Analysis………………………………………………………………. 97 
Experimental Functional Analysis………………………………………………... 105 
Discussion………………………………………………………………………… 115 
Reflections……………………………………………………………………....... 118 
References………………………………………………………………………… 119 
CLINICAL PRACTICE REPORT 4: Case Study  
Abstract…………………………………………………………………………… 129 
Introduction……………………………………………………………………….. 130 
 Assessment………………………………………………………………………... 135 
Formulation……………………………………………………………………….. 142 
Intervention……………………………………………………………………….. 150 
Evaluation………………………………………………………………………… 155 
Reflections………………………………………………………………………... 163 
References………………………………………………………………………… 166 
CLINICAL PRACTICE REPORT 5: Case Study  
Abstract…………………………………………………………………………… 185 
APPENDIX ONE: Audit Tool…………………………………………………... 187 
APPENDIX TWO: Ethics NRES Table………………………………………… 194 
APPENDIX THREE: Results of the Referral Letter to the ASD Team………… 195 
APPENDIX FOUR: Results of the ASD Assessment………………………....... 196 
APPENDIX FIVE: Results of the Assessment of Conditions that may Coexist 
with Autism……………………………………………………………………….. 
 
198 
APPENDIX SIX: Results for Post Assessment Care……………………………. 199 
APPENDIX SEVEN: Consideration of Referrals After the ASD Assessment…. 201 
APPENDIX EIGHT: Number of Days between ASD Assessment and 
Feedback………………………………………………………………………….. 
 
202 
APPENDIX NINE: A Description of the Psychometric Assessments………….. 203 
APPENDIX TEN: Graph displaying Henna’s Pre-Therapy CORE-OM data 
with Clinical Cut-off Scores and Normative Data………………………………... 
 
206 
APPENDIX ELEVEN: Graph displaying Henna’s PIBQ Pre-Therapy 
Assessment Scores and Normative Data…………………………………………. 
 
207 
APPENDIX TWELVE: Henna’s Relapse Prevention Plan…………………….. 208 
APPENDIX THIRTEEN: Graph displaying Henna’s CORE-OM Pre-Therapy 
Assessment Scores………………………………………………………………... 
 
211 
APPENDIX FOURTEEN: Graph displaying Henna’s PIBQ Pre-Therapy and 
Post-Therapy Assessment Scores………………………………………………… 
 
212 
APPENDIX FIFTEEN: Graph displaying Henna’s FORSE Pre-Therapy and 
Post-Therapy Assessment Scores………………………………………………… 
 
213 
 
 List of Figures 
 
Volume Two-Clinical Component 
 
 Page 
CLINICAL PRACTICE REPORT 1: Psychological Models  
Figure 1.1. Family Genogram…………………………………………………. 9 
Figure 1.2. Behavioural Formulation based on Nezu, Nezu and Lombardo’s 
(2004) Model…………………………………………………………………… 
14 
Figure 1.3. Behavioural Formulation of Sarah’s SPOV based on Nezu, Nezu 
and Lombardo’s (2004) Model………………………………………………… 
16 
Figure 1.4. Psychodynamic Formulation based on Malan’s Triangles………... 23 
Figure 1.5. Psychodynamic Formulation of Sarah’s difficulties based on 
Malan’s Triangles: Triangle of Conflict……………………………………….. 
25 
Figure 1.6. Psychodynamic Formulation of Sarah’s difficulties based on 
Malan’s Triangles: Triangle of Person…………………………………………. 
27 
CLINICAL PRACTICE REPORT 2: Service Evaluation  
Figure 2.1. Graph displaying the Results of the Referral Letter to the 
Neurodevelopmental Pathway…………………………………………………. 
 
49 
Figure 2.2. Graph displaying the Results of the ASD Assessment……………. 52 
Figure 2.3. Graph displaying the Results of the Assessment for Conditions 
that may Coexist with ASD…………………………………………………….. 
53 
Figure 2.4. Graph displaying the Results of the Post Assessment Care……….. 55 
Figure 2.5. Graph displaying the Results of Suggestions for Referrals for 
Further Assessment for Conditions that may Coexist with ASD.……………… 
 
56 
Figure 2.6. Results of the Feedback from the ASD Assessment………………. 58 
Figure 2.7. The NHS Change Model (2012)…………………………………... 61 
Figure 2.8. The Organisational ‘Double Loop’ Learning Cycle (Argyris, 1991; 
Kolb, 1984)……………………………………………………………………... 
 
65 
CLINICAL PRACTICE REPORT 3: Single Case Experimental Design  
 Figure 3.1. Behavioural; Formulation of Jenny’s Aggressive Behaviour……... 101 
Figure 3.2. Graph displaying the Frequency of Aggression and Social 
Initiation Behaviour in Analogue Conditions with the Examiner……………… 
 
108 
Figure 3.3. Graph displaying the Frequency of Aggression and Social 
Initiation Behaviour in Analogue Conditions with her Mother………………... 
 
109 
Figure 3.4. Lag Sequential Analysis Using Aggression as the Criterion 
Variable (at 0 seconds; y-axis) and Social Initiation as the Target Variable in 
Conditions with the Examiner, showing the Mean Unconditional Probability 
(filled squares) and the Conditional Probability (unfilled squares) of Jenny 
Displaying Social Initiation Behaviours……………………………………….. 
 
 
 
 
111 
Figure 3.5. Lag Sequential Analysis Using Aggression as the Criterion 
Variable (at 0 seconds; y-axis) and Social Initiation as the Target Variable in 
Conditions with her Mother, showing the Mean Unconditional Probability 
(filled squares) and the Conditional Probability (unfilled squares) of Jenny 
Displaying Social Initiation Behaviours……………………………………….. 
 
 
 
 
111 
Figure 3.6. Lag Sequential Analysis Using Consequence as the Criterion 
Variable (at 0 seconds; y-axis) and Aggression as the Target Variable in 
Conditions with the Examiner, showing the Mean Unconditional Probability 
(filled squares) and the Conditional Probability (unfilled squares) of Jenny 
Displaying Aggression…………………………………………………………. 
 
 
 
 
112 
Figure 3.7. Lag Sequential Analysis Using Consequence as the Criterion 
Variable (at 0 seconds; y-axis) and Aggression as the Target Variable in 
Conditions with her Mother, showing the Mean Unconditional Probability 
(filled squares) and the Conditional Probability (unfilled squares) of Jenny 
Displaying Aggression…………………………………………………………. 
 
 
 
 
113 
Figure 3.8. Lag Sequential Analysis Using Aggression as the Criterion 
Variable (at 0 seconds; y-axis) and Consequence as the Target Variable in 
Conditions with the Examiner, showing the Mean Unconditional Probability 
(filled squares) and the Conditional Probability (unfilled squares) of the 
Examiner Delivering Jenny a Consequence to her Aggression……………… 
 
 
 
 
114 
Figure 3.9. Lag Sequential Analysis Using Aggression as the Criterion 
Variable (at 0 seconds; y-axis) and Consequence as the Target Variable in 
 
 
 Conditions with her Mother, showing the Mean Unconditional Probability 
(filled squares) and the Conditional Probability (unfilled squares) of Jenny’s 
Mother Delivering Jenny a Consequence to her Aggression…………………... 
 
 
114 
CLINICAL PRACTICE REPORT 4: Case Study  
Figure 4.1. Graph displaying Henna’s MHRS Assessment……………………. 139 
Figure 4.2. Diagram displaying Henna’s Longitudinal (Gumley and Power, 
1999) and Maintenance Formulation of Psychosis and Relapse (Gumley and 
Schwannauer, 2006)…………………………………………………………… 
 
 
144 
 
List of Tables 
 
Volume Two-Clinical Component 
 
 Page 
CLINICAL PRACTICE REPORT 1: Psychological Models  
Table 1.1. Table displaying the Assessment Methods…………………………….. 3 
Table 1.2. Table displaying the Strength and Difficulties Questionnaire 
Results…………………………………………………………………………….. 
 
4 
Table 1.3 Table displaying the Revised Children’s Anxiety and Depression Scale 
Results…………………………………………………………………………….. 
 
5 
CLINICAL PRACTICE REPORT 2: Service Evaluation  
Table 2.1. Table displaying the Ethnicity of Participants………………………... 41 
Table 2.2. Evaluation of the Neurodevelopmental Pathway and Team…………... 43 
Table 2.3. Explanation of each Component in the NHS Change Model…………. 62 
Table 2.4. Defining Features of Organisational Learning (Snell, 2002) and how 
they are Implemented in the NHS (Sheaff and Pilgrim, 2006)…………………… 
 
66 
Table 2.5. Defining Features of Organisational Learning (Snell, 2002) and how 
this Culture is Implemented in the NHS (Sheaff and Pilgrim, 2006)……………... 
 
67 
CLINICAL PRACTICE REPORT 3: Single Case Experimental Design  
Table 3.1. A description of the Questionnaire, Interview and Observational  
 Assessment Measures……………………………………………………………... 89 
Table 3.2. Table displaying the Wessex Questionnaire Results………………….. 93 
Table 3.3. Table displaying the Vinelands Adaptive Behaviour Scale Results…… 94 
Table 3.4. Table displaying the Psychometric Results: The Activity 
Questionnaire, The Mood, Interest and Pleasure Questionnaire, The Repetitive 
Behaviour Questionnaire, and the Social Communication Questionnaire……….. 
 
 
96 
Table 3.5. Table displaying the Short Sensory Profile Results…………………... 96 
Table 3.6. Table displaying the Questions About Behavioural Function 
Questionnaire Results…………………………………………………………….. 
 
99 
Table 3.7. Experimental Functional Analysis Analogue Conditions……………... 104 
Table 3.8. Behaviour Codes used for the Experimental Functional Analysis……. 105 
Table 3.9. d Statistic Values for Aggressive Behaviour Displayed by Jenny in 
Low Attention and Demand Compared to High Attention Control Condition and 
Restricted Access to Tangibles Compared to Free Access to Tangibles Control 
Condition………………………………………………………………………….. 
 
 
 
110 
CLINICAL PRACTICE REPORT 4: Case Study  
Table 4.1. Table displaying Henna’s CORE-OM Pre-Therapy Assessment 
Scores, Cut-off Scores and Clinical normative Data……………………………... 
 
141 
Table 4.2. Table displaying Henna’s Pre-Therapy Assessment Scores and 
Normative Data…………………………………………………………………… 
 
141 
Table 4.3. Table displaying Henna’s Pre-Therapy FORSE Assessment Scores….. 142 
Table 4.4. Table displaying Henna’s CORE-OM Pre-Therapy and Post-Therapy 
Assessment Scores………………………………………………………………… 
 
156 
Table 4.5. Table displaying Henna’s RESI Pre-Therapy and Post-Therapy 
Assessment Scores………………………………………………………………… 
 
158 
Table 4.6. Table displaying Henna’s PIBQ Pre-Therapy and Post-Therapy 
Assessment Scores………………………………………………………………… 
 
160 
Table 4.7. Table displaying Henna’s FORSE Pre-Therapy and Post-Therapy 
Assessment Scores………………………………………………………………... 
 
162 
Table 4.8. Table displaying Henna’s Responses on the ARM-5.............................. 163 
 
1 
 
CHAPTER 1 
Sensory Symptoms in Rare Genetic Syndromes: A Systematic Review 
 
Abstract 
Introduction: Sensory modulation difficulties are now part of the Autism 
Spectrum Disorder (ASD) diagnostic criteria in the DSM-5. There is a high number of 
ASD symptomology in rare genetic syndromes, each with unique behavioural 
phenotypes and different profiles of ASD. Therefore, the diagnostic criteria changes 
will potentially have different assessment implications for assessing ASD in individuals 
with genetic syndromes.  
Method: A literature search was completed using twenty-two different 
syndromes and sensory modulation search terms. Sixteen papers examining seven 
syndromes; Angelman syndrome (AS), Down syndrome (DS), Fragile X syndrome 
(FXS), Phelan-Mc Dermid syndrome (PHMDS), Smith-Lemli-Opitz syndrome (SLOS), 
Smith Magensis syndrome (SMS) and Williams syndrome (WS), were included in the 
review. A quality assessment framework was developed and used to determine the 
validity and reliability of the research conclusions.  
Discussion: All of the syndrome groups displayed a range of sensory 
modulation difficulties, although the precise profile of the sensory symptoms was only 
reliably defined for FXS, WS (hyper-sensitivity) and AS (hypo-sensitivity). There was a 
lack of reliable research evidence to draw conclusions about the sensory profiles of the 
other syndromes. Hypotheses are discussed about the potential implications of the 
change in DSM-5 criteria in genetic syndromes. The limitations of the evidence base are 
described, including a lack of comparison groups, the use of single assessments 
methods with questionable validity and few longitudinal studies.  
2 
 
Introduction 
Autism Spectrum Disorder (ASD) is a behaviourally diagnosed 
neurodevelopmental disorder (WHO, 1992) estimated to occur in approximately 1% of 
the general population (Centres for Disease Control and Prevention, 2014). It has 
traditionally been defined by impairments in three domains: social interaction, 
communication and imagination (Wing and Gould, 1979)1. However, recently there has 
been a change in the most influential diagnostic criteria (and thus, arguably, the 
definition) of ASD. The Diagnostic and Statistical manual fifth edition (DSM-5; APA, 
2013) has combined the five previous subcategory diagnoses2 into one ASD diagnosis. 
In addition, the criteria now fall into two rather than three categories. These are: A: 
difficulties in social communication and interactions, and B: restricted and repetitive 
behaviours and interests (RRBI) (Appendix 1). For a diagnosis to be given, individuals 
need to display three symptoms from criterion A and two symptoms from criterion B in 
a child’s early development.  
 
There have been debates in the research literature about whether the DSM-5 has 
increased the reliability and specificity of ASD diagnoses. The Kulage, Smaldone and 
Cohen (2014) meta-analysis of the consequences of the DSM-5 criteria changes 
indicated a 31% reduction in ASD diagnoses. Grapel, Cicchetti and Volkmar (2015) and 
Volkmar, Klin, Siegel, Szatmari, Lord and Campbell (1994) suggest the DSM-5 now 
                                                        
1 Individuals with ASD may be described as ‘aloof’, lack affective expression and have a 
decreased interest in reciprocal social interactions. A lack of flexibility and difficulty adapting 
to changes in routines also characterises the diagnosis (Gerdts and Bernier, 2011). In addition, 
many people diagnosed with ASD display repetitive sensory and motor behaviours (Szatmari et 
al., 2006) and up to 70% of individuals with ASD also have an intellectual disability (ID) 
(Fombonne, 2003).  
2 Asperger’s disorder, Kanner’s syndrome (classic Autism disorder), pervasive developmental 
disorder-not otherwise specified, Rett’s syndrome and childhood disintegrative disorder.  
3 
 
has less discriminant validity. Conversely Mandy, Chairman and Skuse (2012) argue 
that the changes have increased the validity of diagnosis, as confirmatory factor analysis 
revealed that the two-factor model gave a better fit than the three-factor model to the 
presentation of individuals with ASD.  
 
One potentially important change in the DSM-5 ASD criteria is in the 
recognition of “sensory” symptoms, such as tactile, olfactory and taste over-
responsivity (Reynolds and Lane, 2008). Sensory symptoms were previously viewed as 
comprising a peripheral or co-morbid phenomenon in ASD, and thus were not formerly 
considered to be part of the diagnostic criteria for ASD in the DSM-IV (APA, 2000; 
Volkmar, Reichow and McPartland, 2012). However, in the DSM-5, they form part of 
the diagnostic criteria under the category of RRBI (the B set of criteria). Therefore, it is 
timely to consider sensory symptoms (Schaaf and Lane, 2015) and their role in ASD 
diagnoses.  
 
Baranek, Little, Perham, Ausderau, Sabatos-De-Vito (2014) and Schaaf and 
Lane (2015) have described how the different terminology used to describe sensory 
symptoms has led to a lack of clarity in the literature and suggest that future research 
should focus on the sensory modulation terms described in the DSM-5. Sensory 
modulation is defined as abnormal responses to sensory stimuli, which causes 
functional impairments and comprises three different categories: sensory over-
responsivity, under-responsivity and sensory-seeking. Sensory over-responsivity 
(hyper-sensitivity/low threshold) is demonstrated when individuals experience more 
intense sensory experiences and display distress, avoidance or hypervigilance in 
4 
 
response to sensory stimuli.  Sensory under-responsivity (hypo-sensitivity/high 
threshold) is demonstrated when an individual is unaware of, or is slower to respond to 
sensory stimuli, which, normally provokes a response in other individuals. Sensory-
seeking is demonstrated when an individual displays an unusual interest, preoccupation 
or need to experience certain sensory stimuli (Miller, Anzalone, Lane, Cermak and 
Osten, 2007). 
 
Dunn (1997; 2001) proposed a model of sensory modulation, which considers 
individuals’ neurological responses/thresholds and their behavioural responses/coping 
strategies. While some individuals may respond in accordance with their thresholds, 
others respond by attempting to adapt to their thresholds. Therefore, individuals can be 
described as residing in one of four quadrants that are based on two continuous 
dimensions. Firstly, individuals who have high thresholds for noticing sensory stimuli 
show a slow or lack of responsiveness (under-responsivity) and are passive in their 
coping style, are termed ‘low registration’, whereas those who are active in their coping 
strategies try to enhance their sensory experience, are termed ‘sensory seeking’. 
Individuals who have a low threshold, show a quicker and exaggerated responsiveness 
to sensory stimuli (over-responsivity) and are passive in their coping strategies (often 
making them appear lethargic), are termed ‘sensory sensitivity’. Those who are active in 
their coping strategies by trying to avoid or limit their sensory experience are termed 
‘sensory avoiding’ (Figure 1.1).  
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Figure 1.1: Dunn’s (1999) Model of Sensory Processing  
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This model is supported by different types of physiological responses to sensory 
stimuli for sensation seekers and avoiders (Brown, Tollefson, Dunn, Cromwell and 
Filion, 2001; Zuckerman, 1994). Individuals with high thresholds/reactivity display a 
reduced heart rate and an orienting response to sensory stimuli, which, as a result, 
means they are more able to receive and process sensory information, if the sensation is 
detected. Individuals with low thresholds/reactivity, on the other hand, display an 
increasing heart rate and fear.  
 
A large percentage (45-96%) of individuals with ASD have sensory difficulties 
(Baker, Lane, Angley and Young, 2008; Ben-Sasson et al., 2008; Klintwall et al., 2011; 
Leekam, Nieto, Libby, Wing and Gould, 2007; Tomchek and Dunn, 2007), across all 
sensory modalities (Baranek, David, Poe, Stone, and Watson, 2006; Lane, Dennis and 
Geraghty, 2011). Arguably, the severity of ASD symptoms relate to the severity of 
sensory symptoms in children, although not for adolescents or adults (Kern et al., 2007). 
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These sensory difficulties have not only been reported by the parents of individuals with 
ASD but by the individuals themselves (O’Neil and Jones, 1997; Williams, 1994). 
Furthermore, it has been suggested that the high levels of carer strain in parents/ carers 
of children with ASD are related to hyposensitivity and hypersensitivity specifically 
(Kirby, White and Baranek, 2016).  
 
Some studies have reported auditory over-responsivity (Gillberg and Coleman, 
1996), perhaps influenced by enhanced frequency discrimination (Jones et al., 2009), 
whereas, other research has shown auditory under-responsivity and atypical auditory 
attention and processing skills (Baranek, 1999; O’Connor, 2012; Magness, de Gelder, 
van England and Kemner, 2011). Tomchek and Dunn (2007) found that 77.6% of 
children with ASD had auditory sensitivities.  
 
Visual difficulties are reported in the literature, with numerous explanations and 
descriptions of processing difficulties. Specifically, reports describe perceptual 
alterations in face processing (Bachmann, Thomas and Humphreys, 2006), differences 
in eye gaze patterns (Deconinck, Soncarrieu and Dan, 2013) and a reliance on 
peripheral vision (Lord, Rutter and Le Couteur, 1994).   
 
There have been consistent findings of tactile over-responsivity, which is 
described as the most common sensory symptom, with individuals having difficulty 
with touch, clothes materials, grooming and personal hygiene tasks (Reynolds and 
Lane, 2008; Rogers, Hepburn and Wehner, 2003; Tomchek and Dunn, 2007), perhaps 
due to difficulties processing tactile information at the cortical level (Marco, Hinkley, 
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Hill and Nagarajan, 2011). Schaaf and Lane (2015) concluded individuals with ASD 
have a similar lower level somatosensory (e.g. pain and temperature) sensitivity 
threshold to typically developing (TD) individuals.  
 
Some individuals with ASD have high vestibular thresholds, whilst others have 
low. This is attributed to their vestibular processing difficulties and integration of 
sensory information (Kern et al., 2007), potentially contributing to observed motor-
control difficulties, including poor balance, unusual posture, sway, spin and difficulty 
moving on uneven ground (Vernazza-Martin et al., 2005).   
 
Taste and smell over-responsivity has been reported and accounts for a restricted 
food intake, as individuals with AD specifically avoid food with certain textures, tastes, 
temperatures and smells (Cermak, Curtin and Bandini, 2013; Twachtman-Reilly, 
Amaral and Zebrowski, 2008). Whilst there have been no differences found for 
olfactory discrimination (Tavassoli and Baron-Cohen, 2012), individuals with ASD are 
able to detect smells further away in comparison to TD individuals and the over-
responsivity is associated with greater ASD symptomology (Ashwin et al., 2014).  
 
Whilst the majority of sensory modulation research in ASD has focused on 
sensory over-responsivity (Baranek, David, Poe, Stone and Watson, 2006; Ben-Sasson 
et al., 2007; Tomchek and Dunn, 2007) the Ben-Sasson et al., (2009) review found that 
sensory under-responsivity difficulties had the highest prevalence. Overall, there is the 
suggestion that individuals with ASD present with a combination of under and over- 
responsivity (Hazen, Stornelli, O’Rourke, Koesterer and McDougall, 2014).  
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Factor analysis of the Sensory Profile (SP; Dunn, 1999) has revealed that 
children with ASD have four distinct sensory subtypes, which suggests there may be 
specific sensory phenotypes  (Lane, Young, Baker and Angley, 2010; Lane, Dennis and 
Geraghty, 2011; Lane, Molloy and Bishop, 2014). Specifically, there is a subset of 
children (25-40%; Ausderau et al., 2014) who do not experience significant difficulties 
and are thus, sensory adaptive. Secondly, others experience significant taste and smell 
sensitivities, hypo-reactivity, and sensory–seeking and auditory filtering difficulties. 
Whilst another cluster of children experience significant difficulties with low 
energy/weak features, with hypo-reactivity, sensory-seeking and auditory filtering 
difficulties. The final cluster of children experience generalised sensory difficulties in 
all sensory domains, although this is perhaps dependent on the time of assessment.  
 
There have been mixed results investigating sensory symptoms changes with 
age. Some authors report sensory symptoms have no relationship with age (Baranek, 
David, Poe, Stone and Watson, 2006). Therefore, suggesting sensory symptoms remain 
stable over time, except for slight differences based on developmental stage, for 
example, very young children (birth to six-months) are very responsive to tactile and 
oral stimuli (Dunn, 2001). However, retrospective research has reported that sensory 
symptoms in early development, including poor visual orientation, excessive mouthing 
and hypersensitivity to touch and hyposensitivity to auditory stimuli are able to predict 
a later diagnosis of ASD (Baranek, 1999; Goldsmith, Van Hulle, Arneson, Schreiber 
and Gernsbacher, 2006; Lane and Heathcock, 2014).  
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A meta-analysis reported that sensory symptoms increase until they reach a peak 
in children aged six to nine-years-old, and then subsequently decrease (Ben-Sasson et 
al., 2008). However, it has not been determined if this peak is due to environmental 
changes and stress (e.g. entering a school environment) and decreased as children 
develop coping strategies (Kern et al., 2006) due to a maturation process (Kern et al., 
2007) or a selection bias in research focusing only on school-age children, thus 
reporting higher incidence of difficulties in this age range (Baranek, Little, Perham, 
Ausderau and Sabatos-De-Vito, 2014). However, sensory modulation symptoms have 
been reported to continue into adulthood (Billstedt, Gillberg and Gillberg, 2007; Crane, 
Goddard and Pring, 2009).  
 
Individuals with ASD have higher rates of sensory symptoms compared to age 
and IQ matched individuals with developmental delay (DD) (Leekam, Nieto, Libby, 
Wing and Gould, 2007), although, having a lower IQ and more severe ASD 
symptomology are risk factors for developing sensory impairments (Liss, Saulnier, Fein 
and Kinsbourne, 2006; Lane, Young, Baker and Angley, 2010; Ben-Sasson et al., 2009; 
Leekam, Nieto, Libby, Wing and Gould, 2007). It is also hypothesised that executive 
functioning processes influence sensory modulation (Gazzaley and D’Esposito, 2007) 
via attentional control and flexibility to adapt behavioural responses to varying stimuli 
(Gillbert and Burgess, 2008)3. 
 
                                                        
3 Specifically, it has been suggested that sensory over-responsivity is due to over-focusing 
attention (Liss, Sauhier, Fein, Kinsbourbourne, 2006) and that under-responsivity is due to 
difficulties in allocating attention in a sensory environment (Schoen, Miller, Brett-Green and 
Nielsen, 2009). It is noteworthy that, one third of children with ASD would also meet diagnostic 
criteria in the DSM-IV for a diagnosis of ADHD (Simonoff, Pickles, Charman, Candler, Loucas 
and Baird, 2008). 
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In addition, RRBI are part of the diagnostic criteria for the DSM-5, and includes 
hand flapping, body rocking, covering eyes and ears, arranging things in certain orders 
and insisting on sameness (Bodfish, Symons, Parker and Lewis, 2000). Research has 
frequently demonstrated a strong relationship between increased severity of sensory 
symptoms and increased severity of RRBI, in particular, tactile, auditory and visual 
hyper-sensitivity (Chen and Rogers, 2009). Furthermore, self-injurious behaviour can 
be perhaps considered as a more severe form of stereotypic behaviour (Matson et al., 
1997) and sensory symptoms are reported to be the strongest predictor of self-injurious 
behaviour (Duerden, Tannock and Duckstader, 2012).  
 
Factor analysis has revealed five distinctive categories within the RRB 
constructs; repetitive sensory-motor/stereotypic behaviours, ritualistic/insistence on 
sameness behaviours, compulsive behaviours, restricted/circumscribed interests, self-
injurious behaviours (Bishop et al., 2013), and that sensory symptoms are specifically 
related to the first factor of repetitive sensory-motor/stereotypic behaviours (Esbensen, 
Seltzer, Lam, Bodfish, 2009; Mirenda et al., 2010). This factor is considered 
independent from the other factors, as it is more severe in younger children and 
improves with age, whereas, the other factors are not associated with age-related 
changes (Bishop, Richler and Lord 2006). Moreover, factor analysis of the Autism 
Diagnostic Interview (ADI), revealed that sensory symptoms and repetitive behaviours 
were on two distinct factors, which had a low inter-correlation between them 
(Tadevosyan-Leyfer et al., 2003).  
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However, the direction of the relationship between RRB and all three sensory 
modulation symptoms (hyper-sensitivity, hypo-sensitivity and sensory-seeking) is 
unknown, due to the lack of experimental evidence (Boyd et al., 2010). It is possible 
that repetitive sensory-motor/stereotypic behaviours could be a functional coping 
strategy to help regulate and manage sensory symptoms (Cunningham and Schreibman, 
2008; Leakam, Prior and Uljarevic, 2011; Liss et al., 2006). Therefore, suggesting RRB 
may have an underlying sensory origin (Rogers and Ozonoff, 2005). However, there are 
concerns regarding the criterion validity of assessments, as some assessments label 
items as assessing RRB on one scale, whereas, the same items are labelled as assessing 
sensory symptoms in another assessment measure (Gabriel et al., 2008). 
 
In addition, sensory symptoms in individuals with ASD are related to lower 
adaptive functioning and problem behaviours (Jasmin et al., 2009; O’Donnell, Dietz, 
Kartin, Nalty and Dawson, 2012). In particular, sensory hypersensitivity is a risk marker 
for problem behaviours (Lundqvist, 2013).  Furthermore, relationships have been 
reported between sensory symptoms and social communication and engagement (Hilton 
et al., 2010; Hochhauser and Engel-Yeger, 2010). Watson et al., (2011) found that more 
severe hypo-responsivity and sensory-seeking symptoms were associated with more 
severe social communication difficulties and language delays in both children with ASD 
and children with developmental delays.  
 
Research has also focused on the relationship between sensory symptoms and 
anxiety, not only due to the high comorbidity of anxiety in ASD (11-84%; White, 
Oswald, Ollendick, Scahill, 2009), but also due to the similarity between the two 
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constructs. Whilst anxiety and sensory symptoms (specifically over-responsivity) have 
independent clinical definitions, they can manifest behaviourally in similar ways, for 
example, individuals displaying avoidance and dysregulation. This is challenging for 
the observer to interpret the behaviour and to differentiate the two (Ben-Sasson, Carter, 
and Briggs-Gowan, 2009). 
 
The majority of research supports the notion that anxiety is the result of a 
behaviourally conditioned response to distress from sensory stimuli (over-responsivity) 
(Ben-Sasson et al., 2008). For example, in a longitudinal study of toddlers with ASD, 
sensory over-responsivity predicted anxiety a year later, although anxiety was not 
predictive of sensory over-responsivity (Green, Ben-Sasson and Soto, 2012).  
 
Children and adolescents with ASD and more severe sensory difficulties were 
also reported to have a lower mood, more withdrawal and separation anxiety (Ben-
Sasson et al., 2008; Brock et al., 2012). Specifically, adults with sensory defensiveness 
showed significant anxiety and depression (Kinnealey and Fuiek, 1999).  
 
Genetic Neurodevelopmental Syndromes 
As sensory modulation difficulties are not unique to ASD but are reported in ID 
populations with ASD symptomology (Engel-Yeger, Hardal-Nasser and Gal, 2011) and 
due to the high genetic heritability of individuals with a broader ASD phenotype (up to 
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90%; Geschwind, 2009)4, assessing the literature about sensory modulation in genetic 
neurodevelopmental syndromes may prove useful.  
 
As even similar ASD phenotypes do not involve the same genetic markers and 
not every individual with the predicted predisposing genotype developed ASD 
(Woodbury-Smith et al., 2015). There is also evidence that different gene defects may 
sometimes feed into similar molecular pathways in the development of ASD (Voineagu 
et al., 2011). Therefore, it is suggested that underlying genetic contributions are 
complex and interact with the foetal environmental and biological components, which 
develop more specific ASD phenotypes and increase the ASD prevalence in genetic 
syndromes (Marshall et al., 2008; May and Nadler, 2008). Abrahams and Geschwind 
(2008) suggested that genetic syndromes account for 10-20% of all individuals with 
ASD. Zafeiriou, Ververi, Dafoulis, Kalyva and Vargiami (2013) completed a systematic 
search and were able to identify reported rates of ASD symptomology in individuals 
with different genetic syndromes (Appendix 2). Recently, Richards, Jones, Groves, 
Moss and Oliver’s (2015) meta-analysis provided estimates of ASD phenomenology in 
twelve genetic syndromes, which ranged from 11% for individuals with 22q11.2 to 61% 
for individuals with Rett syndrome (Appendix 2)5. 
 
                                                        
4 Despite a lack of precise neuropathological markers (Freitag, 2007; Santangelo and Tsatsanis, 
2005; Voineagu, 2012), over 1000 genetic markers have been suggested (Alarcon et al., 2008; 
Ch’ng, Kwok, Rogic and Pavlidis, 2015; De Rubis et al., 2014;  Santangelo and Tsatsanis, 
2005), although, there is a lack of consistent results (Betancur, 2011; De Rubeis et al., 2014).   
5 There are numerous limitations to the research investigating ASD prevalence in genetic 
syndromes. Consequently, the reported prevalence of ASD diagnosis should only be regarded as 
an estimate of the presence of ASD symptoms (Charman and Gothman, 2013; Richards, Jones, 
Groves, Moss and Oliver, 2015). 
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Moreover, these specific ASD phenotypes are reported more consistently across 
genetic neurodevelopmental syndromes, each with a relatively specific genetic “cause”. 
Despite Kulage et al., (2014) suggesting research should focus on investigating the level 
of ID accounting for variation in diagnosis between the DSM versions. Moss, Howlin, 
Magiati and Oliver (2012) found that differences in ASD symptomology between 
individuals with ASD and Cornelia de Lange Syndrome (CdLS), were not a 
consequence of ID or language skills. They reported that individuals with CdLS 
displayed less repetitive behaviour, sensory interests, stereotyped speech and more eye 
contact and anxiety in comparison to individuals with idiopathic ASD. Highlighting that 
ASD associated with certain genetic neurodevelopmental syndromes differs from 
idiopathic ASD (Moss, Howlin and Oliver, 2011) raises the possibility that the effect of 
changes to the DSM-5 may be different for idiopathic ASD compared to different 
neurodevelopmental syndrome groups (Wheeler et al., 2015).  
 
Rationale and Aim 
 
The literature presented highlights why it is timely to examine the role sensory 
modulation has in ASD diagnosis due to the recent changes to the diagnostic criteria for 
ASD in the DSM-5 (Schaaf and Lane, 2015). Whilst some research has investigated the 
impact of the sensory modulation criteria in the DSM-5 for individuals with idiopathic 
ASD (Kulage, Smaldone and Cohen, 2014), there is a lack of research which has 
investigated the impact for individuals with genetic syndromes. The only study to report 
the implications for the DSM-5 changes was Wheeler et al., (2015) who found that 
significantly fewer individuals with Fragile X Syndrome (FXS) met criteria for DSM-5 
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(27.8%) compared to DSM-IV (38.7%). This reduction was predominantly due to fewer 
individuals meeting the communication/interaction criterion (A), since high percentages 
met the RRBI criterion (B).  
 
Therefore, the changes in the DSM-5 have implications for assessing ASD in 
individuals with genetic syndromes given that the manifestation of symptoms 
compatible with an ASD diagnosis in syndrome groups may differ from idiopathic 
ASD, it is possible that the implications of diagnostic changes differ for syndrome 
groups. Investigating sensory modulation in a range of syndromes with different ASD 
symptomology and behavioural phenotypes allows a unique exploration of the 
relationship between sensory modulation and other behavioural symptoms.  
 
In addition, exploring sensory modulation in genetic syndromes is fundamental 
to the clinical implications that sensory difficulties can have, including a reduced 
quality of life, a restriction on meaningful activity (Bundy, Shia, Qi and Miller, 2007; 
Engel-Yeger, 2008) and significant strain on carers (Kirby, White and Baranek, 2016). 
Moreover, there is a critical need for systematic studies of sensory modulation in 
different genetic syndromes to further understand sensory modulation phenotypic 
characterisation (Hildenbrand and Smith, 2011). Understanding of sensory symptoms in 
genetic syndromes associated with ASD will lead to a better understanding of causal 
pathways to behaviour, with implications for early interventions (Waite et al., 2014).  
 
The present systematic review aims to summarise and evaluate the research 
examining sensory modulation in individuals with rare genetic syndromes associated 
16 
 
with ID and ASD symptomology. The review will then evaluate if the addition of 
sensory modulation difficulties to the ASD criteria in the DSM-5 has implications for 
the potential diagnosis of ASD in genetic syndromes.   
 
Method 
Search Strategy  
In order to focus the systematic search on sensory symptoms and ASD, only 
genetic syndromes associated with ID were selected for which there have been recent 
reports of the raised prevalence of ASD phenomenology. Accordingly, the list of 
syndromes searched was developed from a recent review (Zafeiriou, Ververi, Dafoulis, 
Kalyva and Vargiami, 2013) and meta-analysis (Richards, Jones, Groves, Moss and 
Oliver, 2015) of ASD phenomenology in genetic syndromes. This resulted in twenty-
four syndromes being included in the search.  The Online Mendelian Inheritance in Man 
(OMIM, accessed 06.04.2016) database was used to ensure alternative syndrome names 
were included in the search.  
 
Schaaf and Lane (2015) have described how the different terminology used to 
described sensory symptoms has led to inaccuracy in the literature and suggest that 
future research focuses on the sensory modulation terms described in the DSM. 
However, other sensory processing terms were also used to ensure research articles 
were not missed. The sensory symptoms search terms included: sensory* modulation, 
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sensory* sensitivity, sensory* profile, sensory* information, sensory* processing, 
hypersensitivity* and hyposensitivity*6. 
 
Literature searches were conducted in Ovid PsycINFO (inclusion dates: 1967 to 
April Week 1 2016), Ovid MEDLINE (inclusion dates: 1946 to March Week 5 2016) 
and Ovid Embase (inclusion dates: 1974 to 2016 April 12) on 13.04.2016. A list of the 
syndrome group search terms are displayed in Table 1.1. Searches were conducted by 
combining all variations of the syndrome search terms with any sensory symptom 
search terms.  
 
                                                        
6 Preliminary additional search terms were used to describe each specific modality e.g. visual, 
auditory and olfactory. However, these terms resulted in a vast amount of cognitive processing 
related articles; therefore, the terms were excluded in the final search to increase the specificity 
of the search. 
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Table 1.1: The Search Process. 
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Angelman Syndrome Angelman* syndrome; Happy puppet syndrome; 
Isodicentric 15; Interstitial duplications syndrome; Maternal 
deletion 15q11 2-q13; UBE3A gene mutation 
16 6 0 3 0 2 2 1 2 0 2 
CHARGE Syndrome CHARGE syndrome; Hall-Hittner syndrome; HHS; Choanal 
atresia, retardation, genital and ear abnormalities; CHD7 
gene mutation; 8q12 2 chromosome; SEMA3E gene 
mutation; 7q21 11 chromosome 
16 4 0 4 8 0 0 0 0 0 0 
Chromosome 22q11.2 
Deletion Syndrome 
Chromosome 22q11 2 deletion syndrome; Distal 
chromosome 22q11 2 deletion syndrome 
0 0 0 0 0 0 0 0 0 0 0 
Chromosome 2q37 
Deletion Syndrome 
Chromosome 2q37 deletion syndrome; Albright hereditary 
osteodystrophy-like syndrome; Bachydactyly-mental 
retardation syndrome; BDMR; Chromosome 2q37.2 deletion 
0 0 0 0 0 0 0 0 0 0 0 
Cohen’s Syndrome Cohen* syndrome; Obesity-hypotonia syndrome; Pepper* 
syndrome; Prominent-incisors syndrome; COH1; CHS1; 
8q22 2 chromosome 
2 0 0 0 2 0 0 0 0 0 0 
Cornelia de Lange 
Syndrome 
Cornelia de Lange* syndrome; CDLS; CDL; CDLS1; De 
Lange* syndrome; Branchmann-De Lange* syndrome; 
BDLS; Brachmann* syndrome; typus degenerativus  
Amstelodamensis; NIPBL gene mutation; 5p13 2 
chromosome 
6 2 0 0 1 2 0 0 1 1 0 
DiGeorge syndrome DiGeorge* syndrome; CATCH22; 22q11 deletion 
syndrome; Hypoplasia of thymus and parathyrois; DGS;  
Chromosome 22q11.2 deletion syndrome; Chromosome 
40 5 2 9 12 12 0 0 0 0 0 
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22q11.21 deletion; TBX1 gene mutation 
Down Syndrome Down*; Down syndrome; Trisomy 21; DSCR; Transient 
myeloproliferative disorder; megakaryoblastic of Down 
syndrome; 21q22 3 chromosome; GATA1 gene mutation 
173 53 14 35 32 31 1 1 5 2 3 
Fragile X Syndrome Fragile X mental retardation syndrome; Fragile X syndrome; 
FXS; Martin-Bell* syndrome; Marker X syndrome; X-
linked mental retardation; marXq28 X-linked mental 
retardation; Macroorchidism; xq27 3 chromosome; FMR1 
gene mutation 
132 57 1 16 3 24 16 10 5 1 4 
Klineflter Syndrome Klinefelter* syndrome; Klinefelter’s syndrome; KS; 47XXY 
syndrome; XXY syndrome 
12 4 0 1 3 4 0 0 0 0 0 
Neurofibromatisis 
Type 1 
Neurofibromatosis*; Neurofibromatosis type 1; 
Neurofibromatosis 1; NF1; NF-1 gene; Peripheral 
Neurofibromatosis; Neurofibromin; Recklinghausen disease;  
114 25 1 32 19 21 2 1 1 1 0 
Noonan’s Syndrome Noonan* syndrome; Female pseudo-Turner syndrome; Male 
Turner* syndrome; Turner phenotype with normal 
karyotype; pterygium colli syndrome; 12q24 13 
chromosome; PTPN11 gene mutation 
19 4 0 9 1 5 0 0 0 0 0 
Phelan-McDermid 
Syndrome 
Phelan-McDermid* Syndrome; PHMDS; Chromosome 
22q13.3 deletion syndrome; Telomeric 22q13 monosomy 
syndrome; SHANK3 gene mutation  
6 0 0 0 0 3 2 0 1 0 1 
Potocki-Lupski 
Syndrome 
Potocki-Lupski* syndrome; PTLS; Chromosome 17p11 2 
deletion syndrome 
3 0 0 2 1 0 0 0 0 0 0 
Prader Willi 
Syndrome 
Prader-Willi* syndrome; PWS; Prader-Labhart-Willi 
syndrome; Prader-Willi chromosome region; PCR; Prader-
19 5 0 6 2 4 2 0 0 0 0 
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Willi-like syndrome associated with chromosome 6; 
Isodicentric 15; Interstitial duplications syndrome; Paternal 
15q112 chromosome; imprinted NDN gene; imprinted 
SNRPN gene 
Rett Syndrome Rett* syndrome; Rett disorder; RTS; RTT; Autism-
dementia; Ataxia; Loss of purposeful hand use syndrome; 
xq28 chromosome; MECP2 gene mutation 
115 36 1 28 46 2 1 1 0 0 0 
Smith-Lemli-Opitz 
Syndrome 
Smith-Lemli-Opitz* syndrome; SLOS; SLO syndrome; RSH 
syndrome; Rutledge lethal multiple congenital anomaly 
syndrome; Lethal acrodysgenital syndrome; 11q13 
chromosome; DHCR7 gene mutation 
46 5 1 5 27 5 1 0 1 0 1 
Smith-Magenis 
Syndrome 
Smith-Magenis* syndrome; SMS; Chromosome 17p11 2 
deletion syndrome; Smith-magenis chromosome region; 
SMCR; RAI1 gene mutation 
32 10 2 2 13 3 0 0 2 0 2 
Soto Syndrome Soto* syndrome; STOT1; Sotos syndrome; Cerebral 
gigantism; Chromosome 5q35 deletion syndrome; 
chromosome 5q35 3 deletion; NDS1 gene mutation 
1 0 0 1 0 0 0 0 0 0 0 
Timothy Syndrome Timothy* syndrome; Long QT syndrome with syndactyly; 
Long QT syndrome; LQT8; 12p13 33 chromosome; 
CACNA1C gene mutation 
0 0 0 0 0 0 0 0 0 0 0 
Tuberous Sclerosis 
Complex 
Tuberous sclerosis* syndrome; Tuberous sclerosis complex; 
TSC; TS; TSC1 gene mutation; Harmartin; 9q34 
chromosome 
58 10 8 20 11 10 0 0 0 0 0 
Turner Syndrome Turner* syndrome; Ullrich-Turner syndrome; Gonadal 
dysgenesis; 45X syndrome; X chromosome deletion 
22 7 0 4 9 2 0 0 0 0 0 
 2
1
 
 
Syndrome  
 
Syndrome Search Terms 
R
ec
o
rd
s 
id
en
ti
fi
ed
 t
h
ro
u
g
h
 
d
a
ta
b
a
se
 s
ea
rc
h
 
D
u
p
li
ca
ti
o
n
s 
re
m
o
v
ed
 
N
o
n
-E
n
g
li
sh
 l
a
n
g
u
a
g
e 
jo
u
rn
a
ls
 r
e
m
o
v
ed
 
N
o
n
 e
m
p
ir
ic
a
l 
p
ee
r 
re
v
ie
w
e
d
 j
o
u
rn
a
ls
 r
e
m
o
v
ed
 
A
rt
ic
le
s 
n
o
t 
re
la
te
d
 t
o
 e
a
ch
 
sy
n
d
ro
m
e 
re
m
o
v
ed
 
A
rt
ic
le
s 
n
o
t 
re
la
te
d
 t
o
 
se
n
so
ry
 m
o
d
u
la
ti
o
n
 
re
m
o
v
ed
 
A
n
im
a
l 
st
u
d
ie
s 
re
m
o
v
ed
 
A
rt
ic
le
s 
w
it
h
 n
o
 b
eh
a
v
io
u
ra
l 
d
a
ta
 r
e
m
o
v
ed
 
F
u
ll
 t
ex
t 
a
rt
ic
le
s 
a
ss
es
se
d
 f
o
r 
el
ig
ib
il
it
y
 
E
x
cl
u
d
ed
 a
ft
er
 f
u
ll
 t
ex
t 
re
a
d
 
d
u
e 
to
 a
 l
a
ck
 o
f 
se
n
so
ry
 d
a
ta
 
A
rt
ic
le
s 
in
cl
u
d
ed
 i
n
 r
ev
ie
w
 
Velocardiofacial 
syndrome 
VCF; VCFS; Velocardiofacial* syndrome; Velo-cardio-
facial syndrome; Takao VCF syndrome; Shprintzen VCF 
syndrome; Chromosome 22q11 2 deletion syndrome; TBX1 
gene mutation 
8 0 0 2 3 2 0 1 0 0 0 
William’s Syndrome William* syndrome; Beuren* syndrome; Williams-Beuren* 
syndrome; WBS; Chromosome 7q11 23 deletion syndrome 
64 25 3 16 4 12 0 1 4 1 3 
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Inclusion and Exclusion Criteria 
Research was included if it was available in English and published in a peer-
reviewed journal. Furthermore, research was included if it involved the specific 
syndrome being searched and included human participants. Articles which assessed 
sensory modulation and included behavioural data were included, due to 
recommendations made by previous research to focus on the terminology used in the 
DSM-5 and explore functional impairment and behavioural responses to sensory stimuli 
(Schaaf and Lane, 2015). Thus, articles were excluded which assessed early sensory 
processing at the neuroanatomical level, including assessment of higher cognitive 
operations such as visual and auditory memory and attentional processes at the primary 
and secondary cortices (Light, Swerdlow and Braff, 2007). Finally, some ASD 
assessment measures contain some items regarding sensory symptoms, including the 
Autism Diagnostic Observation Scale (ADOS; Lord et al., 2000) and the Childhood 
Autism Rating Scale (CARS; Schopler and Van Bourgondien, 2010). However, 
research articles that contained these ASD assessments were reviewed to determine if 
there was an adequate amount of specific sensory data was displayed, if not research 
containing only these measures was excluded, as the focus of the research was not 
related to sensory modulation. Therefore, only research that included comprehensive 
measures of sensory symptoms were included (Rogers and Ozonoff, 2005; Table 1.2).  
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Table 1.2: Inclusion and Exclusion Criteria.  
Inclusion Criteria Exclusion Criteria 
Articles published or available in English Articles published in a language other 
than English 
Empirical peer-reviewed papers Conference proceedings, magazines, 
dissertations, review articles and books  
Related to the specific syndrome Articles related to any other difficulties or 
stimuli 
Related to sensory modulation Articles related to any other difficulty or 
stimuli 
Human participants only Animal studies 
Contains behavioural data Contains gene, brain imaging or 
biological data only 
Adequate amount of sensory data Insufficient amount of sensory data to 
draw meaningful conclusions 
 
 
Selection Strategy 
A total of 904 papers were identified by the searches. The titles and abstracts 
were screened for suitability using the inclusion and exclusion criteria. Twenty-two full 
texts were read to determine suitability and six were excluded, due to insufficient 
sensory modulation results to aid discussion.  
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Results  
Participants 
The articles in the review included individuals with seven genetic syndromes 
(Table 1.3). Two studies included individuals with Angelman Syndrome (AS), three 
studies included individuals with Down Syndrome (DS), four studies included 
individuals with FXS, one study included inviduals with Phelan-Mc Dermid Syndrome 
(PHMDS), one study included inviduals with Smith-Lemli-Opitz Syndrome (SLOS), 
two studies included individuals with Smith-Magensis Syndrome (SMS), and three 
studies individuals with Williams Syndrome (WS). Each genetic syndrome is defined 
by a unique behavioural phenotype with different ASD symptomology (Table 1.3).  
 
Specifically, AS, is defined by sensory-seeking behaviours and an excessive 
happy demeanour, with 34% of individuals displaying ASD symptomology (Oliver, 
Horsler, Berg, Bellamy, Dick and Griffiths, 2007; Richards et al., 2015). Individuals 
with DS display motor difficulties and fewer behavioural difficulties and the least 
frequency of ASD symptomology (16%; Chapman and Hesketh, 2000; Richards et al., 
2015). The behavioural phenotype of FXS includes, hyperactivity and social anxiety, 
with 22% of individuals displaying ASD symptomology (Hagerman and Hagerman, 
2002; Richards et al., 2015). The SMS behavioural phenotype includes aggressive and 
repetitive behaviours and nighttime arousal, with a large number of individals 
displaying ASD symptomology (68.4%; Arron, Oliver, Berg, Moss and Burbidge, 2011; 
Zafeirous et al., 2013). Individuals with WS have an over-social personality and fewer 
displays of ASD symptomology (12%; Jarvinen-Pasley et al., 2008; Richards et al., 
 25 
 
2015). The age of participants ranged from three months- thirty-two-years old, although 
the age range was not reported by Horvat, Croce and Zagrodnik (2010). 
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Table 1.3: Descriptions of Genetic Syndromes. 
 
Syndrome Number of 
Articles 
investigating 
the Syndrome 
Genetic 
Mechanisms 
Estimated 
Prevalence 
Behavioural Phenotype Prevalence of 
ASD 
symptomology 
Description of ASD Symptomology 
Angelman 
Syndrome 
(AS) 
2 Loss of 
functioning in the 
UBE3A gene on 
the maternally 
driven 
chromosome 15, 
predominantly 
due to deletions or 
imprinting errors 
(Kishino, Lalande 
and Wagstaff, 
1997). 
One in 
10,000-20, 
000 live 
births 
(Williams, 
2005) 
Severe ID, speech and 
language delays, epilepsy, 
sleep difficulties, ataxic 
gait, sensory-seeking 
behaviours and an 
excessive happy 
demeanour and laughing 
(Oliver, Horsler, Berg, 
Bellamy, Dick and 
Griffiths 2007; Williams et 
al., 2006).  
 
34% (Richards et 
al., 2015) 
50-61% 
(Zafeirous et al., 
2013). 
Peters, Beaudet, Madduri and Bacino (2004) 
found that individuals with AS, despite 
displaying excessive laughing, can still lack 
social engagement and interaction skills. 
However, other research has reported that 
individuals with AS show appropriate social 
reciprocity, and emotional contact (Clayton-
Smith and Lann, 2003; Thompson and Bolton, 
2003) and less stereotyped and repetitive 
behaviours compared to individuals with 
idiopathic ASD. Trillingsgaard and Ostergaad 
(2004) argue that ASD in AS is over-
diagnosed due to individuals’ ID and 
developmental delay.  
 
Down 
Syndrome 
(DS) 
37 An additional 
copy of 
chromosome 21 
(trisomy 21), 
which includes 
genes DYRK1A, 
RCAN1, SIM2 
and GIRK2. 
18.2 in 
10,000 still 
births, live 
births and 
terminated 
pregnancies 
(Cocchi et 
al., 2010) 
Mild to severe ID, 
difficulties with motor 
function, language delays 
and fewer behavioural 
difficulties, compared to 
other genetic syndromes 
(Chapman and Hesketh, 
2000).  
 
16% (Richards et 
al., 2015) 
16-19% 
(Zafeirous et al., 
2013) 
Research has reported that individuals with 
DS and ASD have a similar symptomology to 
individuals with idiopathic ASD, aside from 
individuals with DS being slightly more 
engaged in their environment. (Moss, 
Richards, Nelson and Oliver, 2012). It has 
also been found that the more severe the ID 
and seizures the more likely individuals with 
DS would have a co-morbid diagnosis of ASD 
(Capone, Grados, Kaufmann, Bernard-Ripoll 
and Jewel, 2005; Molloy et al., 2009). 
Fragile X 
Syndrome 
4 The silencing of 
the FMR1 gene at 
One in 5,160 
male births 
Hyperactivity, impulsivity, 
attention difficulties, 
22% (Richards et 
al., 2015) and 15-
The ASD symptomatology in FXS is different 
from idiopathic ASD (Kerby and Dawson, 
                                                        
7 Rogers, Hepburn and Wehner, 2006, also included individuals with DS, although there were no individual data for this syndrome group. 
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Syndrome Number of 
Articles 
investigating 
the Syndrome 
Genetic 
Mechanisms 
Estimated 
Prevalence 
Behavioural Phenotype Prevalence of 
ASD 
symptomology 
Description of ASD Symptomology 
(FXS) chromosome 
Xq27.3, leading 
to production of 
the Fragile X 
mental retardation 
protein (FMRP), 
which is 
associated with 
ID (Kaufmann 
and Reiss, 1999)8 
(more 
severely 
affected) 
(Coffee et 
al., 2009) 
and one in 
8000 female 
births 
(Sherman, 
2002). 
anxiety, shyness, 
aggression, moderate ID, 
SIB, hand-flapping and 
hypersensitivity 
(Hagerman and Hagerman, 
2002).  
 
52% (Zafeirous et 
al., 2013) 
1994). As a group, people with FXS are more 
able to recognise emotional expression (Turk 
and Cornish, 1998) and display better theory 
of mind skills (Mazzocco, Pennington and 
Hagerman, 1994).  
 
Phelan-Mc 
Dermid 
Syndrome 
(PHMDS)  
1 A deletion or 
mutation of 
chromosome 
22q13, which 
includes the 
SHANK3 gene 
that contains 
protein-building 
properties 
necessary for 
glutamatergic 
synapses (Durand 
et al., 2007). 
Unknown 
(Soorya et 
al., 2013). 
There is a lack of details 
about the behavioural 
phenotype, although, it 
does include ID, motor 
skill difficulties and 
delayed or absent speech 
(Soorya et al., 2013). 
 
50% (Zafeirous et 
al., 2013). 
Preliminary research has suggested that the 
ASD symptomology is somewhat unique in 
that individuals with PHMDS display greater 
difficulties in social interaction and 
communication, but less difficulties with 
repetitive behaviour and restricted interests 
(Philippe et al., 2008; Phelan and McDermid, 
2012). It has been suggested that the level of 
developmental delay significantly contributes 
to a co-morbid ASD diagnosis and that 
smaller deletions in PHMDS are not 
associated with greater impairments in social 
communication deficits (Oberman, Boccuto, 
Cascio, Sarasua, and Kaufmann, 2015).  
 
 
Smith-
Lemli-Opitz 
1 An inborn error of 
cholesterol 
One in 
20,000-
ID, hyperactivity, 
repetitive behaviour and 
53-57% 
(Zafeirous et al., 
Sikora, Pettit-Kekel, Penfield, Merkens and 
Steiner (2006) reported that individuals with 
                                                        
8  The gene normally contains 5-50 repetitions of cytosine-guanine-guanine (CGG). Some individuals’ genes may contain 50-200 CGG sequences, and 
these people are known as premutation carriers and may have no symptoms. Individuals with FXS have the full mutation and have more than 200 CGG 
sequences. 
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Syndrome Number of 
Articles 
investigating 
the Syndrome 
Genetic 
Mechanisms 
Estimated 
Prevalence 
Behavioural Phenotype Prevalence of 
ASD 
symptomology 
Description of ASD Symptomology 
Syndrome 
(SLOS) 
metabolism, due 
to mutations in 
gene DHCR7 on 
chromosome 
11912-13, which 
consequently 
causes 
abnormalities in 
embryonic and 
fetal somatic 
development 
(Tierney, 
Nwokoro and 
Kelley, 2000). 
80,000 live 
births 
(Kelley and 
Hennekam, 
2006). 
self-injurious behaviour 
(Ryan et al., 1998; Porter, 
2008). 
2013) SLOS and ASD have specific impairments in 
communication, relative to their social 
interaction skills. However, it has not been 
established if this is a true reflection of the 
ASD symptomology in this syndrome or an 
artefact of a small sample.  
 
Smith 
Magensis 
Syndrome 
(SMS) 
2 A deletion or 
mutation of 
chromosome 
17p11.2 9, which 
includes the RA1 
gene (Elsea and 
Girirajan, 2008; 
Vlangos, Wilson, 
Blancato, Smith 
and Elsea, 2005) 
One in 
25,000 live 
births (Juyal 
et al., 1996) 
Severe to moderate ID 
(Udwin, Webber and Horn, 
2001), aggression, self-
injurious behaviours, 
repetitive behaviours 
(Arron, Oliver, Berg, Moss 
and Burbidge, 2011) and 
sleeping difficulties, 
specifically daytime 
sleepiness and nighttime 
arousal (Gropman, Elsea, 
Duncan and Smith, 2007).  
 
68.4% (Zafeirous 
et al., 2013) 
Research suggests that severity of ASD 
symptoms in individuals with SMS are in the 
mild (Martin, Wolters and Smith, 2006) to 
moderate range (Wolters et al., 2009). It has 
also been suggested that the ASD 
symptomology in SMS is defined by 
considerable repetitive behaviours, yet only 
mildly affected social communication skills 
(Fidler, Philofsky and Hepburn, 2006; Udwin, 
2002).  
 
Williams 
Syndrome 
(WS) 
3 A deletion on 
chromosome 
7q11.23 
containing 21 
genes, which 
One in 7,500 
live births 
(Stromme, 
Bjornstad 
and 
Mild ID, an ‘over-social’ 
personality with 
exaggerated tendency to 
approach others (Jarvinen-
Pasley et al., 2008). It is 
12% (Richards et 
al., 2015) to 50% 
(Zaferious et al., 
2013) 
Authors have suggested that actually WS and 
ASD are ‘opposite’ disorders (Peterson and 
Panksepp, 2004). Individuals with WS have 
more typical face-processing (Lincoln et al., 
2007) and greater social engagement skills, 
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Syndrome Number of 
Articles 
investigating 
the Syndrome 
Genetic 
Mechanisms 
Estimated 
Prevalence 
Behavioural Phenotype Prevalence of 
ASD 
symptomology 
Description of ASD Symptomology 
includes the ELN 
gene (Osborne, 
2006). 
Ramstad, 
2002). 
noteworthy that in WS 
auditory hypersensitivity 
and a strong interest in 
music (Levitin, Cole, 
Chiles, Lai, Lincoln and 
Bellugi, 2004; Levitin, 
2005) is recognised as part 
of the behavioural 
phenotype.  
but display the same vocabulary strengths and 
difficulties with language pragmatics seen in 
individuals with ASD (Asada and Itakura, 
2012).  
 
 30 
 
Articles 
The review includes sixteen articles published between 1999-2016 (Table 1.4). 
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Table 1.4: Descriptions of the Articles Included in the Review. 
 
Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
Baranek, 
Chin, 
Greiss, 
Hess, 
Yankee, 
Hatton and 
Hooper 
(2002) 
n=15 males 
with FXS 
(mean age=53 
months) 
1. Sensory Profile 
(SP) 
2. Tactile 
Defensiveness 
and 
Discrimination 
Test Revised 
(TDDT-R), has 
subscales for 
internally and 
externally 
controlled 
tactile 
experiences. 
3. Sensory 
Approach-
Avoidance 
Rating (SAAR; 
observational 
method 
developed by 
the authors) 
 
 
1. Brief IQ 
2. Vinelands Adaptive 
Behavioural Scale 
(VABS)- only daily 
living skills subscale.  
3. School Function 
Assessment (SFA) 
Teacher 
completed SFA, 
parent completed 
SP and self-help 
skills on VABS. 
Researchers 
completed 
observation 
methods.  
 
SAAR- children 
presented with 
nine 
multisensory toys 
and their level of 
approach or 
avoidance rated 
(used as sensory 
observation). The 
amount of time 
the child engaged 
with toys (used 
as a functional 
play assessment) 
1. BriefIQ in the ‘mild’ range (mean=60), 
although considerable variability n=7 3-
4 SD below mean, n=3 2-3 SD below 
mean, n=1 normal range, 1 unable to 
test. 
2. SP not related to TDDT-R or SAAR.  
3. SP- overall total ‘definite’ differences. 
‘Typical’ performance n=2, ‘probable’ 
difference n=2.  
4. No normative data for TDDT-R and 
SAAR, although authors suggest these 
would be at floor level (0).  
5. TDDT-R- near floor n=2, few concerns 
n=3, others varying levels, high levels 
of aversion/ avoidance n=4.  
6. VABS- mean=56.4, all except 1 fell 
more than 2SD below mean. 
7. SFA- All low, except full participation 
n=3 (100), (93) n=1.  
8. Relationship between TDDT-R and 
VABS- higher aversive- avoidance 
reactions to tactile stimuli related to less 
independence in ADL.  
9. Relationship between SAAR and SFA- 
higher aversive- avoidance behaviours 
lower school function (less 
engagement). 
10. Relationship between SAAR with play 
duration- Higher aversion- avoidant less 
time engaging with toys.  
Baranek, 
Roberts, 
n=13 
children with 
1. The Sensory 
Processing 
1. Mullen Scales of 
Early Learning 
Initially assessed 
at nine-twelve-
1. Children displayed increasing SP 
difficulties over time in SEQ, SPA and 
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2
 
 
Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
David, 
Sideris, 
Mirrett, 
Hatton and 
Bailey 
(2008) 
FXS. Mean 
chronological 
ages across 
assessments= 
nine, twelve, 
eighteen, 
twenty-four, 
thirty-six and 
fifty-four-
months. 
Assessment for 
young children 
(SPA) 
2. Sensory 
Experience 
Questionnaire 
(SEQ) 
3. Test of Sensory 
Function in 
Infants (TSFI) 
4. Baseline heart 
activity whilst 
playing before 
assessments 
5. Inter-beat- 
interval (IBI; 
measure of 
arousal) and 
vagal tone 
(measure of 
neural 
regulation of 
heart activity 
associated with 
parasympatheti
c influences) 
(MSEL) 
2. FMRP DNA 
analysis (n=10) 
 
months old and 
needed at least 
one more 
assessment 
between eighteen 
to sixty-five-
months-old Total 
forty-five 
assessments 
(two-six per 
child).  
Parents 
completed 
questionnaires, 
researcher 
completed 
observation 
methods.  
TSFI.  
2. >90% in TSFI and 70-80% in SPA 
obtained scores indicating high risk or 
deficient performance at nine, twelve 
and eighteen-months old.  
3. None displayed deficient scores at nine-
months, at fifty-four months >40% did.  
4. Only the SPA hyper-responsiveness 
scale increased with chronological age.  
5. The SEQ hypo-responsiveness scale 
decreased with increased cognition.  
6. The TSFI hypo-responsiveness scale 
decreased with increased age and 
cognition.  
7. At nine-months, children with low 
cognition showed more hypo-
responsiveness on TSFI compared to 
children with high cognition. By 
eighteen-months differences were no 
longer significant.  
8. SEQ hypo-subscale decreased at a 
greater rate initially for children with 
lower gross-motor abilities.  
9. TSFI hypo-responsivity decreased from 
children aged at nine-month. Children 
with lower gross motor skills had fewer 
hypo-symptoms than children with 
higher gross motor abilities, but by 
eighteen-months, scores converged.  
Bruni, 
Cameron, 
Dua and 
Noy (2010) 
n=75 children 
with Down 
Syndrome 
(53% 
response rate), 
1. Short Sensory 
profile (SSP) 
2. Parental 
Questionnaire 
(PQ) 
N/A Questionnaires 
posted to parents 
to complete.  
Used constant 
comparative 
1. SP- 49% ‘definite’ differences in 
comparison to normative sample.  
2. Largest differences in low energy/weak 
(69%), under-responsive/ seeks 
sensation (48%) and auditory filtering 
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Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
n=37 male. 
Inclusion 
criteria three 
to ten-years, 
mean age 
missing.  
method to 
identify themes 
in open-ended 
questions in PQ.  
(43%) 
3. ‘Typical’ performance in taste/smell 
sensitivity (68%) and movement 
sensitivity (64%). 
4. PQ- 55% parents spent time trying to 
increase child interests in play and 
participation.  
5. 16% SP significant impact on family 
life, 37% moderate impact on daily life.  
6. Five strategies identified to manage 
sensory difficulties: Seek sensory 
modulation, intolerance to touch during 
ADL, avoidance of environment 
triggers (19%), routines and transitions, 
developmental phrases ‘growing out of 
difficulties’. 
Hildenbran
d and Smith 
(2011) 
n=41 children 
with Smith-
Magenis 
Syndrome, 
n=7 excluded 
due to not 
returning 
forms. n=34 
children 
(mean 
age=6.85 
years).  
Divided into 
two age 
groups 
(younger: 
three-five 
years, older: 
1. Sensory profile 
(SP) and SP 
supplement 
N/A Parents 
completed the 
questionnaire and 
nine participants 
in the younger 
group were 
followed up 
(two-three years 
later) and parents 
completed the 
questionnaire 
again, compared 
to normative 
data. 
1. Significant ‘definite’ differences in 
all sensory profile quadrants and 
modulation areas compared to 
normative data. 
2. ‘Probable’ differences in oral, 
visual and auditory processing. 
3. ‘Definite’ differences in 
multisensory, touch and vestibular 
processing. 
4. Stereotypic behaviours’ difficulties 
observed in less than 50%. 
5. More than 50% had weak muscle 
tone due to lethargy. 
6. Three-five year olds closer to 
norms. 
7. In the longitudinal data, there was a 
trend to more sensory difficulties as 
children grew older, although only 
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Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
six-fourteen 
years) 
significant for sensation-seeking.  
8. Interaction effect of age and gender 
in modulation of sensory input 
affecting emotional responses. 
Older females had the most 
difficulties.  
Horvat, 
Croce and 
Zagrodnik 
(2010) 
n=8 children 
with mild 
intellectual 
disability (ID, 
mean age= 
16.5 years), 
n=8 with 
Down 
Syndrome 
(DS, mean 
age=17.5 
years) 
(identified on 
school 
education 
plans) and 
n=8 without 
intellectual 
disability (TD 
mean 
age=17.7 
years), n=4 
Males in each 
group (age 
range not 
reported) 
1. 
Computerised 
dynamic 
posturography 
performed on 
NeuroComEqit
estSystem using 
Sensory 
Organisation 
Test (SOT) 
protocol. 
N/A SOT tested under 
six sensory 
conditions, each 
three times for 
twenty seconds. 
Conditions 
differed 
depending on 
manipulation of 
somatosensory, 
visual and/ or 
vestibular 
environments 
and resulting 
movements 
measured. 
1. No significant difference between 
groups when no sensory information 
was compromised. 
2. No significant difference in gender 
3. TD significantly higher than ID and DS 
and MID higher than DS on condition 
with inaccurate somatosensory 
information and only accurate 
vestibular information.  
4. TD significantly higher than DS, but 
not ID in three conditions: 1. Inaccurate 
vision, accurate vestibular and 
somatosensory information. 2. 
Inaccurate somatosensory information 
but accurate vestibular and vision 
information. 3. Inaccurate vision and 
somatosensory and vision information, 
but accurate vestibular information.  
5. No significant difference between 
groups in somatosensory scores. 
6. TD and ID higher than DS for visual 
sensitivity. 
7. TD higher than ID and DS, and ID 
higher than DS for vestibular 
sensitivity.  
8. Conclusion- ID and DS worse 
movement abilities when visual, 
vestibular and somatosensory 
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Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
information is disrupted.  
Janes, Riby 
and Rogers 
(2014) 
n=21 children 
with Williams 
syndrome 
(72% consent 
rate). n=12 
male, six-
fifteen-years, 
mean age=9.3 
years. 
1. Short Sensory 
Profile (SSP) 
2. The 
Assessment of 
Sensory 
Processing, 
Repetitive 
behaviour, 
Anxiety, Fear 
in Williams 
Syndrome- 
Semi Structured 
Interview 
(SRAF-SSI) 
 
1. Wechsler 
Intelligence Scale 
for Children (WISC) 
SP posted to 
parents, 
researcher 
completed WISC 
and interview 
with parents.  
1. FSIQ= 52.6 
2. SP mean= ‘definite’ differences range.  
3. Results of thematic analysis of SRAF-
SSI: 
 Vestibular hypersensitivity- 
n=11 oversensitive to body 
movements, n=13 
improvement over time, n=6 
impacts on family life ‘often’ 
or ‘always’.  
 Proprioceptive 
hypersensitivity- n=14 
difficulties, n=11 
improvements over time, n=8 
impacts on family life ‘often’ 
or ‘always’. 
 Auditory hypersensitivity- 
n=14 reported over- sensitive 
to auditory stimuli often or 
always, n=9 improvements 
over time, n=10 impacts on 
family life ‘often’ or ‘always’. 
 Gustatory hypersensitivity- 
n=16 difficulties, n=5 
improvements over time, n=12 
impacts on family life ‘often’ 
or ‘always’. 
 Repetitive behaviours- n=18 
difficulties, n=11 worsened 
over time.  
 Unusual interests- n=14 
difficulties, n=12 stable over 
time.  
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Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
 Special hobbies- n=17 
difficulties, n=12 stable over 
time.  
 Majority indicated anxiety was 
a trigger for RB, and explained 
relationship between SP and 
RB.  
 No hyposensitivity reported.  
 No difficulties with tactile, 
visual and olfactory sensitivity. 
 
John and 
Mervis 
(2010) 
n=78 children 
with 
Williams 
Syndrome 
(mean age= 
6.53 years, 
age range= 
4.0-10.95 
years) 
1. Short Sensory 
Profile (SP) 
 
1. Short Sensory Profile 
(SP) 
2. Kaufman Brief 
Intelligence Test (KBIT-
2) 
3. Peabody Picture 
Vocabulary Test (PPVT) 
4. Behaviour Rating 
Inventory of Executive 
Functioning (BRIEF) 
5. Children’s Behaviour 
Questionnaire (CBQ) 
6. Scales of Independent 
Behaviour-Revised (SIB-
R) 
7. Conners Parent Rating 
Scale Revised (CPRS) 
 
Parents 
completed 
questionnaires 
and researchers 
administered 
KBIT-2 and 
PPVT on 
children. 
1. SP results: 9.9% ‘typical’, 56.3% 
‘definitely problems’, (auditory 
filtering, low weak/energy, under-
responsive/ seeks sensations), 33.8% 
‘probably problems’.  
2. Two clusters identified- high sensory 
impairments and low sensory 
impairments (classified 98.6% of cases) 
on significant difference on age, KBIT-
2 or PPVT. 
3. High sensory impairments clusters 
worse scores on BRIEF (executive 
function), CBQ (temperament), SIB-R 
(independence) and CPRS-R 
(Oppositional, anxious, social problems, 
restless-impulsive and inattentive). 
4. Executive functioning had strongest 
relation to sensory modulation 
impairments (46% variance), then 
temperament (31% variance), then 
adaptive functioning (25% variance) 
and problem behaviour (25% variance).  
Mieses et n=24 children 1. Short Sensory 1. Mullen Scales of Researchers 1. 95% of children with PHMDS met 
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(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
al., (2016) with PHMDS 
(63% male, 
mean age=5.4 
years, 
range=two-
six-years). 61 
children with 
ASD (82% 
male, mean 
age=4.6 years, 
age 
range=two-
ten-years).  
Profile (SSP) 
 
Early Learning 
(MSEL) 
completed the 
MSEL to 
determine 
intellectual 
functioning. 
Parents 
completed SSP.  
criteria for ASD. 
2. Children with ASD and PHMDS had a 
nonverbal developmental quotient 
(NVDQ) score of <70.  
3. 80% of children with PHMDS and 81% 
of children with ASD had ‘probable’ or 
‘definite’ differences in sensory 
modulation.  
4. Children with PHMDS had ‘typical’ 
performance in visual/auditory 
sensitivity, ‘probable’ differences in 
taste/smell sensitivity, auditory 
filtering, and movement sensitivity. 
‘Definite’ differences in under-
responsivity and low-energy/weak.  
5. Children with PHMDS had significantly 
fewer difficulties with taste/ smell 
sensitivity, visual/ auditory sensitivity, 
auditory filtering and tactile sensitivity 
compared to children with ASD. 
However, children with ASD had 
significantly greater difficulties in low-
energy/weak symptoms compared to 
children with PHMDS.  
6. There were no significant differences 
between children with PHMDS in 
movement sensitivity and under-
responsivity.  
Miller, 
McIntosh, 
McGrath, 
Shyu, 
Lampe, 
Taylor, 
Group A: 
n=25 Fragile 
X Mutation 
(FXM) n=15 
male (full 
mutation-full 
1. Sensory 
Challenge 
Protocol (SCP)- 
Laboratory 
paradigm.  
2. Skin 
1. FMRP DNA analysis and 
FMRP 
immunocytochemistry to 
determine percentage of 
lymphocytes expressing 
FMRP.  
The researcher 
presented 
different sensory 
stimulation while 
EDR was being 
recorded. All had 
1. Strong relation among all responses 
across sensory domains, pattern in one 
domain predicted pattern of EDR in 
other domains- so data was averaged.  
2. More lymphocyte FMRP (FXM) 
expression related to more normal EDR,  
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Tassone, 
Neitzel, 
Stackhouse 
and 
Hagerman 
(1999) 
methylation 
n=11, mean 
age= 21 years; 
full mutation- 
partial methyl 
n=3, mean 
age=22 years; 
mosaic, n=3, 
mean age=22 
years; 
permutation, 
n=2 mean 
age= 10 
years) n=6 
female, all full 
mutation, 
mean age=12 
years) 
Group B: 
(selection 
from group A, 
Participants 
with FXM 
and not FXS) 
all male. (Full 
mutation-full 
methylation 
n=11, mean 
age= 21 years; 
full mutation- 
partial methyl 
n=2, mean 
age=29 years; 
mosaic, n=2, 
conductance by 
examining 
electrodermal 
readings (EDR) 
five contiguous 
trials in each of 
five sensory 
systems- 
olfactory 
(wintergreen oil), 
auditory (fire 
engine noise), 
visual (strobe 
light), tactile 
(cloth finger 
puppet with 
feather on) and 
vestibular 
(tipping child 
30%). EDR 
baseline data 
collected.  
3. FXS had a great magnitude of EDR, 
more EDR per stimulation, EDR on a 
greater proportion of trials compared to 
controls.  
4. Controls decreased responding after 
repeated stimulation (habituated), 
whereas, FXS did not cease responding 
to stimuli repetition.  
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Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
mean age=27 
years. Control 
participants 
were age 
matched. (age 
range=4-49 
years) 
Peters, 
Horowitz, 
Barbieri-
Welge, 
Taylor and 
Hundley 
(2012) 
n=42 
individuals 
with 
Angelman 
Syndrome , 
n=17 larger 
class 1 
deletion, n=25 
smaller class 
2 deletion. 
(n=24 male, 
mean age at 
baseline=five-
years, five-
months, 
range= two-
twenty-five-
years) 
1. Behaviour and 
Sensory 
Interests 
Questionnaire 
(BSI)- Unusual 
sensory 
interests/ 
Aversions 
subscale 
 
1. Bayley Scales of Infant 
Development- Third 
Edition (BSID-III) 
2. Autism Diagnostic 
Observation Schedule 
(ADOS) 
3. Autism Diagnostic 
Interview Revised (ADI-
R) (although, not 
reported) 
4. Aberrant Behaviour 
Checklist- excluded 
inappropriate speech 
category 
Assessments 
completed at 
baseline and 
three-year 
follow-up.  
1. No difference in cognitive ability 
between deletion classes both improved 
over time.  
2. No difference in adaptive functioning 
between deletion classes both improved 
in age-equivalent scores over time. 
3. Class 1-deletion higher levels of social 
impairment, no difference over time in 
both groups.  
4. Class 1 deletions more repetitive 
behaviour, no significant difference 
over time in both groups. 
5. Class 1 deletions more likely to exceed 
Autism cut-offs at baseline and 12 
months 
6. No difference in sensory behaviours 
between deletions classes, no 
significant differences over time. Trend 
to increase in sensory seeking.  
7. No difference between deletion classes 
in maladaptive behaviours and no 
significant change over time 
Riby, Janes 
and Rogers 
(2013) 
Same as 
Janes, Riby 
and Rogers 
(2014) 
1. Short Sensory 
Profile (SSP) 
 
1. Repetitive Behaviour 
Questionnaire (RBQ) 
2. Wechsler Intelligence 
Scale for Children 
(WISC) 
Questionnaire 
posted to parents 
and researcher 
completed 
WISC.  
1. FSIQ= 52.6 
2. No significant relationship between 
FSIQ and SP, FSIQ and RBQ.  
3. Higher RBQ associated with more SP 
difficulties. 
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Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
4. Significant relationship between RBQ 
repetitive movement and 3 subscales of 
SP (tactile, taste/ smell and under-
responsive/seeks sensation).  
5. Significant relationship between RBQ 
repetitive language and under-
responsive/seeks sensation subscales of 
SP.  
6. Significant relationship between RBQ 
sameness of behaviour and taste/smell 
sensitivity subscale on SP. 
Rogers, 
Hepburn 
and 
Wehner 
(2003) 
n=102 
children 
Autism n=26, 
Fragile X 
n=20, some 
with and 
without 
autism, 
developmenta
l delay n=32 
(n=15 Down 
Syndrome), 
(mean= 31 
months, 
range= 21-50 
months) 
typically 
developing 
n=24 (mean 
age=19 
months) 
1. Short Sensory 
Profile (SSP) 
 
1. Autism Diagnostic 
Interview- Revised (ADI-
R) 
2. Autism Diagnostic 
Observation Scale 
(ADOS) 
3. Mullen Scales of Early 
Learning (MSEL) 
4. Vinelands Adaptive 
Behavioural Scale 
(VABS) 
TD group 
matched on 
mental age using 
MSEL. Mothers 
completed SSP, 
and children 
were 
administered 
other tests by 
researcher.  
1. ‘Definite’ sensory impairments in ASD 
and FXS, but not DS, TD or DD. 
2. Participants with FXS had more 
difficulties in low weak energy/weak 
muscles compared to all other 
participants and participants with ASD 
had more difficulties with taste/smell 
sensitivity compared to all other 
participants. 
3. ASD more repetitive behaviours than 
FXS- more likely to identify between 
groups, rather than SP.  
4. Difficulties in SP were associated with 
a clinical diagnosis of ASD or FXS, 
rather than IQ or developmental delay, 
except for FXS. 
5. No significant relationship between 
social-communication scores and 
sensory scores in ASD, DD and TD, 
except for FXS. Results indicate those 
with co-morbid ASD and FXS had 
more SP difficulties.  
6. Relationship between more SP 
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Authors 
(Year) 
Participants Sensory Assessment Additional Assessments Procedure Results/Conclusion 
difficulties and lower adaptive 
functioning, stronger relationship, than 
ASD severity, although only 4%. 
7. Substantial correlation between SP, 
ADOS repetitive and restrictive scores, 
provides independent validation of 
parent questionnaire data. 
Smith, 
Hildenbran
d and 
Smith, 
(2009) 
Thirty-seven-
month-old 
female twins, 
one with 
Smith-
Magenis 
syndrome, 
one typically 
developing.  
1. Sensory Profile 
(SP) 
 
1. Sensory Profile (SP) 
2. Brief Assessment of 
Motor Function (BAMF) 
3. Peabody Developmental 
Motor Scales, second 
edition (PDMS-2) 
4. Paediatric Evaluation of 
Disability Inventory 
(PEDI) 
Occupational 
therapist 
administered SP, 
BAMF (fine 
motor scale) and 
PDMS-2 (fine 
motor scale) and 
physical therapist 
administered 
BAMF (lower 
extremity gross 
motor scale) and 
PDMS-2 (gross 
motor subset) 
and PEDI.  
1. Twin with SMS- ‘typical’ sensory 
processing in visual processing, touch 
processing, behavioural outcomes of 
sensory processing and items indicating 
thresholds for responses.  
2. Twin with SMS- ‘probable’ difference 
in auditory and vestibular processing.  
3. Twin with SMS- ‘definite’ differences 
in multisensory and oral processing. 
More difficulty with high threshold 
items.  
4. Twin with SMS- ‘probable’ to definite’ 
differences in all items of modulation 
and ‘typical’ emotional/ social 
responses.  
5. TD twin- ‘typical’ sensory processing.  
6. SMS twin- more difficulties in fine and 
gross motor tasks.  
7. SMS twin- more difficulty in visual-
motor integration. 
8. SMS twin- more difficulties in self-
care, mobility and social function. 
Tierney, 
Nwokoro, 
Porter, 
Freund, 
Ghuman, 
n=56 
individuals 
with Smith-
Lemli-Opitz 
Symdrome 
1. Sensory Profile 
(SP) 
 
1. Questions to parents 
about their concerns and 
cholesterol 
supplementation. 
2. Screen for Social 
Parents 
completed 
questionnaires 
and researchers 
completed 
1. SSI (n=13), compared to aged matched 
TD, Autism and DD, SLOS less 
difficulties than Autism group and same 
level as DD group.  
2. Nisonger CBRF (n=31), 3% 
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and Kelley 
(2001) 
(SLOS), n=31 
male, (age 
range= three-
months to 
32.4 years, 
mean age= 
7.8 years) 
 
Data used 
from previous 
research 
studies for 
individuals 
with Autism, 
Aspergers, 
ADHD, FXS, 
DD and TD.  
Interaction (SSI) 
3. Nisonger Child 
Behaviour Rating Form- 
parent version (Nisonger-
CBRF) 
4. Infant Toddler Symptom 
Checklist (ITSC) 
5. Temperament and 
Atypical Behaviour Scale 
(TABS) 
6. MacArthur 
Communicative 
Developmental Inventory 
(MacArthur CDI) 
7. Autism Diagnostic 
Interview-Revised (ADI-
R) 
8. Parenting Global Rating 
Form- question asking if 
the child’s behaviour had 
improved since receiving 
cholesterol 
supplementation.  
interviews and 
assessments. 
Comparison data 
from other 
research studies.  
hyperactive (>85th percentile) and 19% 
self injury/stereotypic. 
3. ITSC- (n=8) No children under twenty-
two-months had impairment, but all 
older did show regulatory disorder.  
4. TABS- (n=11) Compared to TD, 
Autism and DD and FSX. SLOS more 
dysfunction of temperament and self-
regulation than TD, DD but less than 
Autism and FXS. SLOS more 
dysfunction of sleep and self-soothe 
than TD, Autism, FXS and DD. Total 
score- 36% SLOS higher than FXS and 
18% higher than Autism.  
5. SP (n=35) Comparison to normative 
data, Autism, Aspergers, ADHD and 
DD. Auditory, oral, tactile and visual 
processing difficulties greater than 2SD 
from TD. Visual processing- n=30 
SLOS greater than TD, ADHD, 
Asperger, Autism and DD.  
6. McArthur CDI, (n=49), 78% expressive 
language age 30 months or less and 
79% receptive language ages 16 months 
or below.  
7. ADI-R (n=17), 53% met criteria for 
Autism 
8. Parent Global Rating Scale- (n=38), 
75% believed cholesterol 
supplementation had a very positive 
effect on average.  
Walz and 
Baranek 
(2006) 
n=340 
individuals 
with 
1. Sensory 
Experience 
Questionnaire 
1. Parent report of genetic 
subtype 
Parents 
completed the 
questionnaire. 
1. 75% abnormalities in sensory 
processing, mostly in hypo-
responsiveness to tactile and vestibular 
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Angelman 
Syndrome 
(mean age= 
10.98 years, 
range= three-
twenty-two-
years).Includi
ng Maternal 
deletion of 
15q11.2-q13 
n=203, 
Paternal 
uniparental 
disomy n=25.  
 
(SEQ)  
 
input- ‘sensory seeking’.  
2. Most hyper-responsive behaviours- 
mixed sensory response styles within 
same individual. 
3. More difficulties compared to 
normative data. 
4. Hyper-responsiveness behaviours 
highly inter-correlated. 
5. Hypo-responsiveness behaviours highly 
inter-correlated. 
6. Hypo-behaviours slight decrease with 
age. 
7. Hyper-behaviours not related to age and 
persist into adolescence.  
8. No relationship between seizures, 
gender and genetic subtype (maternal 
deletion and paternal uniparental 
disomy) and sensory experience.  
Wuang, and 
Su (2011) 
n=246 
children met 
criteria 
n=206 agreed 
to participate 
(average 
age=eight-
years, one-
month) 
Down 
Syndrome.  
Divided into 
three age 
groups: 1. 
Young (six-
eight- years), 
1. Sensory profile 
(SP) 
 
1. Demographic 
Questionnaire 
2. Hooper Visual 
Organisation Test 
(HVOT) 
3. Wechsler Intelligence 
Scale for Children 
(WISC) 
4. Vineland Adaptive 
Behaviour Scale (VABS) 
5. School function 
assessment (Chinese 
version) 
Parents and 
teachers 
completed 
questionnaires 
and children 
were 
administered the 
HVOT and 
WISC by 
researchers. 
1. Poorer visual organisation ability in DS 
compared to normative data on HVOT, 
although was age related improvement. 
There were significant correlations 
between HVOT and VABS and SFA, 
showing relationship between visual 
ability and activity performance.  
2. Difficulties in sensory processing and 
modulation (low energy/ weak, under-
responsive/ seek sensation, auditory 
processing and tactile sensitivity), 
compared to normative data, although 
age-related improvements. 
3. Sensory processing related to 
hypotonia. 
4. Sensory processing difficulties related 
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2. Middle 
(nine-ten-
years), 3. Old 
(eleven-
thirteen-
years). 
to lower participation in school 
activities and poorer adaptive 
behaviours, due to less responsivity to 
sensations. 
5. IQ related to sensory processing (small 
effect). 
6. No effect of age or sex on SP.  
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Assessment Methods 
The research articles used a number of different methods to assess sensory 
modulation (Table 1.5). The most frequent assessment method was the Sensory Profile 
(SP; Dunn, 1999) and the Short Sensory Profile (SSP; Dunn, 1999). These assessments 
are parent/carer questionnaires, which assess their childs sensory responses to everyday 
functioning. The questionnaire has normative data for both individuals with ASD and 
TD individual’s aged three-years to fourtten-years-old, has good discriminative validity 
(McIntosh, Miller and Shyu, 1999) and internal consistency (Dunn, 2006). The Sensory 
Experience Questionnaire (SEQ; Baranek, 1999c) is similiary a parent/carer 
questionnaire, which was used by two research articles. The questionnaire assessess 
children’s sensory behaviours across a range of modalities and response patterns, which 
also has good psychometric properties (Baranek, David, Poe, Stone and Watson, 2006). 
Additional parent questionnaires/interviews included the Behaviour and Sensory 
Intrests Questionnaire (BSI; Hason et al., 2016), Parental Questionnaire (PQ; Bruni, 
Cameron, Dua and Noy, 2010) and the Assessment of Sensory Processing, Repetitive 
Behaviour, Anxiety, and Fear in Williams Syndrome-Semi Structuted Interview 
(SRAF-SSI; Janes, Riby and Rogers, 2014).  
 
Other studies used observational methods including the Sensory Processing 
Assessment for Young Children (SPA; Baranek, 1999b), Test of Sensory Function in 
Infants (DeGangi and Greenspan, 1989), Tactile Defensiveness and Discrimination 
Test-Revised (TDDT-R; Baranek, 1997), and Sensory-Approach-Avoidance Rating 
(SAAR; Baranek et al., 2002). These assessments coded childrens behaviour including 
their play and engagement with their sensory environments.  
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Three articles used physiological response methods, including measurement of 
body movements, skin readings, balance and heart activity, which are reported to have 
questionable validity (Hessl et al., 2002). Furthermore, other studies used experimental 
methods including the Sensory Organisation Test (SOT; Guskiewicz, 2001) and the 
Sensory Challenge Protocol (SCP; Miller et al., 1999).  
 
Overall, the quality of the assessments used varied considerably with some 
established assessments demonstrating high validity and reliability, whilst others were 
specifically designed for the research article and, therefore were exploratory and lacked 
psychometric properties (Table 1.5).
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Table 1.5: Descriptions of the Assessment Methods used by the Research Articles. 
 
Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
Behaviour and 
Sensory 
Interests 
Questionnaire 
(BSI) 
 
Hason, 
Sideridis, 
Jackson, 
Porche, 
Campe and 
Huntington 
(2016) 
1 A 174-item semi-structured interview 
designed to assess type, frequency, intensity, 
age of onset and duration of unusual 
behaviours and sensory interests in children 
>18months old with DD and ASD.  It 
contains two factors including repetitive and 
sensorimotor behaviours and insistence on 
sameness. It contains seven subsections 
including stereotyped behaviours, unusual 
sensory interests/aversions, compulsive and 
ritualistic behaviours, rigidity, 
aggression/self-injurious behaviour, 
language perseverations and perseverative 
interests. It includes codes for ‘current’ and 
‘ever’ and asks age of onset of behaviours to 
detect change over time. Other items asked 
parents/carers to report if behaviours are 
present and are coded zero ‘behaviour of 
that type not currently present’ – three 
‘marked mannerisms of type specified 
associated with social impairment and/or 
distress when interrupted. There are also 
additional codes when these codes are not 
applicable. Training is necessary before the 
interview can be administered and scored.  
Normative data 
for individuals 
two to twenty-
four-years-old 
with ASD, DD 
and TD.  
Discriminant 
validity good 
between individuals 
with ASD and TD 
(sensitivity= 72-
80%, specificity= 
44-77%). 
Internal 
consistency for 
repetitive and 
sensorimotor 
behaviours= .83 
and for 
insistence on 
sameness= .73. 
Test-retest 
reliability= .95, 
inter-rater 
reliability=.95 
(Hason et al., 
2016).  
Computerised 
Dynamic 
Posturography 
performed on 
NeuroComEqite
Guskiewicz 
(2001) 
NeuroCom 
International
, 2001).  
1 The system is a form of posturography and 
measures the body’s movement and balance 
in response to different sensory 
manipulations including; somatosensory, 
visual and/or vestibular conditions. The 
Condition 1 used 
as baseline data, 
no normative 
data.  
Guskiewicz, 
Riemann, Perrin 
and Nasher  (2001) 
and Shumway-
Cook and 
Wrisley et al 
(2007) used 
healthy adult 
participants and 
reported a 
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
system using the 
Sensory 
Organisation 
Test (SOT) 
system was designed for use on adult’s 
eighteen to sixty-five-years-old. 
 
The SOT contains six different conditions 
each lasting twenty-seconds. It determines 
the participant’s ability to rely on other 
senses to compensate sensory 
misconceptions/errors. Condition one 
provides accurate vestibular, visual and 
somatosensory information. Condition two 
provides accurate vestibular and 
somatosensory information and 
compromised visual sensory information. 
Condition three provides accurate vestibular 
and somatosensory information and 
compromised visual information. Condition 
four provides accurate vestibular and visual 
information but compromised 
somatosensory information. Condition five 
provides accurate vestibular information and 
compromised somatosensory information. 
Condition six provides accurate vestibular 
information and compromised visual and 
somatosensory information.  
The score is the weighted average of 
postural stability scores in each condition.  
Woollacott (2006) 
report the 
NeuroCom device 
is a valid 
instrument for 
assessing balance in 
healthy adults.  
 
Whitney, Marchetti 
and Schade (2006) 
reported composite 
scores <38 can 
identify repeat 
fallers 
(sensitivity=53%, 
specificity=87%) 
and that scores 
were significantly 
related with 
reported falls 
history.  
Cohen and Kimball 
(2008) reported 
sensitivity= 85% 
and specificity= 
77% for adult 
participants with 
vestibular 
conditions.  
standard error of 
measurement= 
2.81, composite 
score 
reliability= .67 
and individual 
equilibrium 
scores =.35—
0.79.  
 
Ford-Smith, 
Wyman, 
Elswick, 
Fernandez and 
Newton (1995 
reported test-
retest 
reliability=.66) 
Heart Activity-  
Inter-beat 
Interval 
- 1 Inter-beat-interval (IBI) used to measure 
arousal and vagal tone (measure of neural 
regulation of heart activity associated with 
Baseline heart 
activity prior to 
assessment is 
Lack of correlation 
between IBI and 
vagal tone with 
- 
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
(arousal), 
Vagal Tone 
(neural activity) 
parasympathetic influences. The heart 
activity was collected, edited and analysed 
following validated procedures (Roberts, 
Boccia, Bailey, Hatton and Skinner, 2001).  
used as 
comparison data.  
SPA TSFI (Baranek 
et al., 2008).  
Arousal may be 
related to anxiety 
(Hessl et al., 2002).  
Parental 
Questionnaire 
(PQ) 
Bruni, 
Cameron, 
Dua and 
Noy (2010) 
1 A thirty-three-item parent/carer completed 
questionnaire designed to supplement the SP 
with additional information. Questions ask 
parents to state the frequency of sensory 
behaviours and presence of medical 
difficulties. There are additional open-ended 
questions regarding the impact of sensory 
symptoms on occupational performance in 
daily life and related strategies parents use to 
manage the child’s sensory behaviours. Also 
parents have to rate to what degree of impact 
sensory symptoms have on daily life, from 
‘not at all’ to ‘significantly’. It contains nine 
themes including; seeks sensor stimulation, 
intolerance to touch during activities of daily 
living, avoidance of environmental triggers, 
routines and transitions, developmental 
phases, attention and engagement, 
independence and inclusion, communication 
and time, and activity level. The last 4 
themes do not relate to sensory processing.  
- - - 
Sensory 
Challenge 
Protocol (SCP) 
Miller et al 
(1999) 
1 A laboratory experiment, in which 
experimenters present a range of different 
sensory stimuli in a pretend ‘space ship’, 
whilst recording skin conductance- 
electrodermal readings (EDR). It includes 
ten contiguous trials of five sensory 
Own recording of 
EDR at baseline 
level used as 
comparison. No 
normative data. 
Individuals with 
anxiety also show 
abnormal EDR 
activity, including 
failure to habituate 
to stimuli 
- 
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
domains; olfactory, auditory, visual, tactile 
and vestibular. Each sensory stimulus is 
presented for three seconds and with a 
recorded set of instructions. The olfactory 
stimulus was wintergreen oil placed 2.5cm 
from the participant’s nose. The auditory 
stimuli were recorded fire engine sirens 
placed at ninety decibels. The visual stimuli 
were a twenty watt-strobe light with ten 
flashes per second. The tactile stimulus was 
a cloth finger puppet with a feather placed 
on the participant’s ears and chin. The 
vestibular stimulus involved the 
experimenter tipping the participant back at 
a thirty-degree angle.  
 
EDR recordings are quick phasic changes 
imposed on shifts in tonic level in 
conductivity (Fowles, 1986). They are 
recorded at baseline (before sensory stimuli), 
during exposure and afterwards 
(habituation). Hypo-responsiveness 
indicated by decreased amplitude of EDR. 
(Boucsein, 1992) 
Sensory 
Experience 
Questionnaire 
(SEQ) 
Baranek 
(1999c) 
2 A 105-item parent report questionnaire to 
assess sensory symptoms in children aged 
two to twelve- years. It assesses frequency 
of sensory behaviours across sensory 
response patterns, modalities and social and 
non-social contexts. The first ninty-seven 
items assess frequency of sensory 
behaviours on a five-point Likert scale 
ranging from ‘almost never’ to ‘almost 
ASD normative 
data being 
developed 
(Ausderau, 
Sideris, Little and 
Baranek, in 
preparation). Well 
validated in TD 
children, ASD 
Good 
discriminative 
validity as can 
identify the unique 
sensory pattern for 
ASD from TD 
children or DD 
(Baranek, David, 
Poe, Stone and 
High internal 
consistency for 
each modality, 
Cronbach’s 
alpha for hyper-
responsivity= 
.73, hypo-
responsivity= 
.75, sensory-
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
always’. The final eight questions are not 
scored, but give qualitative contextual 
information. A total score is given, plus sub-
scores for four types of sensory patterns 
including; hyper-responsivity, hypo-
responsivity, sensory-seeking and enhanced 
perception, and scores for each of the five 
modalities including; auditory, visual, 
tactile, gustatory and vestibular, and a score 
for social and non-social contexts. A higher 
score indicates more severe sensory 
symptoms.  
and DD (Baranek, 
David, Poe, Stone 
and Watson, 
2006).  
Watson, 2006). The 
SEQ in 
combination with 
other sensory 
assessments has 
been used to 
validate sensory 
patterns and assess 
their unique 
association with 
repetitive 
behaviours (Boyd et 
al., 2010) and social 
communication 
difficulties (Wason 
et al., 2011). The 
factor structure 
implies a distinct 
construct that 
significantly 
correlated (r=.19-
.77; Ausderau, 
Sideris, Little and 
Baranek, in 
preparation).   
seeking= 80, 
social= .69 and 
non-social= .78. 
Sensory Profile 
(SP) 
Dunn (1999) 5 125-item parent/proxy questionnaire, which 
assesses children’s responses to sensory 
stimuli and their impact on everyday 
functioning. On a five-point Likert scale 
assessing the frequency of behaviours from 
‘always’ to ‘never’. The questionnaire 
contains fourteen categories, although, Dunn 
TD and ASD, 3-
14 years old 
Good convergent 
validity with the 
School Function 
Assessment (Dunn, 
1999) 
Cronbach’s 
alpha internal 
consistency = 
.47-.91 and the 
standard error of 
measurement= 
.8-.9 (Dunn, 
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
(2006) recommends use of the four quadrant 
scores, which coincide with the model. A 
lower score indicates greater difficulties. It 
provides published cut-off scores;< 1SD 
below the mean= ‘typical’, ≥1SD below the 
mean= ‘probable difference’, ≥2SD below 
the mean= ‘definite difference 
2006).  
Sensory-
Approach- 
Avoidance 
Rating (SAAR) 
Baranek et al 
(2002) 
1 An observational measure in a naturalistic 
context, which assesses level of engagement 
with sensory toys. Items were selected based 
on Dunn’s (1997) model. The child is 
presented with nine novel multisensory toys, 
selected by the authors. The toys had a 
minimum of three interactive sensory 
properties and included primary features of 
three tactile, three auditory, one visual and 
two vestibular. The child’s level of approach 
and avoidance was observed and rated on a 
three-point scale from ‘engages-approaches’ 
to ‘avoids engagement-aversion’ for each 
toy.  
- Inter-observed 
agreement reported 
to .98 (Baranek et 
al., 2002). 
The authors 
reported the 
SAAR 
significantly 
correlated with 
the TDDT-R 
internal-control 
score (r=.62), 
however, not 
with external-
control score 
(r=-.11) or the 
SSP (r=.09).  
Short Sensory 
Profile (SSP) 
Dunn (1999) 6 Thirty-eight- item parent/proxy 
questionnaire, taken from the SP. Questions 
organised into seven categories; tactile 
sensitivity, taste/smell sensitivity, movement 
sensitivity, under responsive/seeks 
sensation, auditory filtering, low 
energy/weak and visual/auditor sensitivity. 
TD and ASD 
three to ten- 
years-old 
Strong discriminate 
validity, as it is able 
to distinguish >
95% of children 
with and without 
sensory symptoms 
(McIntosh, Miller 
and Shyu, 1999).  
 
Strong inter-
rater reliability 
(Dunn, 2005). 
Cronbach’s 
alpha for the 
total score 
ranges from .90-
.95 for the 
normative 
sample (Dunn, 
1999). 
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
Tactile 
Defensiveness 
and 
Discrimination 
Test-Revised 
(TDDT-R) 
Baranek 
(1997) 
1 Standardised, structured, behavioural 
observation assessing tactile sensitivity, 
which contains two subscales. The 
externally controlled subscale involves the 
examiner touching the child with stickers or 
a finger puppet and assessing their response. 
The internally controlled subscale assesses 
child’s responses to their own initiated 
exploration of tactile toys. The child’s 
responses are measured on a four-point scale 
e.g. hyper-responsive behaviours 
(avoidance, negative affective reactions), 
seeking-behaviours (excessive engagement, 
strong positive affective reactions). Overall 
scores calculated by averaging scores 
according to the manual. Higher scores 
indicate greater tactile sensory difficulties. 
The assessment needs to be administered by 
trained professionals, video-recorded and 
inter-observer reliability checked.  
No TD normative 
data, although 
validated in 
children with DD 
and ASD, ages 
two to fourteen-
years (Baranek 
and Berkson, 
1994; Watson et 
al., 2011) 
 
Good inter-observer 
reliability 
reported=0.951 
(Sensory 
defensiveness) and 
0.904 (seeking-
behaviour) (Foss-
Feig, Heacock and 
Cascio, 2012). 
Total inter-observer 
reliability ≥ .90 
(Baranek et al., 
2002).  
- 
Test of Sensory 
Function in 
Infants (TSFI) 
DeGangi 
and 
Greenspan, 
(1989) 
1 A twenty-four-item observational 
assessment of sensory symptoms. Assesses 
five sensory functions including reactivity to 
tactile deep pressure, visual-tactile 
integration, adaptive motor responses, 
ocular-motor control and reactivity to 
vestibular stimulation. Designed for children 
four-months to eighteen-months-old with 
regulatory disorders. Scores classify children 
as ‘normal’, ‘at risk’ or ‘deficient’ in each of 
the five sections. A lower score indicates 
greater severity of sensory symptoms, 
Norms for TD 
children with 
regulatory 
disorders.  
The authors suggest 
the assessment is 
most valid for 
children >7 months 
old and can used for 
children >10 
months old if they 
had a DD.  
Test-retest 
reliability for 
TD children, 
Pearson 
correlation 
coefficient for 
the total r=.81 
and for the 5 
subtests r=.26-
.96 (DaGangi 
and Greenspan, 
1989).  
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
although, reversed scoring used by Baranek 
et al., (2008).  
Lower test-
retest reliability 
reported in the 
‘borderline’ 
range for 
children with 
DD, Pearson 
correlation for 
the total r=.78 
and for the 5 
subtests r=.54-
.74 (Jirikowic, 
Engel and Dietz, 
1997).  
The Assessment 
of Sensory 
Processing 
Repetitive 
Behaviour, 
Anxiety, and 
Fear in Williams 
Syndrome-Semi 
Structured 
Interview 
(SRAF-SSI) 
Janes, Riby 
and Rogers 
(2014) 
1 A twenty-nine-item semi-structured 
interview delivered to parents. It was 
developed after considering other resources 
including the ADI (Lord, Rutter and Le 
Couteur, 1994) and the sensory modulation 
literature. The sensory section covers seven 
different features including; tactile 
hypersensitivity and hyposensitivity, 
proprioception, visual hypersensitivity and 
hyposensitivity; auditory hypersensitivity 
and hyposensitivity, gustatory features and 
olfactory features. Each question includes a 
description of the target behaviour and 
parents are asked if the behaviours displayed 
by their child and described in what way. 
Also asked to indicate on a five-point Likert 
scale the frequency and intensity of the 
behaviour and if it has changed over time. 
- - - 
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Assessment Authors 
(Year) 
Number of 
Studies in the 
Review Using 
the Assessment 
Description Normative Data Validity Reliability 
The Sensory 
Processing 
Assessment for 
Young Children 
(SPA) 
Baranek 
(1999b) 
1 A semi-structured, play-based observational 
assessment of sensory symptoms in young 
children. Observers have to code children’s 
responses based on four scales including; 
play with novel toys (rates hyper-
responsivity and sensory-seeking 
behaviours), habituation (responses to 
repeated sensory stimuli), orienting (hypo-
responsivity) and stereotyped behaviours 
(marked as observed or not). Designed for 
children with ASD or DD aged nine-months 
to six-years-old. 
Used on children 
with DD and ASD 
(Boyd et al., 
2010). 
- - 
 56 
 
Quality Review 
A quality framework was developed to guide evaluation of each research article 
to consider the value of the conclusions made across studies. A pre-existing broad 
quality framework was not used due to the need for the assessment to focus on specific 
features considered important to research in rare genetic syndromes. Richards et al., 
(2015) developed a quality framework used in the meta-analysis of ASD in rare genetic 
syndromes, which considered the sample identification of participants, the confirmation 
of the syndrome and the assessment method used. These quality criteria were used and 
adapted for the purposes of this review. The additional quality criteria were developed 
by reviewing the literature on critical appraisals (Young and Solomon, 2009), sensory 
modulation (e.g. Ben-Sasson et al., 2009; Schaaf and Lane, 2015), standardised quality 
frameworks for intervention studies (Downs and Black, 1998) and observational studies 
(CASP, 2014; Von Elm, Altman, Egger, Pocock, Gotzsche and Vandenbroucke, 2007) 
(see Appendix 3 for the explanation and description of additional items).  
 
Additional criteria included evaluation of the comparison group/data, 
confounding variables and developmental changes. In line with Richard et al., (2015), 
criteria were colour-coded (red (0)= poor, yellow (1)= adequate, amber (2)= good, 
green (3)= excellent). Total and mean calculations and mean colour codes are reported 
for each research article and each criterion to help visually summarise the overall 
quality of the research. However, it is noteworthy each criterion is arguably not equally 
important to the validty of the research. Furthermore, the evaluation checked that p 
values were reported (Downs and Black, 1998, question ten) (Table 1.6). 
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Table 1.6: The Quality Assessment Framework. 
Table 3 0 
Poor 
1 
Adequate 
2 
Good 
3 
Excellent 
Sample 
Identification 
Not specified/ 
reported 
Single restricted or non-random sample e.g. 
a specialist clinic or previous research study. 
 
Single regional sample e.g., a regional 
parent support groups. 
Multiple restricted or non-random samples e.g., 
multi-region specialist clinics. 
 
National non-random sampling e.g., national parent 
support groups. 
Random or total population sample. 
Confirmation 
of Syndrome 
Not 
confirmed/ 
reported 
 
Clinical 
diagnosis only 
suspected  
Clinical diagnosis by ‘generalist’ e.g. 
General Practitioner or Paediatrician. 
Clinical diagnosis by ‘expert’ e.g., Clinical 
Geneticist or Specialist Paediatrician. 
Molecular/Cytogentic/ 
Metabolic confirmation of diagnosis. 
Sensory 
Assessment 
Not specified/ 
reported 
 
Clinician 
judgement 
only  
 
Assessment methodologies, which have not 
been validated in previous research e.g. 
methods specifically designed for the 
research paper. 
 
Validated or previously used assessments, 
which have not been used on individuals 
with ID or ASD or are being used out of the 
normative age range. 
 
Validated assessment measures, which have been 
validated or previously used on individuals with ID 
or ASD and are being used on participants in the 
normative age range, includes physiological data. 
Consensus from multiple assessments 
and that at least one of these 
assessments would have obtained a 
score of 2 in isolation. 
  
Comparison 
Group 
No 
comparsion 
group or data 
Published normative data only or published 
data in other research articles. 
Use of one or more comparison group, TD, ID, or 
another syndrome group recruited by the paper 
 
 
Age, ID or different syndrome / 
difficulty matched comparison group 
recruited by the paper. 
Confounding 
Variables 
Not reported 
 
At least one known confounding variable 
assessed, e.g. age, ID, repetitive behaviours, 
social communication, but only used to 
describe participant sample.  
At least one known confounding variable assessed 
and the relationship between constructs were 
considered e.g. correlational analysis between 
sensory modulation and repetitive behaviour 
assessment or age, functional ability. However, 
At least one known confounding 
variables assessed and controlled for 
in analysis or used in direct analysis 
(non-correlational) to determine the 
interaction between different domain 
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confounding variables were not controlled for in 
sensory analysis. 
and sensory modulation.  
Developmental 
Changes 
Not reported 
Retrospective developmental data.  
 
or correlational data analysed between age 
and sensory modulation. 
Comparison across specific age ranges with the 
same syndrome.  
Longitudinal data collected from 
multiple assessments from same 
participants.  
 59 
 
 
The results of the quality review are displayed (Table 1.7). One research article 
did not report the sample identification, whilst ten recruited from a single regional 
sample and five recruited from multiple or national samples. Therefore, the overall 
quality of the sample identification was considered ‘adequate’ (mean score=1.38). Four 
research articles did not report how confirmation of the genetic syndrome was 
established and one study established the syndrome by the view of a general 
practitioner. However, genetic testing was used in eleven studies, thus overall syndrome 
confirmation across the studies were considered to be ‘good’ (mean score=2.13). Five 
research articles used assessments that were not validated or that had been validated but 
used out of the normative sample, nine used a valid sensory assessment in the age range 
of the normative data. Yet, only two studies used multiple established methodologies. 
The results of the evaluation criteria found the sensory assessmens to be ‘good’ (mean 
total=1.94). Nine research articles compared sensory assessment data to normative 
samples, whilst seven had the advantage of using matched comparison groups, Thus 
sudies were rated as ‘good’ (mean score=2.06). Furthermore, five research articles 
described possible confounding constructs to describe participants, three studies 
considered the relationship between these constructs and eight controlled for 
confounding constructs in the sensory analysis. The assessment of confounding 
variables across studies was also considered ‘good’ (mean score=2.13).  The majority of 
studies (n=10) neglected to report developmental changes, three studies displayed 
retrospective data, one study made comparisons across age groups and three used a 
longitudinal method. Therefore, the overall assessment of developmental changes were 
considered to be ‘poor’ (mean score=0.63). Finally, three studies failed to provide 
precise p values. 
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Table 1.7: Results of the Evaluation Criteria Applied to the Research Articles. 
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Comment 
Baranek, Chin, 
Greiss, Hess, 
Yankee, Hatton and 
Hooper (2002) 
           No 12 2  Many significant findings are dependent on the SAAR 
assessment, which is the invalidated observational assessment.  
TDDTR and SAAR= 90-98% agreement. 
                 
Baranek, Roberts, 
David, Sideris, 
Mirrett, Hatton and 
Baily (2008) 
           Yes 15 2.5  SEQ used out of age range.  
SPA and TSFI subscales= 87-95% and 82-96% agreement. 
                 
Bruni, Cameron, 
Dua and Noy (2010) 
           N/A 6 1   Descriptive analysis only.  
PQ used qualitative constant comparative analysis to identify 
themes. No inter-rater reliability checked. 
No information about syndrome confirmation 
                 
Hildenbrand and 
Smith (2011) 
           Yes 6 1   Lack of information recruitment, just that participants were part 
of an on-going SMS study. 
     
Horvat, Croce and 
Zagrodnik (2010) 
           Yes 6 1  Syndrome identified using school education plans. 
Assessment not validated on individuals with ID and no ID 
normative data. 
                                                        
9 Have the actual probability values been reported (e.g. 0.035 rather than <0.05) for the main outcomes except where the probability value is <0.001 
(Down and Black, 1998; question 10). 
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Comment 
         
Janes, Riby and 
Rogers (2014) 
       
 
    N/A 11 1.83  Descriptive analysis only.  
Thematic analysis and frequency counting used to analyse the 
SRAF-SSI. 
The relationship between confounding variables and 
developmental changes were based on the SRAF-SSI only and 
is the invalidated interview assessment. 
         
John and Mervis 
(2010) 
           Yes 10 1.67  Lack of information about recruitment, just that participants 
were part of an on-going study in WS. 
         
Mieses et al., (2016)            Yes 12 2.00  Comparison groups differed on sex and marginal difference in 
age.  
SP used out of age range 
         
Miller, McIntosh, 
McGrath, Shyu, 
Lampe, Taylor, 
Tassone, Neitzel, 
Stackhouse and 
Hagerman (1999) 
           No 10 1.67  For twelve participants, KIDCal was unable to locate baseline, 
thus, analysis set the baseline at which most responses bottomed 
out over the entire data collection period. Also, for three 
participants, the analysis adjusted the baseline due to artefact.  
Cronbach’s alpha for magnitude and number of peaks= .94 and 
.92.  
         
Peters, Horowitz, 
Barbieri-Welge, 
Taylor and Hundley 
(2012) 
           Yes 15 2.50  Sensory-seeking behaviours corrected for skewing, although 
sensory aversions could not be due to considerable skewing.  
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Comment 
Riby, Janes and 
Rogers (2013) 
           Yes 11 1.83   SP and RBQ Cronbach alpha >.8= good reliability. 
         
Rogers, Hepburn and 
Wehner (2003) 
           Yes 10 1.67  Lack of details about recruitment, but part of a larger trial.  
SSP used out of age range.  
ADOS and ADI-R= 80-85% agreement.  
Preliminary analysis revealed no significant differences in 
mental functioning or sensory modulation between DS and DD, 
thus, groups collapsed into one group. 
Corrections made for non-normality of SSP. 
         
Smith, Hildenbrand 
and Smith, (2009) 
           N/A 6 1.00  Descriptive analysis only.  
SP used out of age range. 
No information about syndrome confirmation 
         
Tierney, Nwokoro, 
Porter, Freund, 
Ghuman, and Kelley 
(2001) 
           N/A 7 1.17  SP used out of age range 
Comparison to published data for individuals with TD, Autism, 
Asperger’s, DD and ADHD 
Descriptive analysis only 
         
Walz and Baranek 
(2006) 
           No 9 1.5  No information about confirmation of the syndrome, but 
recruited through AS support group and parents reported genetic 
subgroup. 
SEQ used out of normative age range. 
Correlational analysis between age and sensory modulation.  
No separate demographic data given for each genetic subtype.  
Comparison between maternal deletion and parental-uniparental 
disomy. 
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Comment 
         
Wuang and Su 
(2011) 
           Yes 8 1.33  Lack of information about where participants were recruited 
from, although the authors did explain that they used a 
purposeful sampling method.  
  
                 
Total Score 22  34  31  33  34  10      
Mean Score 1.38  2.13  1.94  2.06  2.13  0.63      
Mean Total Colour                  
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Discussion 
Angelman Syndrome  
Two studies examined sensory modulation in individuals with AS (Peters et al., 
2012; Walz and Baranek, 2006). Both articles used assessments, which have been 
validated in individuals with ID and both studies made use of good genetic subtype 
comparison groups. Peters et al., (2012) completed a longitudinal comprehensive 
assessment of a range of confounding variables including cognitive ability, adaptive 
functioning, ASD phenomenology and maladaptive behaviours. The research was 
considered to be ‘excellent’ by the quality review framework, thus the Peters et al., 
(2012) paper should be considered more methodologically sound and results should be 
considered more valid.  
 
Walz and Baranek (2006) reported 75% of individuals with AS had sensory 
modulation difficulties in comparison to TD normative data, especially hypo-
responsivity to tactile and vestibular input. Difficulties in sensory modulation were also 
found by Peters et al., (2012), although the BSI does not provide specific scores in each 
modality. Peters et al. (2012) reported no differences between class 1 and class 2 
genetic subtypes10 in cognitive and adaptive functioning, and both genetic subgroups 
improved with age. However, individuals with class 1 deletions had greater social 
impairment, were more likely to exceed ASD cut-off scores and display more repetitive 
behaviours than class 2 deletions, which did not change over time. Despite this, there 
were no differences in sensory modulation over time or between deletion classes, 
                                                        
10 Deletion breakdown was established by microarray-based genomic hybridization using 
chromosome 15 specific bacterial artificial chromosome. Class 1 deletions are larger and extend 
from BP1 to PB3. Class 2 deletions are smaller and extend from BP2 to PB3. Larger deletions 
extending from BP4 to PB5 were excluded.  
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however, there was a trend towards increased sensory-seeking with age. Similarly, Walz 
and Baranek (2006) found no differences between maternal deletion and parental-
uniparental disomy deletion classes in sensory modulation. However, in contrast, they 
reported hypo-responsivity decreased with age, where hyper-responsivity was not 
related to age. Overall, both papers report individuals with AS have sensory modulation 
difficulties, specifically, sensory-seeking/hypo-responsivity with no differences 
between genetic subtypes, although they do not report consistent findings regarding 
age-related changes.  
 
Sensory modulation difficulties are reported in mice with AS (Yashiro et al., 
2009) and children with AS have been reported to have fascinations with tactile and oral 
stimulation (Williams, 2005; Williams et al., 2006). Thus, previous research supports 
Peters et al., (2012) and Waltz and Baranek (2006) findings of sensory-seeking/hypo-
responsivity difficulties. However, research has reported low RRB in the AS phenotype 
(Thompson and Bolton, 2003), suggesting individuals are not using their own body 
movements to seek sensory sensations, which might have been expected due to the 
relationship between RRB and sensory modulation. It is possible their sensory-seeking 
is directed at specific tactile stimuli, such as a fascination with water (Clarke and 
Marston, 2000). Furthermore, it could be hypothesised that due to the high frequency of 
sensory symptoms, a higher proportion of individuals with AS may meet criterion B in 
the DSM-5 since the addition of sensory symptoms due to the lower frequency of 
RRBI.  
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Fragile X Syndrome 
Four studies (Baranek et al., 2002; Baranek et al., 2008; Miller e al., 1999; 
Rogers, Hepburn and Wehner, 2003) investigated sensory modulation in FXS. Baranek 
et al., (2002) and Baranek et al., (2008) research is evaluated to be methodologically 
sound due to a more valid assessment of sensory modulation and consideration of more 
confounding variables. Baranek et al (2008) was the only study to assess developmental 
changes using a longitudinal design. However, Miller e al., (1999) and Rogers, Hepburn 
and Wehner (2003) were the only studies to use well-matched comparison groups. The 
quality review considered all studies to be ‘good’, except Branek et al., (2008), which 
was considered as ‘excellent’. 
 
Baranek et al., (2002) reported ‘definite’ differences in sensory modulation, 
although, did not provide differences for specific modalities. Furthermore, the authors 
reported varying levels of sensory difficulty assessed by the TDDT-R and SAAR. 
Higher levels of aversion/avoidance were related to less independence, less engagement 
at school and with play. Rogers, Hepburn and Wehner (2003) also reported ‘definite’ 
differences in sensory modulation, which, overall were more severe compared to 
sensory modulation difficulties in participants with ASD, DD, DS and TD. Participants 
with FXS had more difficulties in low weak energy/weak muscles compared to all other 
participants and participants with ASD had more difficulties with taste/smell sensitivity 
compared to all other participants. Sensory difficulties were related to a lower IQ, 
delayed development, lower adaptive functioning and more social-communication 
difficulties only for FXS participants. Furthermore, the authors reported that 
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participants with ASD had significantly more RRB compared to participants with FXS, 
which was more likely to identify the different syndrome groups.  
 
Miller et al., (1999) concluded physiological responses indicated 
hypersensitivity difficulties across all modalities, as participants with FXS did not 
habituate to the repeated presentation of sensory stimuli. Furthermore, they concluded 
that participants with FXS had more sensory difficulties compared to those participants 
with FXM. These physiological findings in FXS have been supported by other research 
(Castren, Paakkonen, Tarkka, Ryynanen and Partanen, 2003; Rojas, Benkers, Rogers, 
Teale, Reite and Hagerman, 2001), although Baranek et al., (2008) found a lack of 
relationship between physiological measures and their other sensory modulation 
assessments, which, perhaps is explained by the difference in age between participants 
across groups. Baranek et al., (2008) also reported individuals with FXS have sensory 
modulation difficulties, which worsen from nine to eighteen-months-old. Specifically, 
hyposensitivity decreased or remained stable with age, whilst, hypersensitivity 
increased with age.  
 
Baranek et al., (2008) concluded age, lower cognitive ability and motor skill 
difficulties impact on sensory modulation difficulties in different ways at different 
developmental stages. However, it is possible sensory difficulties in young children 
restrict their learning and engagement; therefore, as sensory difficulties improve, 
children may be more responsive to learning.  
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Overall, the research reviewed here and additional sensory processing literature 
(Cohen, 1995; Hagerman, 2002), suggests individuals with FXS specifically 
demonstrate hypersensitivity difficulties. This conclusion also supports the ASD 
symptomology research, which suggests individuals with FXS are less able to engage in 
social communication due to hypersensitivities (Roberts, Weisenfeld, Hatton, Heath and 
Kaufmann, 2007). However, Rogers, Hepburn and Wehner (2003) reported fewer 
RRBs, whereas, Wheeler et al., (2015) described frequent RRB in individuals with 
FXS, highlighting the consistencies across research. Furthermore, Wheeler et al., (2015) 
suggested fewer individuals with FXS meet criterion A of the DSM-5, yet more 
individuals meet criterion B; a suggestion which is supported by this review due to the 
high frequency of sensory modulation difficulties.  
 
Williams Syndrome 
Three studies (Janes, Riby and Rodgers, 2014; John and Mervis, 2010; Riby, 
Janes and Rodgers, 2013) investigated sensory modulation in WS. All studies used the 
SSP to assess sensory modulation. Two studies analysed the relationship between 
sensory modulation and confounding variables (Riby, Janes and Rogers, 2013; John and 
Mervis, 2010). Neither John and Mervis (2010) or Riby, Janes and Rogers (2013) 
assessed developmental changes, whilst Janes, Riby and Rogers (2014) used the SRAF-
SSI to retrospectively consider age-related changes. All three studies were considered to 
be ‘good’ by the quality review.  
 
Both Janes, Riby and Rogers (2014) and Riby, Janes and Rogers (2013) reported 
‘definite’ differences in the total SSP in comparison to normative data, although they 
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did not report the precise results for each modality. Nevertheless, Riby, Janes and 
Rogers (2013) found that IQ was not related to sensory difficulties; yet, found more 
RRB were related to more sensory difficulties. Specifically; repetitive movement was 
related to tactile, taste/smell and under-responsive/seeks sensation, repetitive language 
was related to responsive/seeks sensation and sameness of behaviour was related to 
taste/smell sensitivity. Janes, Riby and Rogers (2014) also reported individuals had 
hyper-responsivity difficulties with vestibular, proprioceptive, auditory and gustatory 
stimuli, which impacted on daily life, although, improved over time. They reported 
typical sensitivity with tactile, visual and olfactory modalities. They also reported 
frequent RRB, which were often triggered by anxiety. Similarly, John and Mervis 
(2010) found over 90% had ‘probable’ to ‘definite’ differences in sensory modulation 
and specifically in auditory filtering, although they also reported specific difficulties in 
low/weak energy and under-responsive/seeks sensation. Furthermore, those individuals 
with more severe sensory modulation difficulties had more executive functioning, 
temperament, oppositional and functioning difficulties.  
 
Despite, Riby, Janes and Rogers (2013) reporting no relationship between IQ 
and sensory modulation, John and Mervis (2010) concluded that sensory difficulties 
might be due to executive functioning deficits. This hypothesis has also been suggested 
in the literature (Gazzaley and D’Esposito, 2007; Gillbert and Burgess, 2008). The 
findings of auditory sensory modulation difficulties in WS are supported by the auditory 
processing research literature (Leyfer, Woodruff-Borden, Klein-Tasman, Fricke and 
Mervis, 2006; Marler, Elfenbein, Ryals, Urban and Netzloff, 2005), specifically, 
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auditory hypersensitivity to loud noises and auditory aversions (Levitin, Cole, Lincoln 
and Bellugi, 2005).  
 
Riby, Janes and Rogers (2013) concluded that RRB occurs as a consequence of 
tactile under-responsivity and sensory-seeking, in an attempt to regulate their hypo-
arousal. This relationship has also been suggested for individuals with ASD, whereby 
RRB are potentially used as a coping strategy to manage hypo-responsivity (Baker, 
Lane, Angley and Young, 2008; Chen, Rogers and McConachie, 2009; Leekam, Prior 
and Uljarevic, 2011). However, this relationship may also be accounted for due to the 
lack of construct validity and theoretical clarity between RRB and sensory modulation. 
Furthermore, Janes, Riby and Rodgers (2014) reported no tactile hyposensitivity 
difficulties. The review suggests that due to the sociability of the behavioural phenotype 
and the high frequency of sensory symptoms and RRBs, individuals with William 
Syndrome are more likely to meet criterion B and not meet criterion of A of the DSM-5.  
 
Down Syndrome 
Three studies (Bruni, Cameron, Dua and Noy, 2010; Horvat, Croce and 
Zagrodnik, 2010; Wuang and Su, 2011) investigated sensory modulation in DS. None 
of the research used multiple validated sensory assessments and only Horvat, Croce and 
Zagrodnik (2010) made use of age-matched comparison groups with mild ID and TD. 
Wuang and Su (2011) considered the most confounding variables and was the only 
study to investigate age-related changes and compared difficulties across three different 
age groups. The methodology used in all three studies is relatively weak in comparison 
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to the methodology examining other genetic syndromes, and was considered to be 
‘adequate’ by the quality review, thus less valid conclusions can be made.  
 
Bruni, Cameron, Dua and Noy (2010) reported 49% of participants had ‘definite’ and 
25% of participants had ‘probable’ differences in sensory modulation. Both Bruni, 
Cameron, Dua and Noy (2010) and Horvat, Croce and Zagrodnik (2010) studies 
reported the most difficulties were in under-responsive/seek sensation, auditory filtering 
and low weak energy, whereas, there was ‘typical’ performance in taste/smell, 
movement and visual/ auditory filtering. However, Wuang and Su (2011) reported 
difficulties in tactile sensitivity, whereas Bruni, Cameron, Dua and Noy (2010) reported 
‘typical’ tactile sensitivity. Wuang and Su (2011) further reported participants with DS 
had poorer visual ability, which was related to lower adaptive functioning and school 
functioning, and sensory modulation difficulties were related with more hypotonia, 
lower participation in school activities, poorer adaptive functioning and a slightly lower 
IQ, although there was no relationship between sensory modulation and sex and age. 
Bruni, Cameron, Dua and Noy (2010) also reported 55% of parents spent time trying to 
increase their child’s participation and 37% of parents reported that their child’s sensory 
difficulties had a moderate impact on daily life.  
 
Horvat, Croce and Zagrodnik (2010) concluded individuals with DS and ID 
have balance difficulties when presented with inaccurate visual, somatosensory and 
vestibular information. Moreover, that both groups use sensory information differently 
compared to TD individuals, which results in movement difficulties, although this may 
partly be accounted for by low muscle functioning (Horvat, Ramsey, Amestoy and 
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Croce, 2003). The results are congregant with authors that suggest individuals with DS 
have sensory difficulties, which are related to slower reaction times and slower pre-
motor activities (Davis, Sparrow and Ward, 1991). The authors suggest that these 
difficulties may also be explained by reduced cognitive abilities and are not specific to 
DS, as these motor-control difficulties are also seen in individuals with ASD (Vernazza-
Martin et al., 2005).  Thus, suggesting the sensory modulation difficulties displayed in 
DS are perhaps similar to those displayed by individuals with idiopathic ASD, which is 
supported by Moss, Richards, Nelson and Oliver (2012). However, reliable conclusions 
are difficult to establish due to the methodological weakness of the articles including no 
idiopathic ASD comparison samples and the lack of an established consistent sensory 
profile found across individuals with idiopathic ASD. It is also noteworthy that 
individuals with DS as a group perhaps display the lowest and less severe sensory 
modulation difficulties, which may partly explain the low percentage of individuals who 
have DS and ASD.  
 
Phelan-McDermid Syndrome 
One study (Mieses et al., 2016) investigated sensory modulation in PHMDS, 
which used the SSP questionnaire to assess sensory modulation. The study made use of 
an age, IQ and ASD comparison groups. The research controlled for sex, age and IQ, 
though did not investigate age-related changes in sensory modulation and was overall 
considered to be ‘good’.  
 
The results revealed 80% of children with PHMDS and 81% of children with 
ASD had ‘probable’ or ‘definite’ differences in sensory modulation. Children with 
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PHMDS displayed ‘typical’ performance in visual/auditory sensitivity, ‘probable’ 
differences in taste/smell sensitivity, auditory filtering, and movement sensitivity, 
‘definite’ differences in under-responsivity and low-energy/weak. Children with 
PHMDS had significantly fewer difficulties with taste/smell sensitivity, visual/auditory 
sensitivity, auditory filtering and tactile sensitivity compared to children with ASD. 
However, children with ASD had significantly greater difficulties in low-energy/weak 
symptoms compared to children with PHMDS. There were no significant differences 
between children with PHMDS in movement sensitivity and under-responsivity. Thus, 
suggesting individuals with PHMDS have different sensory modulation profiles 
compared to those with ASD suggesting differences are a result of genetic conditions, 
rather than ID or ASD symptomology. However, ASD symptomology was not 
controlled for, although, 95% of individuals with PHMDS met criterion for ASD. To 
date, this is the only research to evaluate sensory modulation in PHMDS.  Future 
research should examine the unique ASD symptomology in PHMDS (more social 
interaction difficulties) and their sensory profile. It is also suggested the ‘typical’ tactile 
sensitivity reported perhaps may explain the lack of RRB in the syndrome (Phelan and 
McDermid, 2012). However, due to the high sensory modulation difficulties individuals 
are more likely to meet Criterion B on the DSM-5 now sensory modulation difficulties 
have been included.  
 
Smith-Magensis Syndrome 
Two studies examined sensory modulation in individuals with SMS 
(Hildenbrand and Smith, 2011; Smith, Hildenbrand and Smith, 2009). Both studies used 
the SP to assess sensory modulation. Smith, Hildenbrand and Smith (2001) also used a 
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TD twin to aid comparison. Whilst both studies considered some confounding variables, 
neither study considered ID and ASD symptoms. Nevertheless, Hildenbrand and Smith 
(2011) used a longitudinal design and compared older and younger children to provide 
results about age-related changes, which was not offered by Smith, Hildenbrand and 
Smith (2009). It is noteworthy that Smith, Hildendrand and Smith (2009) research 
included a single participant with SMS, which significantly limits generalizability. Both 
studies were considered to be ‘adequate’ by the quality review.  
 
Both studies reported ‘definite’ differences in registration, seeking, sensitivity 
and avoiding and ‘probable’ to ‘definite’ differences in all area of modulation in 
comparison to the TD normative data and the TD twin. However, Hillenbrand and 
Smith (2011) reported slightly more difficulties in behavioural and emotional responses 
compared to Smith, Hildenbrand and Smith (2009). The studies reported different 
outcomes in terms of specific sensory modalities, apart from both reporting ‘definite’ 
difficulties in multisensory processing and ‘probable’ differences in auditory 
processing. However, Smith, Hildenbrand and Smith (2009) reported ‘typical’ ability in 
visual and touch processing, whereas, Hildenbrand and Smith (2011) reported 
‘probable’ and ‘definite’ differences. Moreover, Smith, Hildenbrand and Smith (2009) 
reported ‘probable’ differences in vestibular processing, although, Hildenbrand and 
Smith (2011) reported ‘definite’ differences. Additionally, Smith, Hildenbrand and 
Smith (2009) reported ‘definite’ differences in oral processing, whereas Hildenbrand 
and Smith (2011) reported ‘probable’ differences. Thus, Hildenbrand and Smith (2011) 
reported more sensory difficulties compared to Smith, Hildenbrand and Smith (2009), 
except for oral processing.   
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Furthermore, Smith, Hildenbrand and Smith (2009) reported more difficulties in 
fine and gross motor skills, visual-motor integration, mobility, social function and self-
care for the SMS twin, compared to the TD twin. Hildenbrand and Smith (2011) 
reported stereotypic behaviours in less than 50% of participants and weak muscle tone 
in over 50% of participants, although the relationship between these difficulties and 
sensory processing was not considered.  
 
Hildenbrand and Smith (2011) reported a trend for increasing difficulties with age, 
which, was significant for sensory-seeking. Moreover, they reported gender and age 
effects affecting emotional responses, in which older females had the most difficulties. 
This reported age-related change may explain the more severe sensory difficulties in 
their sample compared to Smith, Hildenbrand and Smith’s (2009) participant. 
Moreover, the more severe difficulties in oral processing reported by Smith and 
Hildenbrand and Smith (2009) perhaps would be expected due to the participant being 
younger (thirty-seven-months-old), as children with ASD are also more sensitive to oral 
stimuli when younger (Dunn, 2001).  
 
The research supports other anecdotal evidence of sensory modulation 
difficulties in SMS (Gropman, Duncan and Smith, 2006; Gropman, Elsea, Duncan and 
Smith, 2007; Hicks, Ferguson, Bernier and Lemay, 2008; Laje, Morse, Richter, Ball, 
Pao and Smith, 2010). However, there are inconsistencies in sensory profiles across 
modalities, making it difficult to determine how these sensory difficulties relate to their 
reported high levels of RRB, nevertheless support research which suggests their 
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associated constructs. Due to the high frequencies of RRBs it is suggested inclusion of 
sensory symptoms would not increase the number of individuals meeting criterion B in 
the DSM-5 criteria.  
 
Smith-Lemli-Opitz Syndrome 
One study (Tierney, Nwokoro, Porter, Freund, Ghuman and Kelley, 2001) 
assessed sensory modulation in SLOS using the SP. The results were compared against 
TD, Autism, Asperger’s, DD and ADHD previously published research data, some 
confounding variables were considered, although, they did not examine age-related 
changes and was considered to be ‘adequate’ the quality review.  
 
The authors reported that participants with SLOS had less social interaction, and 
temperament difficulties, although more difficulties in sleep and self-soothing than 
individuals with ASD. Furthermore, 53% of individuals met criteria for ASD, 78% had 
expressive language age equivalent of thirty-months or younger and 79% had receptive 
language age equivalent of sixteen-months or younger. The SP revealed that 
participants with SOLS had ‘definite differences’ in auditory, oral, visual and tactile 
sensory hyper-responsivity. The most severe difficulties were in visual processing, 
which was greater in comparison to individuals with ADHD, Asperger’s, Autism and 
DD. To date, this is the only research to evaluate sensory modulation in SLOS, 
therefore, no conclusions can be made about the relationship between sensory 
modulation difficulties and their ASD symptomology, although the severity of the 
sensory modulation difficulties described suggest the individuals would meet criterion 
B of the DSM-5. 
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Conclusion 
The review evaluated sixteen research articles examining sensory modulation in 
individuals with rare genetic syndromes associated with ASD symptomology and ID. 
The review has highlighted a range of sensory modulation difficulties across domains 
and syndromes. Whilst the sensory profile phenotype is more consistently described by 
better quality research in some syndromes, such as FXS and WS displaying 
predominantly hypersensitivity difficulties and AS predominantly displaying hypo-
responsivity/sensory-seeking difficulties, there is a lack of research evidence to draw 
conclusions in other syndrome groups. Moreover, it is difficult to make comparisons of 
the sensory profile in genetic syndromes compared to that displayed in idiopathic ASD, 
due to the considerable inconsistency described in the ASD literature (Grapel, Cicchetti 
and Volkmar, 2015). This inconsistency could be a result of different sensory subtypes 
or a genuine range of sensory profiles due to internal and environmental interactions or 
a reflection of the inconsistencies in the research methodology, and sensory assessments 
lacking validation. It is also noteworthy that the systematic search found that a number 
of genetic syndromes, including Prader-Willi syndrome, Rett syndrome and CdLS had 
no research investigating the sensory profile of the syndrome, despite the high reported 
rates of ASD in these syndromes (Richards et al., 2015). 
 
The review was also able to draw on the literature to hypothesise about how the 
DSM-5 criteria changes might impact on individuals with genetic syndromes and ASD. 
Firstly, it is suggested that individuals with FXS are more likely to meet criterion B due 
to their frequency of hyper-responsivity and less likely to meet criterion A due to their 
desire to communicate socially (Garrett et al., 2004). This suggestion is supported by a 
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large national study which found that fewer individuals met criterion A, yet a high 
percentages met criterion B, as a result, meant that significantly fewer individuals with 
FXS met criteria for DSM-5 (27.8%) compared to DSM-IV (38.7%) (Wheeler et al., 
2015). Thus, it is proposed that individuals with FXS have a higher desire to 
communicate socially, but difficulties with hyper-sensitivity across modalities in the 
social environment, and social anxiety limit their communication ability (Cohen, 1995; 
Cohen, Vietze, Sudhalter, Jenkins and Brown, 1989; Roberts, Weisenfeld, Hatton, 
Heath and Kaufmann, 2007). 
 
It is suggested that this profile of ASD symptomology and DSM-5 implications 
are perhaps similar for other syndromes which have a behavioural phenotype consisting 
of a lack of social communication difficulties such as SMS or for syndromes or an over 
approachable personality including AS and WS. Therefore, the DSM-5 may have led to 
a reduction in individuals meeting criterion A. However, the research highlights these 
syndromes would be more likely to meet criterion B, due to the high incidence of 
unusual sensory symptoms.  
 
Individuals with DS are possibly less likely to meet both criterion A and B due 
to the lower frequency of social and sensory difficulties, which may reflect the low 
frequency of ASD symptomology in this group, although the research investigating DS 
had particularly weak methodology. In contrast individuals with PHMDS are perhaps 
more likely to meet both criteria due to the high frequency of sensory difficulties 
despite a lack of repetitive behaviour.  
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Clinical Implications 
Clinicians need to be made aware of the lack of published, valid assessment 
tools, which have been specifically designed for individuals with ASD to evaluate 
sensory symptoms. Whilst it is acknowledged this task would be challenging due to the 
heterogeneity of individuals with ASD, this is an ongoing difficulty in the research 
literature due to a lack of standardised normative data for ASD populations (Hazen, 
Stornelli, O’Rourke, Koesterer and McDougall, 2014) 11. 
 
It is recommended that assessments contain social and non-social items to isolate the 
role of sensory modulation difficulties in ASD, from the social communication 
symptoms. In addition, Schaaf and Lane (2015) suggested assessments need to be 
sensitive to age-related changes and to detect sensory symptoms in early development 
(2-5 years). Furthermore, that a comprehensive assessment should assess the frequency 
and type of sensory difficulties across multiple domains. Longitudinal assessments are 
also needed to measure sensory symptoms into adolescence and adulthood as these are a 
neglected research group. Furthermore, assessments should use multiple assessment 
methods, due to a lack of consistency between parent report measures and observations 
assessing the same sensory modality (Goldberg, Landa, Lasker, Cooper and Zee, 2000; 
Miller, Reisman, McIntosh and Simon, 2001). Specialist observations by clinicians are 
required to assess the underlying constructs displayed by specific behaviour, for 
example to observe if anxiety or sensory symptoms drive RRBI. 
                                                        
11 The gold standard assessment of sensory symptoms for children (four-years- eight-years, 
eleven-months) with ASD is the Sensory Integration and Praxis Test (SIPT; Ayers, 1989). 
However, it takes a long time to administer, needs to be administered by a trained therapist and 
is only suitable for those children which can understand and follow instructions, therefore, it is 
not suitable for use for individuals with syndromes associated with ID. 
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Research has suggested that the decrease in individuals with FXS meeting 
criterion A of the DSM-5 is perhaps due to increased sensitivity for identifying those 
individuals with ‘true’ ASD as opposed to anxiety or sensory symptoms which restricts 
social engagement (Wheeler et al., 2015). If this pattern of change and symptomology is 
true for other genetic syndromes, which is suggested by this review, then this may lead 
to differences in interventions. Therefore, individuals may perhaps receive interventions 
more specifically targeted at anxiety or sensory management, as opposed to social 
communication interventions. This will also have implications for service eligibility and 
provision (Taheri and Perry, 2012; Wheeler et al., 2015).  
 
Research and Theoretical Implications  
Future studies should use control groups, who are matched on level of disability. 
Lots of research has used different methods to determine mental age, which has limited 
the comparisons that can be made (Ben-Sasson et al., 2009). Rogers and Ozonoff (2005) 
made suggestions for future research including detailed demographics of participants 
and a clear diagnosis, use of clinical and TD control groups and use a combination of 
assessment methods e.g. behavioural and physiological. Moreover, many assessments 
lack construct validity, especially constructs of sensory symptoms and RRBIs, 
therefore, the relationship between the constructs needs to be established (Baranek et 
al., 2014; Militerni, Bravaccio, Falco, Fico and Palermo, 2002). It is finally 
recommended that research should examine how the DSM-5 changes impact on ASD 
diagnosis for individuals with a range of genetic syndromes. 
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Evaluation  
Whilst the review demonstrates strengths in the systematic search of the 
literature, it has not been able to conclusively calculate the amount of sensory 
symptoms across syndrome groups. The sensory literature reflects a broad range of 
terms and concepts even within the sensory modulation term, which perhaps reflects the 
unique sensory experiences of individuals (Baranek et al., 2014). However, the terms 
may also reflect different conceptualisations of sensory symptoms, which makes it 
difficult to draw comparisons between articles and consequently may have led the 
review to develop conclusions based on the same sensory terms, which perhaps present 
very different clinically for individuals. Furthermore, only one researcher evaluated the 
papers against the evaluation criteria, therefore inter-rater reliability was not 
established. Finally, the hypothesis made about the DSM-5 implications are only 
exploratory as the review only focused on sensory modulation as the other DSM-5 
criteria were not in the remit of the review.  
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CHAPTER 2 
 
Exploring the Behavioural Phenotype of Pallister-Killian Syndrome 
 
 
Abstract 
Introduction: Research has suggested individuals with Pallister-Killian 
Syndrome (PKS) have significant developmental delays, are non-verbal, non-mobile, 
have low adaptive skills, a lack of motivation to explore their environment and display 
challenging behaviour. However, the research has not used a comparative approach and 
has lacked well-validated assessment measures.  
Method: Sixteen parents of individuals with PKS completed questionnaires 
exploring challenging behaviour, mood, activity, repetitive behaviours, ASD 
symptomology and sensory symptoms. This data was compared against age and ability 
matched individuals with Angelman syndrome (AS) and non-matched individuals with 
AS, Fragile X syndrome (FXS) and Cornelia de Lange syndrome (CdLS).  
Results: The results revealed individuals with PKS displayed a range of 
abilities, but as a syndrome group they displayed a similar frequency of challenging 
behaviour, social communication and repetitive behaviours compared to individuals 
with AS. Individuals with PKS displayed lower mood and less over-activity, compared 
to individuals with AS. Individuals with to individuals with FXS and CdLS. 
Furthermore, individuals with PKS displayed less sensory seeking behaviours and more 
hyposensitivity behaviours compared to individuals with AS and FXS.  
Discussion: The results are discussed in relation to previous research examining 
PKS and established behavioural phenotype research of AS, FXS and CdLS. Clinical 
implications focus on the assessment of ASD symptomology and timely sensory 
interventions.  
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Introduction 
Pallister-Killian Syndrome (PKS) is a rare sporadic multisystem developmental 
disorder (Bartsch, Loitzsch, Kozlowski, Mazauric and Hickmann, 2005). The syndrome 
was first identified in an adult (Pallister et al., 1977) and child (Teschler-Nicola and 
Killian, 1981) who were reported to have mosaic isochromosome12 12p, which acted as 
a supernumerary marker chromosome. Both individuals were reported to display a 
similar phenotype, which was described as including: epilepsy, profound intellectual 
disability, “spasticity”, cataracts, kyphoscoliosis and “coarse” facial features. Since this 
original description research has focused on physical characteristics, physical health 
difficulties and genetic causes, with less focus on the behavioural phenotype of the 
syndrome.  
 
The percentage of cells containing the isochromosome depends on which tissue 
is examined (Blyth et al., 2015). Thus, the syndrome is possibly under-diagnosed due to 
difficulty in making a diagnosis from peripheral blood (Izumi and Krantz, 2014) and 
due to the wide range of ability displayed by individuals with PKS (Kostanecka Close, 
Izumi, Krantz and Pipan, 2012).  
 
Leube, Majewski, Gebauer and Royer-Pokora (2003) reported an individual with 
tetrasomic 12p mosaic in fibroblasts and trisomy 12p mosaic in lymphocytes who had a 
milder phenotype (at nineteen-months this individual was able to sit, grasp objects and 
began to develop speech). The authors argue there is a possible more favourable 
prognosis in individuals with 12p PKS, rather than i(12p) mosaic, where the mosaic is 
                                                        
12 An abnormal chromosome, which contains two identical arms, due to the duplication of one 
arm and the deletion of another.  
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absent in lymphocytes. However, more recent research has not confirmed genotype-
phenotype associations, with some data indicating no correlation between the mosaic 
ratio and severity of the phenotype (Wilkens et al., 2012; Tilton, Wilkens, Krantz and 
Izumi, 2014).  
 
Individuals with PKS have been reported to have numerous physical health 
difficulties, including structural heart differences (40%; Tilton, Wilkens, Krantz and 
Izumi, 2014), hypotonia (54.55%), hypermobility (40.91%), dental disruption (54.55%), 
seizures (72.73%; Blyth et al., 2015), early onset epilepsy (53%; Candee et al, 2012) 
and structural brain abnormalities (60-70%; Wilkens et al., 2012). Congenital anomalies 
include diaphragmatic hernia, exomphalos, anal atresia, sacral appendages and 
polydactyly (Bergoffen et al, 1993: Chaouachi, Ben, Ennine, Chaabouni, Sfar, 
Chaabouni, Marrakchi, 2010; De Oliveira, Ortega, Ciamponi, 2006: Schinzel, 1991). 
Gastrointestinal system disorders are also reported (52%) resulting in feeding 
difficulties, dysphagia, constipation and reflux (Izumi and Krantz, 2014: Wilkens et al., 
2012). 
 
Dysmorphic features include hypertelorism, epicanthic folds, flat nasal bridge, 
long philtrum, a large mouth, low-set posteriorly rooted ears, prominent forehead, 
anterior hairline, macroglossia, sparse eyebrows and eyelashes, alopecia (improving 
with age), micrognathia (especially in childhood), prognathia (especially in adulthood) 
and supernumerary nipples (Horneff, Majewski, Hildebrand, Voit, and Lenard, 1993: 
Genevieve et al., 2003).  
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Hearing impairments have also frequently been reported (75%; Kostanecka, 
Close, Izumi, Krantz and Pipan, 2012; 72%; Blyth et al., 2015) causing sensorineural 
(38%), conductive (29%) and mixed hearing loss (33%; Wilkens et al., 2012). Similarly, 
visual impairments are highly prevalent (72%; Blyth et al., 2015; 75%; Kostanecka, 
Close, Izumi, Krantz and Pipan, 2012) including myopia and hypermetropia, 
astigmatism or strabismus and significant visual pathway impairments, causing 
blindness (19%; Kostanecka, Close, Izumi, Krantz and Pipan, 2012; 40.90%; Blyth et 
al., 2015).  
 
There are significant physical and developmental delays in the PKS group, 
specifically; growth retardation is related to elevated levels of insulin-like growth factor 
binding protein-2 (IGFBP2) (Izumi et al., 2015). Most individuals with PKS described 
in the literature who are eighteen-months-old or older have no speech (73.1%) and most 
individuals who are four –years-old or older are unable to walk (61.8%) (Blyth et al., 
2015).  Therefore, PKS was thought to be associated with severe to profound 
intellectual disability, although more recent literature now reports individuals with PKS 
with higher levels of functioning, suggesting a wider spectrum of the phenotype (Blyth 
et al., 2015: Kostenecka, Close, Izumi, Krantz and Pipan, 2012). For example, a four-
year-old was able to speak five words but could not stand unsupported (Warburton, 
Anyane-Yeboa, Francke and Reynolds, 1987), whereas, adults have been reported to 
walk independently but could not speak (Reynolds et al., 1987: Quarrell, Hamill and 
Hughes, 1988). Another four-year-old was reported to be able to walk, although verbal 
abilities were not described (Speleman et al., 1991).  Genevieve et al., (2003) reported 
that an individual could independently sit at seven-months, walk at twenty eight -
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months and speak at three-years-old.  Wilkens et al., (2012) reported that children are 
able to roll at ten- months, independently sit at twenty-months, independently walk at 
thirty-eight-months and develop speech at thirty-six-months. Moreover, one individual 
with PKS had a reported IQ of eighty-one (Vogel, Lyngbye, Nielsen, Pedersen and 
Hertz, 2009). Finally, children have been reported to function in mainstream schools, 
although needing specialised schooling at seven-years (Warburton, Anyane-Yeboa, 
Francke and Reynolds, 1987) and fifteen-years-old (Genevieve et al., 2003).  
 
Blyth et al., (2015) population based study of twenty two individuals with PKS 
(age range four-months to thirty one-years) found a developmental delay in all cases, 
except a four-month-old. Eight of twenty individuals who were twelve-months or older 
were able to sit independently. Most individuals who were four-years or older were able 
to walk who were four- years or older, one individual who walked at youngest age was 
sixteen-months old. However, the authors also reported an eight-year-old learning to 
walk for the first time and an eighteen-year-old learning to toilet independently. 
Therefore, continued developmental progress can be gained, despite significant delay.  
 
Kostenecka, Close, Izumi, Krantz and Pipan, (2012) is the only population-
based study (sixteen individuals with PKS; age range: sixteen-months – nineteen-years) 
using a range of validated developmental assessments. The Vineland Adaptive Behavior 
scale (VABS) revealed that gross and fine motor skills were below an age equivalent of 
seven-month-old. Only two individuals were able to display purposeful hand 
movements; a nine-year, ten-month-old was able to hold a cup and a three-year, two-
month old was able to feed herself using her fingers. Furthermore, fourteen individuals 
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displayed verbal language abilities at below the age equivalent of a nine-month-old 
using the VABS. However, a sixteen-month-old showed the highest level of verbal 
ability and was able to produce fifty words.  
 
The authors also reported two individuals who were higher functioning. One 
individual was a six-year, seven-month female who displayed gross motor and daily 
living skills at the age equivalent of a twenty four-month old. She was able to walk 
independently, and feed and dress herself with help. She also had normal hearing and 
could communicate twenty words with additional use of communication gestures and 
the Social Communication Questionnaire (SCQ) revealed no indication of autism 
spectrum disorder (ASD). The second individual was a five-year, four-month old female 
who displayed gross motor and daily living skills at the age equivalent of a twenty four- 
month-old. She was able to walk and climb stairs independently. Her language abilities 
were at an age equivalent of a four-year, eleven-month-old, with auditory 
comprehension at a three-year, nine-month-old and expressive communication at a 
three-year, three-month-old using the VABS. She was able to speak in three or four 
word sentences. She had an IQ of sixty-nine using the Brief Intelligence Test.  
However, the SCQ indicated probable ASD and this was confirmed using the Autism 
Diagnosis Interviews (ADI).  
 
Stalker, Gray, Bent-Williams and Zori (2006) reported a single case study of an 
individual with PKS who rolled at six months, sat at nine months, walked at fifteen-
months and spoke first words at twelve-months and who had early intervention from 
occupational therapy, physical and speech therapies from fifteen-months-old. They also 
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reported good cognitive development at four years old with an IQ of eighty-three 
(Stanford-Binet). At age seven-years a full scale IQ was eighty-six, with verbal IQ of 
eighty-three and performance IQ of ninety-three (WISC III). They did note however, 
deficits in auditory memory and processing speed. At eleven-years old a full scale IQ 
was ninety-six, with fluid reasoning IQ of ninety-four and spatial visual IQ of ninety-
two. At thirteen-years-old a full scale IQ of ninety-three was reported (Stanford-Binet). 
At fourteen-years they reported average mathematical application (standard score: 
ninety-one, age equivalent: twelve-years), spelling ability (standard score: 105, age 
equivalent: fifteen-years, six-months) and reading comprehension (standard score: 
ninety-one, age equivalent: eleven-years, six-months) and above average ability in 
reading decoding (standard score: 112, age equivalent: eighteen-years, three-month). 
However, the authors reported below average skills in mathematic computation 
(standard score: seventy-six, age equivalent: nine-years, nine-months).  
 
There is a lack of research specifically examining the behavioural phenotype of 
PKS. Kostanecka, Close, Izumi, Krantz and Pipan, (2012) used the Aberrant Behavior 
Checklist (ABC) and identified many participants were described as “lethargic and 
withdrawn” (68%) and “drowsy during daily activities” (31%).  This in combination 
with visual and hearing difficulties, hypotonia and hyposensitivity (50%), may result in 
an apparent lack of motivation to explore the environment, consequently contributing to 
developmental delays displayed by individuals. However, the authors suggest this 
hypothesis needs to be further researched, as well as the high levels of tactile 
hyposensitivity, as no research has undertaken a comprehensive sensory assessment. 
Furthermore, the ABC has not been standardised in children younger than six-years-old 
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and has limited validity in children with multiple disabilities (Aman, Singh, Stewart and 
Field, 1985; Kostanecka, Close, Izumi, Krantz and Pipan, (2012). 
 
Many individuals with PKS are reported to display challenging behaviour, 
including self-stimulatory behaviour (45.45%; Blyth et al., 2015) and self-injurious 
behaviour (25%; Wilkens et al., 2012; 36.36%; Blyth et al., 2015),  mostly in the form 
of hand biting (Blyth et al., 2015). Filloux et al., (2012) reported individuals with 
hypohidrosis and who experience episodes of hyperventilation would deliberately hold 
their breath. Additionally, two individuals without hyperventilation deliberately held 
their breath and one individual was also described to breath-hold, which caused 
seizures. High frequencies of repetitive hand and body movements have also been 
reported (75%; Kostanecka, Close, Izumi, Krantz and Pipan, 2012) 
 
Blyth et al., (2015) reported 27.27% of individuals with PKS displayed features 
consistent with an ASD. Stalker et al (2006) also reported a 14-year-old individual with 
higher abilities, who had difficulties in social skills, daily living skills, had idiosyncratic 
speech, made repetitive movements and met diagnosis criteria for ASD. Similarly, 
Schinzel (1991) also reported an individual with ASD characteristics. However, none 
used standardised assessment and relied on clinical judgement. Whilst, Kostanecka, 
Close, Izumi, Krantz and Pipan (2012) used the Modified Checklist for Autism in 
Toddlers (M-CHAT), the Autism Diagnostic Interview Revised (ADI-R) and the SCQ 
to assess ASD symptomology, it was only used for individuals with a developmental 
age of more than 18-months-old, which excluded the majority of the sample.  
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Research into other genetic syndromes has revealed syndrome related 
behaviours, which has developed a precedent for establishing behavioural phenotype 
characteristics in other genetic syndromes, rather than simply classifying syndromes on 
the level of ID (Feinstein and Singh, 2007). The first behavioural phenotype was 
established for Lesch-Nyhan and Cornelia de Lange Syndromes (CdLS; Nylan, 1972). 
Dykens (1995) describes a behavioural phenotype as “the heightened probability or 
likelihood that the people with a given syndrome will exhibit certain behavioural and 
developmental sequelae relative to those without the syndrome” (as cited in Cook, 
2009; p.146).  
 
In summary, the research highlights a lack of an established behavioural 
phenotype despite three population-based studies (Wilkens et al., 2012) (Blyth et al., 
2015; Kostanecka, Close, Izumi, Krantz and Pipan, 2012); Wilkens et al., 2012). This is 
due to a lack of formal standardised assessments suitable for individuals with ID and 
research to date only involves single group descriptions of PKS. More recent 
behavioural phenotype research has concentrated on comparative approaches (Nelson, 
Moss and Oliver, 2014). This comparative approach is currently missing from the PKS 
literature, but is critical to developing the description of a behavioural phenotype.  
 
Therefore, comparisons needs to be made against other genetic syndromes with 
comparable level of disability, chronological age and gender to ensure findings are not 
artifacts of these characteristics (Dykens and Hadapp, 2001).  
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Individuals with Angelman Syndrome (AS) provide a useful comparison group, 
firstly due to their low adaptive ability (Peters, Beaudet, Madduri and Bacino, 2004), 
lack of mobility (Dan, Bouillot, Bengoetxea, Boyd and Cheron, 2001) and verbal 
communication (Jolleff and Ryan, 1993) allowing accurate matching of ability to 
participants with PKS and secondly due to the well-known behavioural phenotype of 
AS (see Table 1). Additional comparisons are also made with individuals with CdLS 
and FXS, also due to their ability and well-documented behavioural phenotype (see 
Table 1). 
 
Additionally, several domains need to be assessed to determine a behavioural 
phenotype including, behavioural self-regulation, sensory modulation, social 
development, cognitive and adaptive functioning, psychiatric disorders and challenging 
behaviour (Tierney, Nwokoro, Porter, Freund, Ghuman and Kelley, 2001), which again 
is absent from the previous PKS literature.  
 
Aims 
The aim of this study is to further characterise the behavioural phenotype of 
PKS, specifically by assessing autism symptomology, sociability, mood, challenging 
behaviour, repetitive behaviour, over-activity and impulsivity and sensory experiences.  
The research will use assessment questionnaires appropriate for individuals with 
intellectual disability, which are reliable and valid. Individuals with PKS will be 
compared to individuals with other genetic syndromes, including AS, CdLS and FXS 
(Table 2.1). In addition, the study aims to explore the wellbeing of parents/carers of 
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individuals with PKS, by specifically assessing clinical symptoms of anxiety and 
depression. 
  
 
1
3
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Table 2.1: Descriptions of Angelman Syndrome, Fragile X syndrome and Cornelia de Lange Syndrome. 
Syndrome Genetic Mechanisms Estimated 
Prevalence 
Behavioural Phenotype 
Angelman 
Syndrome 
(AS) 
Loss of functioning in the 
UBE3A gene on the 
maternally driven 
chromosome 15, 
predominantly due to 
deletions or imprinting errors 
(Kishino, Lalande and 
Wagstaff, 1997). 
One in 10,000-20, 
000 live births 
(Williams, 2005. 
Severe ID, speech and language delays, epilepsy, sleep difficulties, ataxic gait, sensory-
seeking behaviours and an excessive happy demeanour and laughing (Oliver, Horsler, 
Berg, Bellamy, Dick and Griffiths 2007; Williams et al., 2006).  Richards et al., (2015) 
reported an ASD prevalence of 34%. Peters, Beaudet, Madduri and Bacino (2004) 
found that individuals with AS can still lack social engagement and interaction skills. 
However, other research has reported that individuals with AS show appropriate social 
reciprocity, and emotional contact (Clayton-Smith and Lann, 2003; Thompson and 
Bolton, 2003) and less stereotyped and repetitive behaviours compared to individuals 
with idiopathic ASD.  
 
Fragile X 
Syndrome 
(FXS) 
The silencing of the FMR1 
gene at chromosome Xq27.3, 
leading to production of the 
Fragile X mental retardation 
protein (FMRP), which is 
associated with ID 
(Kaufmann and Reiss, 
1999).13 
One in 5,160 male 
births (more 
severely affected) 
(Coffee et al., 
2009) and one in 
8000 female births 
(Sherman, 2002). 
Hyperactivity, impulsivity, attention difficulties, anxiety, shyness, aggression, 
moderate ID, SIB, hand-flapping and hypersensitivity (Hagerman and Hagerman, 
2002). Richards et al., (2015) reported an ASD prevalence of 22%. The ASD 
symptomatology in FXS is different from idiopathic ASD (Kerby and Dawson, 1994). 
As a group, people with FXS are more able to recognise emotional expression (Turk 
and Cornish, 1998) and display better theory of mind skills (Mazzocco, Pennington and 
Hagerman, 1994).  
 
Cornelia de 
Lange 
Syndrome 
(CdLS) 
Predominantly (65%) due to 
heterozygous mutations in 
NIPBL on 5p13 or the 
SMC1A and SMC3 on 
Xp11.22-p11.21 and 10q24 
(Liu and Baynam, 2010).  
1.24 in 1000,000 
births (Barisic et 
al., 2008).  
Mild to profound ID, feeding difficulties, over-activity, mood disturbances, self-injury 
and stereotyped behaviours (Basile, Villa, Selicorni and Molteni, 2007; Berney, Ireland 
and Burn, 1999). Richards et al., (2015) reported an ASD prevalence of 43%; a high 
proportion compared to other genetic syndromes (Oliver, Arron, Hall and Sloneem, 
2008), yet lower levels of repetitive behaviours (Oliver, Berg, Moss, Arron and 
Burbidge, 2011). 
 
                                                        
13 The gene normally contains five-fifty repetitions of cytosine-guanine-guanine (CGG). Individuals with FXS have the full mutation and have more 
than 200 CGG sequences. 
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Method 
Recruitment 
Individuals with PKS were recruited via UNIQUE, which is a rare chromosome 
disorder support group. Families were contacted, inviting them to take part in the 
research by sending them a link to complete the questionnaires online using 
LimeSurvey. The invitation email was sent to fifty-two families and sixteen families 
gave consent and participated in the research (30.77% return rate).  
 
Procedure  
Participants were asked to complete a set of online questionnaires, which also 
contained information sheets, consent procedures and a background information 
questionnaire (Appendix 4). One follow up email was sent to remaining families about 
participating in the research, in an attempt to improve recruitment to the study. Ethical 
Approval for the study was approved by the Coventry NHS Research Ethics Committee 
(REC reference: 10/H1210/1) (Appendix 5).  
 
Participants 
There were sixteen individuals with PKS (Table 2.2), although one participant 
(ID=16) was excluded in all the analysis except for the health questionnaire due to their 
young age of 18-months-old, thus other assessments were not applicable. One 
participant (ID=7) was not included in the SCQ or the SQID analysis due to the 
assessments not being applicable to children under  four-years of age. All participants 
had an adequate amount of data (missing no more than two questionnaires) and all 
participants reported a PKS diagnosis confirmed by a clinical geneticist. Table 2 
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displays the demographic characteristics of the group. The mean age of the sample was 
10.57 years (SD=4.73; Range=three-twenty one years), eleven (73.33%) were male and 
three (20.00%) were classed as able/partly able (≥6 on the self-help subscale of the 
Wessex questionnaire; Kushlick, Blunden & Cox, 1973), four (26.60%) were mobile, 
four (26.60%) were verbal (used more than thirty words or signs), five (33.33%) had 
normal hearing and four (26.60%) had normal vision. 
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Table 2.2: Description of Individual Participants with Pallister-Killian Syndrome. 
                                                        
14 Data derived from the Wessex Scale (Kushlick, Blunden and Cox, 1973). 
15 Data derived from the Social Communication Questionnaire (SCQ; Rutter, Bailey and Lord, 2003). 
16 Data derived from the Challenging Behaviour Questionnaire (CBQ; Hyman, Oliver and Hall, 2002). 
ID Clinical 
Diagnosis 
Age Genetic Mechanism Gender Verbal Mobile Vision Hearing Self 
Help
14 
Autism 
cut off15 
SIB16 
1 
 
PKS 11  47,XY,+mar[9]/46,XY[6] Male No No Poor Deaf/Almost 3 Yes No 
2 
 
PKS 12  48,XY,i(12)(p10),+i(12)(p10) Male Yes Yes Normal Poor 7 No No 
3 
 
PKS 4 Additional genetic info not 
provided 
Male No No Poor Normal 3 Yes No 
4 PKS 16  Intrachromosomal triplication of 
12p. 46xytrp12pl 1.2p13113 / 46x 
Male No No Blind/Almost Deaf/Almost 3 Yes No 
5 
 
PKS 9 Missing Male No No Blind/Almost Deaf/Almost 3 Yes No 
6 
 
PKS 4 Missing Male No No Poor Poor 3 Yes Yes 
7 
 
PKS 3  47,XX,+mar Female No No Normal Poor 3 N/A N/A 
8 
 
PKS 13  Missing Female No No Blind/Almost Poor 3 Yes Yes 
9 
 
PKS 11  Missing Male Yes Yes Poor Normal 7 No Yes 
10 
 
PKS 21  47,XY,+i(12)(p10)dn Male No No Normal Normal 4 Yes Yes 
11 
 
PKS 11  47,XY,+i(12p)[3]/46,XY[6] Male No No Poor Poor 3 Yes Yes 
12 
 
PKS 13 Missing Female Yes Yes Normal Normal 9 No No 
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17 Participant excluded from analysis, due to their young age. 
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PKS 10  47,XY,+i(12)(p10)[24]/46,XY[6]d
e novo 
Male No No Poor Normal 4 No No 
14 
 
PKS 12 Missing Male No No Poor Poor 4 Yes Yes 
15 
 
PKS 7 Missing Female Yes Yes Poor Poor 3 No Yes 
16
17 
PKS 1 Missing Male No No Normal Normal 3 No No 
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Comparison group participants with AS had previously participated in other 
research investigating their behavioural phenotype and had given consent for their data 
to be included in future research. The group was matched, in descending order of 
priority, on chronological age (+/- 3 years), self-help score (+/- 3), gender, and whether 
individuals were verbal and mobile obtained from the Wessex Scale. Self-help scores 
were utilised as a proxy measures of degree of disability. Table 3 displays the 
demographic characteristics of the AS group. In total there were fifteen individuals with 
AS. The mean age of the sample was 10.33 years (SD=4.59; Range= two-twenty years), 
ten (66.67%) were male and three (20.00%) were able/partly able, seven (46.67%) were 
mobile, one (6.67%) was verbal. No significant differences were found between the 
groups for age (U=.007, N1 =11, N2 =10, p=.934) gender (χ
2
=.159, (1), p=.500), self-
help (U=.077, N1 =3, N2 =3, p=.782), mobility (U=.708, N1 =2, N2 =4, p=.400) or 
verbal ability (χ
2
= 2.160, (1), p=.142) (Table 2.3). 
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Table 2.3: Demographic Characteristics and Statistical Analyses for Participant 
Groups: Pallister-Killian Syndrome and Matched Individuals with Angelman 
Syndrome. 
 
 PKS 
N=15 
AS 
N=15 
Chi squared and Mann-
Whitney U significant 
tests 
χ
2
/U 
df p value 
Age Mean 10.47 10.33 .007 1 .934 
(sd) 4.73 4.59 
Range 1-21  2-20 
Median 11  10 
IQR 7-13 6-14 
Gender  Male 
(%) 
11 
(73.33%) 
10 
(66.67%) 
.159 1 .500 
Self Help Mean 4.13 3.93 .077 1 .782 
(sd) 1.92 1.67 
Range 3-9 2-7 
Median 3 3 
IQR 3-4 3-4 
Mobility Mean 3.33 3.87 .708 1 .400 
(sd) 1.68 1.81 
Range 2-6 2-6 
Median 2 4 
IQR 2-5 2-6 
Verbal18       (%) 4 
(26.67%) 
1 
(6.67%) 
2.160 1 .142 
 
As it was not possible to use the matched AS participants on every 
questionnaire, data from additional groups of non-matched participants with AS, FXS 
and CdLS were used for the Sociability Questionnaire for Intellectual Disability (SQID) 
and the Sensory Experience Questionnaire (SEQ). Whilst there were no significant 
group differences in age there were significant differences between groups in their 
gender distribution (χ
2
=31.869, (3), p<.001), self-help skills (h=37.456, (3), p<.001); 
the PKS group displayed a lower ability in comparison to the FXS group (U=75.329, N1 
=3, N2 =7, p<.001) and mobility (h=29.665, (3), p<.001); The PKS group were less 
                                                        
18 Able to speak or sign more than thirty words. 
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mobile in comparison to the AS group (U=-37.083, , N1 =2, N2 =5, p<.001) and the 
FXS group (U=69.454, N1 =2, N2 =5, p<.001) (Table 2.3). 
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Table 2.4: Demographic Characteristics and Statistical Analyses for Participant Groups: Pallister-Killian Syndrome and Non-Matched 
Individuals with Angelman Syndrome, Fragile X Syndrome and Cornelia De Lange Syndrome. 
 
 PKS AS (Non-
Matched 
CdLS FXS Chi Squared and Kruskal-
Wallis Significant Tests 
Post Hoc Mann-Whitney U 
Significant Tests 
χ
2
/h 
Df p Value Significant 
PKS 
Direction 
χ
2
/h 
p Value 
N 15 91 28 40 6.991 3 .072 N/A N/A N/A 
Age Mean 10.47 7.29 7.89 9.25    
(sd) 4.73 3.73 4.10 3.84    
Range 1-21  2-15 2-15 2-15    
Median 11  7 7.5 9    
IQR 7-13 4-10 4-12 5-12    
Gender  Male 
(%) 
11 45 17 40 31.869 3 <.001 PKS<FXS 11.503 0.00419 
Self Help Mean 4.13 4.96 4.68 6.65 37.456 3 <.001 PKS<FXS 75.329 <.001 
(sd) 1.92 1.48 1.81 1.53    
Range 3-9 3-9 3-9 6-7.75    
Median 3 4 4 7    
IQR 3-4 4-6 3-6 3-9    
Mobility Mean 3.33 4.74 4.29 5.63 29.665 3 <.001 PKS<AS 37.083 0.027 
(sd) 1.68 1.41 1.67 0.95 PKS<FXS 69.454 <.001 
Range 2-6 1-6 2-6 2-6    
Median 2 5 4.5 6    
IQR 2-5 4-6 2.25-6 6-6    
                                                        
19 Fishers exact p value reported as 50% had an expected count <5. 
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Measures 
Parents/careers completed eleven questionnaires suitable for individuals with ID. 
This included the demographic questionnaire, which obtained information about age, 
gender, mobility, verbal ability, parent age and income and diagnosis information, 
including the time of diagnosis and precise genetic mechanism. Other questionnaires 
included the Challenging Behaviour Questionnaire (CBQ; Hyman, Oliver and Hall, 
2002), the Sensory Experience Questionnaire (SEQ; Baranek, 1999), The Activity 
Questionnaire (TAQ; Burbidge and Oliver, 2008), the Health Questionnaire (HQ; Hall, 
Arron, Sloneem and Oliver, 2008), the Mood, Interest and Pleasure Questionnaire 
(MIPQ; Ross and Oliver, 2003), the Repetitive Behaviour Questionnaire (RBQ; Moss, 
Oliver, Arron, Burbidge and Berg, 2009), the Sociability Questionnaire for Intellectual 
Disability (SQID; Collins and Oliver, 2007), the Social Communication Questionnaire 
(SCQ; Rutter, Bailey and Lord, 2003) and the Wessex Questionnaire (WQ; Kushlick, 
Blunden and Cox, 1973). These questionnaires were parent reports of their child’s 
health, wellbeing and behaviour. The Hospital Anxiety and Depression Scale (HADS; 
Zigmond and Snaith, 1983) was used to assess parents/carers own mental wellbeing 
(Table 2.5; Appendix 6: full assessments with copyright permission only). 
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Table 2.5: Descriptions of the Assessments and including the Psychometric Properties. 
 
Assessment Authors Description of the Assessment Psychometric Properties 
Challenging 
Behaviour 
Questionnaire 
(CBQ) 
Hyman, 
Oliver and 
Hall 
(2002),  
The questionnaire is in two parts. Part one 
assesses the presence or absence of five types of 
challenging behaviour; self-injury, physical 
aggression, verbal aggression, destruction of 
property and inappropriate vocalizations over the 
last month. It also assesses eight topographies of 
self-injurious behaviour (Bodfish et al., 1995). 
Part two determines the severity of each 
challenging behaviour identified in part one. 
Responses are on a five-point scale.  
The authors reported Inter-rater reliability of .61-.89. 
Hospital Anxiety 
and Depression 
Scale (HADS) 
Zigmond 
and Snaith 
(1983) 
A screening assessment to detect anxiety and 
depression in adults. It contains fourteen items in 
total with two scales the HADS-D (depression) 
and HADS-A (anxiety) containing seven items 
each. The questionnaire includes symptoms of 
physical disorders.  
The measure has been reviewed to be both reliable and 
valid (Bjelland, Dahl, Haug and Neckelmann, 
2002;Hermann, 1997).  
Cut off scores of 8> in each scale are suggested to identify 
depression/anxiety, with sensitivity and specificity of .90 
(Abiodun, 1994). Although using a cut-off score of 9> in 
the HADS-A had sensitivity of .66 and specificity of .93. 
Using a cut-off score of 7> in the HADS-D had sensitivity 
of .66 and specificity of .97 (El Rufaie and Absood, 1995).  
Good internal consistency between HADS-A and HADS-D 
(r=.40-.74; Bjelland, Dahl, Haug and Neckelmann, 2002). 
Research also confirmed the two factor model (Lisspers, 
Nygren and Soderman, 1997).  
Good concurrent validity with the Beck Depression 
Inventory (r=.73; Lisspers, Nygren and Soderman, 1997) 
and the General Health Questionaire-28 (r=.50-.68; Caplan, 
1994).  
Sensory 
Experience 
Questionnaire-
Baranek 
(1999) 
A forty-one-item parent report questionnaire to 
assess children’s behavioural responses to a range 
of sensory activities in children aged six-months 
Discriminant validity good between individuals with ASD 
and TD (sensitivity= 72-80%, specificity= 44-77%; 
Baranek, David, Poe, Stone and Watson, 2006).  
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Assessment Authors Description of the Assessment Psychometric Properties 
Short Form 
(version 2.1) 
(SEQ) 
to six-years. It assesses frequency of sensory 
behaviours across sensory response patterns, 
modalities and social and non-social contexts. The 
first fifty-three items assess frequency of sensory 
behaviours on a five-point likert scale ranging 
from ‘almost never’ to ‘almost always’. The final 
questions are not score, but give qualitative 
contextual information. A total score is given, 
plus sub-scores for three types of sensory patterns 
including; hyper-responsivity, hypo-responsivity, 
and sensory-seeking, and scores for each of the 
five modalities including; auditory, visual, tactile, 
gustatory and vestibular, and a score for social 
and non-social contexts. A higher score indicates 
more severe sensory symptoms. 
Internal consistency for repetitive and sensorimotor 
behaviours= .83 and for insistence on sameness= .73. Test-
retest reliability= .95, inter-rater reliability=.95 (Hason, 
Siderdis, Jackson, Porche, Campe and Huntington, 2016). 
The 3 responses patterns were validated in confirmatory 
factor analysis (Watson, Pattern, Baranek, Poe, Boyd and 
Lorenzi, 2009).  
High internal consistency for each domain; hyper-
responsivity (α =.73), hypo-responsivity (α =.75), sensory 
seeking (α =.80), social contexts (α =.69), and non-social 
contexts (α =.78).  
Good concurrent validity with the Sensory Processing 
Assessment (Baranek and Costello, 2003) 
Also used to determine sensory patterns in children with 
genetic syndromes up to eighteen-years-old including 
Angelman syndrome (Walz and Baranek, 2006) and Fragile 
X Syndrome (Baranek et al., 2008).  
The Activity 
Questionnaire 
(TAQ). 
Burbidge 
and Oliver 
(2008). 
An eighteen-item questionnaire used to assess 
frequency of activity. It contains three subscales 
measuring over activity, impulsivity and 
impulsive speech. Informants respond on a five-
point scale ranging from zero (never/ almost 
never)- five (always/ almost all of the time). 
The measure has good item level inter-rater reliability 
(range= .31-.75, mean= 0.56). Test-retest reliability (range= 
.60-.90, mean= 0.75) and moderate internal consistency 
(.50-.59) (Burbidge et al., 2010). The authors also report 
that factor analysis confirmed the integrity of the sub-
scales.  
The Health 
Questionnaire 
(HQ) 
Hall, 
Arron, 
Sloneem 
and Oliver 
(2008). 
A fifteen-item questionnaire, which measures the 
presence and severity of health difficulties total 
score by adding two subsections; lifetime and the 
last month. The assessment is based on health 
problems in the Tenth Revision of the 
International Statistical Classification of Disease 
and related Health Problems or ICD-10 (World 
Health Organisation, 1998). Responses are 
recorder on a three-point scale ranging from zero 
The authors report the measure has good kappa coefficient 
inter-rater reliability for the lifetime total (=. 72, range= 
.32-1.00) and for the last month total (= .76, range= .32-
1.00). Good internal consistency fir individuals with Rett 
syndrome (=.77; Clanfaglione, Clarke, Kerr, Hastings, 
Oliver and Felce, 2015).  
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Assessment Authors Description of the Assessment Psychometric Properties 
(never) to three (Severe problems). There is a total 
score for the last month and lifetime difficulties.  
The Mood Interest 
and Pleasure 
Questionnaire- 
Short Form 
(MIPQ-S).  
Ross and 
Oliver 
(2003). 
A questionnaire to measure two sub scales of 
mood and interest and pleasure. The measure has 
twelve items and is based on behavioural signs in 
last two weeks. It has a five-point scale, with a 
maximum score of fourth-eight; a higher score 
indicates positive effect and higher interest and 
pleasure.  
The authors report the measure has good test-retest 
reliability (.97), inter-rater reliability (r=.85) and internal 
consistency ( total=.88, mood= .79, interest and 
pleasure=.87) 
The measure has good concurrent validity as it correlated 
highly with the lethargy and social withdrawal scale on the 
Aberrant Behavior Checklist (ABC: Aman, Singh, Stewart 
and Field, 1985; .73).  
The Repetitive 
Behaviour 
Questionnaire 
(RBQ) 
Moss, 
Oliver, 
Arron, 
Burbidge 
and Berg 
(2009). 
A nineteen-item questionnaire used to measure 
repetitive behaviours using five subscales: 
Stereotyped behaviour, compulsive behaviour, 
insistence on sameness, restricted preferences and 
repetitive speech. Informants rate the frequency of 
operationally defined behaviours over the last 
month on a five-point Likert scale ranging from 
‘never’ to ‘more than once a day’.  
The assessment contains four items only 
applicable to verbal individuals. Thus, there are 
two different scoring methods for verbal and non-
verbal individuals. For verbal individuals the total 
score range is zero to seventy-six and for non-
verbal individuals the range is zero to sixty. The 
item level clinical cut-off score is ≥3 on an item. 
At the subscale level the cut off is three or more 
on at least one item within the subscale.  
The authors report good Spearman’s coefficient inter-rater 
reliability (.46-.80), and good Spearman’s test retest 
reliability (61-.93). The assessment has good internal 
consistency for the full scale (α>.80) and for the stereotyped 
behaviour and compulsive behaviour subscales (α>.70), 
although lower consistency for the restricted preferences 
(α=.50), repetitive speech (α=.54) and insistence on 
sameness (α=.65) subscales.  
The assessment also has good context and concurrent 
validity as it correlated with the repetitive behaviour 
subscale from the Autism Screening Questionnaire 
(Berument et al., 1999) (.60; p<.001).  
The Sociability 
Questionnaire for 
Intellectual 
Disabilities (SQID) 
Collis and 
Oliver 
(2007) 
An informant based questionnaire, which assesses 
social interaction and social anxiety with familiar 
and unfamiliar people. Items one to twenty-one 
ask how frequently individuals initiate social 
interaction using verbal and non-verbal strategies 
The assessment has good concurrent validity with the Child 
Sociability Rating Scale (CSRS, Moss et al., 2013) (r=.36-
.52). The SQID also has good inter-rater reliability for items 
1-21 (r=.43-.80) and for questions, 22-25 ( α>=.44-.96). 
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Assessment Authors Description of the Assessment Psychometric Properties 
on a seven-point scale from rarely/never to nearly 
always. Items twenty-two to twenty-five ask about 
the use of language using a yes or no answer. It 
comprises twenty-five items and contains eight 
subscales (four familiar and four unfamiliar) 
including; receive interaction (receiving an 
interaction/being approached by another), ongoing 
interaction (one-on-one ongoing interaction), 
approach or initiate interaction (initiating an 
interaction with another) and performance (a 
group interaction). It also assesses behaviours 
indicative of selective mutism. The informant 
completes the questionnaire based on the 
participant’s behaviour in social settings over the 
past two months.  
 
Clinical cut-off points for subscales for excessive 
sociability (>13) and shyness (<3).  
The Social 
Communication 
Questionnaire 
(SCQ). 
Rutter, 
Bailey and 
Lord 
(2003). 
A questionnaire used to screen for ASD 
symptomatology, by assessing communication, 
social functioning and repetitive and stereotyped 
patterns of behaviour. It contains forty items 
requiring a yes/no response.  
Has cut-off score for Autism (≥22) and ASD 
(≥15). 
Using a cut-off score of fifteen the questionnaire was able 
to discriminate between individuals with Pervasive 
Developmental Disorder (PDD) and individuals with other 
diagnoses, with a specificity of .80 and sensitivity of .96, 
and between individuals with ASD from individuals with 
ID, with a specificity of .67 and sensitivity of .96. Using a 
higher cut-off score of 22 the assessment was able to 
discriminate between individuals with Autism and other 
PDD with a sensitivity of .75 and specificity of .60.  
The measure has good convergent validity, due to a high 
correlation with the Autism Diagnostic Interview (ADI) and 
the Autism Diagnostic Observation Schedule (ADOS: 
Berument et al., 1999; Bishop and Norbury, 2002). 
Specifically, Howlin and Karpf (2004) reported high 
internal consistency and concurrent validity with the ADOS 
and ADI with individuals with Cohen Syndrome.  
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Assessment Authors Description of the Assessment Psychometric Properties 
 
The Wessex 
Questionnaire 
(WQ) 
Kushlick, 
Blunden 
and Cox 
(1973) 
The questionnaire assesses the degree of ID and 
presence of speech. It has two overall factors; the 
social and incapacity (SPI) scale and the Speech, 
Self-help and Literacy (SSL) scale, which 
includes five subscales; continence, mobility, self-
help skills, speech and literacy.  
The authors report the measure has good inter-rater 
reliability for the SPI (α=0.65) and the SSL(α=0.76). 
Modest inter-rater reliability for each subscale ( α=.54-.62) 
and overall classification ( α=.64).  
Appropriate for large study questionnaire research with 
both children and adults (Palmer and Jenkins, 1982). 
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Data Analysis 
Given the small sample size and resultant difficulties assessing adherence to the 
additional assumptions of parametric tests, non-parametric tests were utilised where 
possible.  
 
Group Comparisons 
In order to compare behaviours reported in the PKS group with those of the 
matched AS comparison group, total and subscale scores were analysed for mood (using 
the MIPQ), repetitive behaviours (using the RBQ) and activity (using the TAQ). A 
series of Mann-Whitney U tests were performed to test for group differences in the 
subscales between the two groups. The proportions of individuals displaying a range of 
challenging behaviours in each syndrome group was also compared using Chi-Squared 
tests and Fishers, and the severity of challenging behaviour was compared between 
syndrome groups using a Mann-Whitney U test (using the CBQ).  
 
The profile of autism phenomenology (using the SCQ) in the PKS group 
(participants aged >4 years-old) was explored by comparing total and subscale scores 
with those of the AS matched syndrome group, and testing for significant differences 
using the Mann-Whitney U test. To investigate the prevalence of autism 
phenomenology in the PKS and AS matched group, the percentage of each group 
scoring above the cut-off for ASD (>15) and autism (>22) on the SCQ was assessed. 
Differences in the frequency with which individuals in the two groups scored above 
these cut-off scores were compared using Chi-Square tests. To further explore the 
sociability (using the SQID) of individuals with PKS, total and subscale scores were 
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compared against non-matched AS, CdLS and FXS groups using a series of Kruskal-
Wallis tests and, where significant group differences were identified, post-hoc 
compassions were made using Mann-Whitney U tests.  
 
Sensory experiences (using the SEQ) in PKS were explored by comparing total 
and subscale scores from the SEQ between the non-matched AS, CdLS and PKS group 
using a series of Kruskal-Wallis tests and where significant group differences were 
identified, post-hoc contrast were made using Mann-Whitney U tests.  
 
Relationships between variables for participants with PKS 
For participants with PKS, non-parametric correlations with age of mood, 
sociability and hyperactivitiy/impulsivity were undertaken. These are variables known 
to systematically vary with age for some other groups, such as CdLS (Berney, Ireland 
and Burn, 1999; Nelson, Moss and Oliver, 2014; Oliver, Berg, Moss, Arron and 
Burbidge, 2011) and Kleefstra Syndrome (unpublished data).  
 
Alpha  
Effects at p<0.05 are reported as significant. This is despite the numerous tests 
employed. It is acknowledged that this raises the possibility of Type I errors (rejecting 
the null hypothesis incorrectly). However, where samples are small, as tends to be the 
case for research into rare syndrome groups, there is always a substantial risk of making 
Type II errors (accepting the null hypothesis incorrectly) due to insufficient power. 
Thus, effects are reported as significant at p < 0.05, it must be borne in mind at the point 
of interpretation that caution is required, and replication in future studies is paramount.  
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Results 
Health Questionnaire 
The most frequently reported lifetime health difficulties were ear problems 
(n=14, 87.6%)20, which were mostly described as moderate difficulties (n=6, 37.5%) for 
which eleven individuals (68.8%) needed corrective treatment. The second most 
frequent reported health difficulty was dental problems (n=13, 81.4%), which were 
mostly described as mild (n=5, 31.3%) and moderate (n=5, 31.3%), for which four 
individuals (25%) needed corrective treatment. Other frequent health difficulties were 
epilepsy/seizures (n=11, 88.8%; moderate: n=5, 31.3%), skin problems (n=10, 62.5%; 
mild: n=8, 50%) and gastrointestinal problems (n=8, 50%, moderate: n=4, 25%) (see 
Appendix 7). 
 
Challenging Behaviour 
Approximately half of the individuals with PKS displayed SIB (n=7, 46.67%) 
and stereotyped behaviour (n=8, 53.33%) in the last month, with lower levels of 
physical aggression (n=2, 13.33%) and destruction of property (n=3, 20.00%). The 
frequency of property destruction and physical aggression was lower than that seen for 
the AS group, although, there were no significant differences between groups in SIB 
(χ
2
=0.556, (1), p=.456), destruction of property (χ
2
=2.400, (1), p=.121), physical 
aggression (χ
2
=3.968, (1), p=.109) and stereotyped behaviour (χ
2
=0.130, (1), p=.713).  
The PKS group’s challenging behaviour is displayed with lower severity than 
seen for the AS group (U=5.056, N1 =6, N2 =9.5, p=.025) (Table 2.6).  
                                                        
20 Percentages displayed for the whole sample. 
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Table 2.6: Number and Percentage of Individuals with Pallister-Killian Syndrome 
and Matched Individuals with Angelman Syndrome displaying Challenging 
Behaviour and Chi-Squared Analysis. 
 
 PKS 
N=15 
AS 
N=15 
Chi-Squared Test 
 
χ
2
 
df p Value 
Displayed SIB in the last month 
(%) 
 
7 
(46.67%) 
5 
(33.33%) 
0.556 1 .456 
Displayed Destruction of 
Property in the last month (%) 
 
3 
(20.00%) 
7 
(46.67%) 
2.400 1 .121 
Displayed Physical Aggression in 
the last month (%) 
 
2 
(13.33%) 
7 
(46.67%) 
3.968 1 .10921 
Displayed Stereotyped Behaviour 
in the last month (%) 
8 
(53.33%) 
9 
(60.00%) 
0.130 1 .713 
 
Mood 
Individuals with PKS showed significantly lower scores than individuals with 
AS on the mood subscale (U=17.019, N1 =14, N2 =22.50, p<.001), interest and pleasure 
subscale (U=10.084, N1 =11, N2 =18.5, p<.001) and total MIPQ score (U=14.944, N 1 
=25, N2 =40, p<.001) (Table 2.7). 
 
For the PKS group, there was a strong positive correlation between age and the 
mood subscale of the MIPQ (rs = 0.70, p = 0.003, n = 16), indicating that older 
participants may be reported to display more positive mood than younger participants.  
 
Activity 
Individuals with PKS showed significantly lower scores compared to individuals 
with AS on the impulsivity subscale (U=4.576, N1 =3, N2 =7, p=.032), over-activity 
                                                        
21 Fishers exact p value reported as 50% had an expected count <5.  
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(U=7.398, N1 =6, N2 =18, p=.007) and total TAQ score (U=6.945, N 1 =12, N2 =18, 
p=.008) (Table 2.7). 
 
There were no significant or near-significant correlations of any of the TAQ 
scores with age for the PKS group, indicating no systematic linear association with age 
in measures of activity. 
 
Behaviours associated with Autism 
Repetitive Behaviours 
Individuals with PKS displayed a similar score to the AS group on the total 
RBQ score (U=0.758, N1 =11, N2 =12, p=.384), the stereotyped behaviour subscale 
(U=82.99, N1 =8, N2 =8, p=.191), compulsive behaviour subscale (U=111.00, N1 =0, 
N2 =0,  p=.929) and the insistence on sameness subscale (U=112.00, N1 =0, N2 =0, 
p=.972) demonstrating both groups displayed similar levels of repetitive behaviour 
(Table 2.7).  
 
Items typically requiring higher levels of ability were rarely endorsed by 
informants (e.g., repetitive questioning, n=2, 14.3%; excessive cleaning, n=1, 7.1%). 
However, some other items were endorsed more frequently, including object 
stereotypy22 (n=7, 50.0%; all of these at least once a day), body stereotypy (n=8, 57.1%; 
n=7, 50.0% at least once a day) and hand stereotypy (n=9, 64.3%; n=8, 57.1% at least 
                                                        
22 A term used to categories repetitive behaviors often displayed by individuals with Autism, 
which offer sensory automatic feedback and socially mediated reinforcement (Cunningham and 
Schreibman, 2008).  
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once per day). Also five people were reported to show a strong attachment to specific 
objects (n=5, 35.7%; n=4, 28.6% at least once a day). 
 
 Autism Spectrum Disorder 
Individuals with PKS showed significantly higher scores compared to 
individuals with AS on the total SCQ (U=48.50, N1 =23, N2 =20, p=.021). However, 
there were no significant differences between the two groups on any of the subscales 
including Communication (U=4.576, N1 =3, N2 =7, p=.734), Repetitive, Restrictive and 
Stereotyped Behaviors (U=128.00, N1 =13, N2 =13, p=.178), and Reciprocal Social 
Interaction (U=168.00, N1 =12, N2 =9, p=.114) (Table 2.7).  
 
In both groups nearly all participants (92.9%) met criteria for ASD according to 
the SCQ, suggesting similar prevalence rates of ASD (χ
2
=0.000, (1), p=.759). However, 
significantly more individuals from the PKS group compared to the AS group met 
criteria for Autism, suggesting a higher prevalence rate of Autism for individuals with 
PKS (χ
2
=7.337, (1), p=.007) (Table 2.8). 
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Table 2.7: Median (Inter Quartile Range) for Pallister-Killian Syndrome and 
Matched Individuals with Angelman Syndrome Subscales of the Challenging 
Behaviour Severity Score, Mood, Interest and Pleasure Questionnaire, the Repetitive 
Behaviour Questionnaire, the Activity Questionnaire and the Social Communication 
Questionnaire with Results for Mann-Whitney U Analysis.  
 PKS AS Mann-Whitney U Test 
U df p Value 
CBQ Severity N 7 6 5.056 1 .025 
 Median 6 9.5 
IQR 
 
3-9 8.25-11.25 
MIPQ 
Mood 
N 15 14 17.019 1 <.001 
 Median 14 22.50 
IQR 
 
13-16 21-23 
MIPQ Interest and 
Pleasure 
N  15 14 10.084 1 .001 
 Median 11 18.5 
IQR 
 
8-14 15-21.5 
MIPQ Total N 15 14 14.944 1 <.001 
 Median 25 40 
IQR 
 
23-30 35.5-44 
RBQ total N 15 15 .758 1 .384 
Median 11 12 
IQR 
 
8-16 9-14 
RBQ- Stereotyped 
Behaviour 
N 15 15 82.00 1 .191 
Median 8 8 
IQR 
 
0-12 8-12 
RBQ- Compulsive 
Behaviour 
N 15 15 111.00 1 .929 
Median 0 0 
IQR 
 
0-0 0-0 
RBQ- Insistence on 
Sameness 
N 15 15 112.00 1 .972 
Median 0 0 
IQR 
 
0-0 0-0 
TAQ- 
Impulsivity 
N 15 15 4.576 1 .032 
 Median 3 17 
IQR 
 
0-11 6-22 
TAQ- Overactivity N 15 15 7.398 1 .007 
 Median 6 18 
IQR 
 
2-13 15-24 
TAQ Total N 15 15 6.945 1 .008 
 Median 12 18 
IQR 5-31 15-24 
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 PKS AS Mann-Whitney U Test 
U df p Value 
 
 
SCQ- Total 
 
N 
 
14 
 
14 
 
48.50 
 
1 
 
.021 
Median 23 20 
IQR 19.75-
25.25 
17.75-
20.75 
SCQ- Communication N 14 14 106.00 1 .734 
Median 13 13 
IQR 8.75-
13.00 
11-13 
SCQ- Restricted, 
repetitive and stereotyped 
behaviours 
N 14 14 128.00 1 .178 
Median 2 2.50 
IQR 
 
2-4.25 1-3.5 
SCQ- Reciprocal Social 
Interaction 
N 14 14 168.00 1 .114 
Median 12 9.00 
IQR 8.50-
13.25 
8.50-10.50 
 
Table 2.8: Number and Percentage of Individuals with Pallister-Killian Syndrome 
and Matched Individuals with Angelman Syndrome Meeting Criteria for ASD and 
Autism from the Social Communication Questionnaire and Chi-Squared Analysis. 
 
 PKS 
N=14 
AS 
N=14 
Chi-Squared Test 
 
χ
2
 
df p. Value 
Met ASD criteria from the SCQ 
(%) 
 
13 
(92.9%) 
13 
(92.9%) 
0.000 1 .75923 
Met Autism criteria from the 
SCQ (%) 
9 (64.3%) 2 (14.3%) 7.337 1 .007 
 
Sociability 
Overall analyses for PKS, AS, FXS, and CdLS showed significant group 
differences on familiar (h=69.439, (3), p<.001) and unfamiliar subscales (h=84.956, (3), 
p<.001) of the SQID. Post hoc analysis revealed that individuals with PKS displayed 
lower scores compared to individuals with AS on both familiar (U=-75.401, N1 =36, N2 
=53, p<.001) and unfamiliar subscales (U=-50.077, N1 =28, N2 =41, p=.004), 
indicating individuals with PKS were less sociable. This pattern of lower scores 
                                                        
23 Fishers exact p value reported as 50% had an expected count <5. 
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compared to the AS group was reported on all subscales except for interaction with 
unfamiliar individuals (p>.050). There were no significant post hoc differences between 
PKS and CdLS and PKS and FXS participants, except there was a trend24 for 
individuals with PKS to display significantly lower scores compared to individuals with 
FXS for approaching or initiating interaction with familiar others (U=-41.423, N1 =5, 
N2 =10, P=.047), implying that individuals with PKS may approach/initiate interaction 
with familiar others less than people with FXS do. Overall, data from the SQID suggest 
that individuals with PKS may display levels of sociability similar to individuals with 
CdLS and FXS (Table 2.9). 
 
There were significant positive correlations with age for the PKS group on the 
Total Familiar (rs = 0.55, p = 0.04, N = 14), the Familiar Approach or Initiate Interaction 
(rs = 0.62, p = 0.019, N = 14), and the Unfamiliar Approach or Initiate Interaction (rs = 
0.58, p = 0.03, N = 14) subscales, indicating greater sociability in some areas with age. 
                                                        
24 Caution needs to be taken when interpreting these results due to a possible type I error.  
 1
5
7
 
 
Table 2.9: Median (Inter Quartile Range) for Pallister-Killian Syndrome, and Non-Matched Individuals with Angelman Syndrome, 
Cornelia de Lange Syndrome and Fragile X Syndrome Subscales of the Sociability in Intellectual Disabilities Questionnaire with 
Results for Kruskal-Wallis Analysis and Post Hoc Mann-Whitney U Analysis. 
 
 PKS 
n= 13 
AS 
n= 91 
CdLS 
n=27 
FXS 
n=39 
Kruskal-Wallis Tests Post Hoc Comparison: Mann-Whitney U 
Test 
H df p PKS 
Significance 
Direction 
U df P Value 
Familiar Total Median 36 53 44 42 69.439 3 <.001 PKS<AS -75.401 1 <.001 
IQR 
 
28.50-44.50 49-55 35-48 36-47        
Familiar Receive 
Interaction 
Median 9 13 11 11 57.416 3 <.001 PKS<AS -57.907 1 <.001 
IQR 
 
8-13 12-14 9-12 9-12        
Familiar- 
Interaction 
Median 10 14 12 12 42.263 3 <.001 PKS<AS -61.852 1 <.001 
IQR 
 
9-12.50 13-14 10-13 11-13        
Familiar- 
Approach or 
Initiate interaction 
Median 5 13 9 10 41.261 3 <.001 PKS<FXS -41.423 1 .047 
IQR 
 
 
3.50-9.50 11-14 6-13 8-12    PKS<AS -74.566 1 <.001 
Familiar- 
Performance 
Median 9 14 12 9 75.883 3 <.001 PKS<AS -65.214 1 <.001 
IQR 
 
8-11 13-14 10-12 5-12        
Unfamiliar Total Median 28 41 28 18 84.956 3 <.001 PKS<AS -50.077 1 .004 
IQR 
 
26-31 32-50 21-39 11-24        
Unfamiliar 
Receive Interaction 
Median 8 10 7 4 80.685 3 <.001 PKS<AS -45.522 1 .010 
IQR 
 
 
7-8.5 9-12 5-10 3-5        
Unfamiliar- Median 8 11 8 5 60.078 3 <.001 - - - - 
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 PKS 
n= 13 
AS 
n= 91 
CdLS 
n=27 
FXS 
n=39 
Kruskal-Wallis Tests Post Hoc Comparison: Mann-Whitney U 
Test 
H df p PKS 
Significance 
Direction 
U df P Value 
Interaction IQR 8-9 8-12 4-10 2-7        
Familiar- 
Approach or 
Initiate interaction 
Median 4 10 6 5 61.967 3 <.001 PKS<AS -72.945 1 <.001 
IQR 2.50-5 8-12 4-8 3-6        
Unfamiliar- 
Performance 
Median 8 11 8 3 77.488 3 <.001 PKS<AS -40.489 1 .032 
IQR 6.5-8 9-13 5-11 2-4        
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Sensory Experiences  
Table 2.10 displays mean SEQ subscale scores with standard deviations for the 
PKS and unmatched comparison groups. Mean group scores are also classified 
according to Baranek’s (1999) classifications defined in relation to normative data for 
TD individuals. On average, participants with PKS displayed deficient25 sensory 
experiences in hypo-responsivity and in social, and displayed typical performance in 
hyper-responsivity and sensory seeking and in non-social contexts (Table 2.10).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                        
25 Criterion cut-points based on typically developing normative data (Baranek, 1999).  
Hypo-responsivity: Typical Range (6-10), At Risk Range (11-12) and Deficient Range (13-30), 
Hyper-responsivity: Typical Range (14-29), At Risk Range (30-34) and Deficient Range (35-
70), Sensory Seeking: Typical Range (13-38), At Risk Range (39-47) and Deficient Range (48-
65), Social Contexts: Typical Range (10-18), At Risk Range (19-21) and Deficient Range (22-
50), Non-Social Contexts: Typical Range (22-55), At Risk Range (56-65) and Deficient Range 
(66-110). 
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Table 2.10: Mean, Standard Deviation and Classification of Sensory Experiences in 
individuals with Pallister-Killian Syndrome, and Non-Matched Individuals with 
Angelman Syndrome, Cornelia de Lange Syndrome and Fragile X Syndrome. 
 
Raw Scores PKS 
n=15 
AS 
n=91 
CdLS 
n=28 
FXS 
n=40 
Hypo-
responsivity 
Mean 19.20 12.37 17.32 13.83 
SD 5.75 3.43 4.46 3.99 
Classification Deficient At Risk Deficient Deficient 
Typical % 
 
13.3% 34.1% 3.6% 20.0% 
Hyper-
responsivity 
Mean 28.47 28.21 34.11 34.20 
SD 5.10 6.66 9.42 9.23 
Classification Typical Typical At Risk At Risk 
Typical % 
 
53.6% 62.7% 36.0% 35.0% 
Sensory 
Seeking 
Mean 28.73 41.08 39.93 37.33 
SD 6.40 3.43 6.91 9.32 
Classification Typical At Risk At Risk Typical 
Typical % 
 
93.3% 36.3% 46.8% 55.0% 
Social Contexts Mean 23.87 20.44 25.43 25.13 
SD 4.41 4.05 6.88 6.48 
Classification Deficient At Risk Deficient Deficient 
Typical % 
 
20.1% 36.6% 14.4% 17.5% 
Non-Social 
Contexts 
Mean 49.73 59.42 63.54 58.53 
SD 7.08 7.95 10.04 11.07 
Classification Typical At Risk At Risk At Risk 
Typical % 
 
73.7% 28.6% 25.2% 40.0% 
 
 
There were significant differences across syndromes groups in the number of 
individuals scoring in the ‘typical’ range in all three sensory types and across social and 
non-social contexts (p<.050). Specifically, individuals with PKS had displayed 
significantly less sensory-seeking behaviours compared to individuals with AS 
(χ
2
=16.994, (1), p<.001), individuals with FXS (χ
2
=6.362, (1), p=.012) and individuals 
with CdLS (χ
2
=9.197, (1), p=.002). Furthermore, individuals with PKS had displayed 
significantly more sensory difficulties across non-social contexts compared to 
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individuals with AS (χ
2
=11.843, (1), p=.001), individuals with FXS (χ
2
=4.850, (1), 
p=.028) and individuals with CdLS (χ
2
=9.376, (1), p=.002) (Table 2.11).
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Table 2.11: Number of Individuals with Pallister-Killian Syndrome, and Non-Matched Individuals with Angelman Syndrome, Cornelia 
de Lange Syndrome and Fragile X Syndrome Scoring in the ‘Typical’ Category on the Sensory Experience Questionnaire with Results 
for the Chi-Squared Analysis. 
 
Raw Scores PKS 
n=15 
AS 
n=91 
CdLS 
n=28 
FXS 
n=40 
Chi-Squared Test Post Hoc Chi-Squared 
χ
2
 
df P PKS Significance 
Direction 
χ
2
 
df P Value 
Hypo-Responsivity 2 31 1 8 12.154 3 .007 None for PKS N/A N/A N/A 
Hyper-Responsivity 8 57 10 14 11.680 3 .009 None for PKS N/A N/A N/A 
Sensory-Seeking 14 33 13 22 18.850 3 <.001 PKS<AS 
PKS<FXS 
PKS<CdLS 
16.994 
6.362 
9.197 
1 
1 
1 
<.001 
.012 
.002 
Social Contexts 3 33 4 7 8.461 3 .037 None for PKS N/A N/A N/A 
Non-Social Contexts 11 26 7 16 13.526 3 .004 PKS>AS 
PKS>FXS 
PKS>CdLS 
11.843 
4.850 
9.376 
1 
1 
1 
.001 
.028 
.002 
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There were significant differences between syndromes groups in their hypo-
responsivity (h=36.550, (3), p<.001), hyper-responsivity (h=18.810, (3), p<.001) and 
sensory seeking (h=27.028, (3), p<.001). Specifically, individuals with PKS displayed 
higher hypo-responsivity scores compared to individuals with FXS (U=45.292, N1 
=3.50, N2 =2.25, p=.017) and lower sensory seeking scores compared to individuals 
with AS (U=-70.156, N1 =2.31, N2 =3.15, p<.001), CdLS (U=-62.251, N1 =2.31, N2 
=3.00, p=.001) and FXS (U=-47.958, N1 =2.31, N2 =3.85, p=.010). There were no 
significant differences between individuals with PKS and other syndrome groups in 
hyper-responsivity scores (p>.050).  
 
There were also significant differences between syndrome groups in their 
sensory experiences in social (h=27.256, (3), p<.001) and non-social (h=21.396, (3), 
p<.001) contexts. Individuals with PKS displayed higher scores in comparison to 
individuals with AS for social context sensory experiences (U=38.722, N1 =2.40, N2 
=2.10, p=.034). However, they displayed lower scores in comparison to individuals with 
AS (U=-53.125, N1 =2.38, N2 =2.86, P=.001), CdLS (U=-73.474, N1 =2.38, N2 =3.07, 
p<.001) and FXS (U=-46.804, N1 =2.38, N2 =2.79, P=.013) in non-social contexts.  
 
There were significant differences between syndromes groups in all five sensory 
modalities, tactile (h=21.178, (3), p<.001), auditory (h=16.106, (3), p=.001), visual 
(h=25.653, (3), p=.001), olfactory (h=27.120, (3), p<.001) and vestibular (h=28.530, 
(3), p<.001). Specifically, individuals with PKS scored significantly lower (more typical 
scores) in comparison to individuals with CdLS in their tactile sensory experiences (U=-
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42.542, N1 =2.40, N2 =2.90, p=.049). They also scored lower in comparison to 
individuals with FXS in their auditory sensory experiences (U=-45.162, N1 =2.33, N2 
=2.83, p=.017). Individuals with PKS scored significantly higher scores (more abnormal 
scores) in comparison to individuals with AS (U=55.648, N1 =3.50, N2 =2.33, p>.001) 
and FXS (U=52.608, N1 =3.50, N2 =2.17, p=.003) in their visual sensory experiences. 
Individuals with PKS scored lower in comparison to individuals with FXS (U=-40.817, 
N1 =1.67, N2 =2.17, p<.001), CdLS (U=-52.070, N1 =1.67, N2 =2.33, p=.007), and AS 
(U=67.888, N1 =1.67, N2 =2.50) in their olfactory sensory experiences. Finally, 
individuals with PKS scored significantly lower in comparison to individuals with 
CdLS (U=63.463, N1 =2.38, N2 =3.07, p<.001), AS (U=-70.646, N1 =1.75, N2 =3.25, 
p<.001), and FXS (U=-76.592, N1 =1.75, N2 =3.50) in their vestibular sensory 
experiences (Table 2.12).  
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Table 2.12: Median (Inter Quartile Range) for Individuals with PKS, Non-Matched Individuals with Angelman Syndrome, Cornelia de 
Lange Syndrome and Fragile X Syndrome subscales of the Sensory Experience Questionnaire with Results for Kruskal-Wallis Analysis 
and Post Hoc Mann-Whitney U Analysis. 
 
Mean Scores PKS AS CdLS FXS Kruskal Wallis Tests Post Hoc Comparison: Mann-Whitney U 
Test 
H df p Value PKS 
Significance 
Direction 
U Df P Value 
Total SEQ 
Median 2.44 2.56 2.75 2.53 
13.387 3 .004 
PKS<CdLS -53.892 1 .005 
IQR 2.19-
2.59 
2.34-
2.81 
2.45-
3.16 
2.31-2.98  
Seeking 
Median 2.31 3.15 3.00 3.85 
27.028 3 <.001 
PKS<FXS -47.958 1 .010 
IQR 1.77-
2.54 
2.77-
3.62 
2.77-
3.50 
2.38-3.31 PKS<CdLS -62.251 1 .001 
PKS<AS -70.156 1 <.001 
 
Hypo-
responsivity 
Median 3.50 2.00 2.92 2.25 
36.550 3 <.001 
PKS>AS 62.674 1 .010 
IQR 2.83-
4.00 
1.67-
3.33 
2.33-
3.46 
1.83-2.83 PKS>FXS 45.292 1 .017 
 
Hyper-
responsivity 
Median 2.23 2.08 2.54 2.58  
18.810 
 
3 
 
<.001 
None for 
PKS 
N/A N/A N/A 
IQR 1.84-
2.46 
1.85-
2.46 
2.08-
3.13 
2.10-3.08 
 
Social 
Median 2.40 2.10 2.45 2.40  
27.256 
 
3 
 
<.001 
PKS>AS 38.722 1 .034 
IQR 2.20-
2.70 
1.70-
2.20 
2.13-
2.93 
2.10-3.08 
Non-Social 
Median 2.38 2.86 3.07 2.79  
21.396 
 
3 
 
<.001 
PKS<FXS 
PKS<AS 
PKS<CdLS 
-46.804 
-53.125 
-73.474 
1 
1 
1 
.013 
.001 
<.001 
IQR 2.05-
2.71 
2.62-
3.10 
2.63-
3.31 
2.48-3.10 
Tactile 
Median 2.40 2.40 2.90 2.60 
21.178 3 <.001 
PKS<CdLS -42.542 1 .049 
IQR 2.30- 2.20- 2.53- 2.13-2.98 
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6
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Mean Scores PKS AS CdLS FXS Kruskal Wallis Tests Post Hoc Comparison: Mann-Whitney U 
Test 
H df p Value PKS 
Significance 
Direction 
U Df P Value 
2.80 2.70 3.38 
Auditory 
Median 2.33 2.50 2.50 2.83 
16.106 3 .001 
PKS<FXS -45.162 1 .017 
IQR 2.17-
2.67 
2.33-
2.83 
2.21-
3.00 
2.50-3.33 
Visual 
Median 3.50 2.33 2.83 2.17 
25.653 3 <.001 
PKS>AS 55.648 1 <.001 
IQR 2.83-
3.67 
1.83-
2.83 
2.33-
3.33 
1.83-2.83 PKS>FXS 52.608 1 .003 
    
Olfactory 
Median 1.67 2.50 2.33 2.17 
27.120 3 <.001 
PKS<FXS 
PKS<CdLS 
PKS<AS 
-40.817 
-52.070 
-67.888 
1 
1 
1 
<.001 
.007 
<.001 
IQR 1.67-
2.17 
2.33-
2.83 
1.92-
2.96 
2.00-2.67 
Vestibular 
Median 1.75 3.25 3.25 3.50 
28.530 3 <.001 
PKS<CdLS 
PKS<AS 
PKS<FXS 
-63.463 
-70.646 
-76.592 
1 
1 
1 
<.001 
<.001 
<.001 IQR 1.50-
2.25 
1.75-
4.25 
2.75-
3.50 
3.75-4.00 
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Parent/Carer Anxiety and Depression 
The majority of parents/ carers of individuals with PKS reported borderline 
(n=6, 42.85%) to abnormal (n=6, 42.85%) anxiety, whilst the majority of parents/carers 
of individuals with AS reported normal levels of anxiety (n=12, 41.4%). Both groups of 
parents mostly reported normal levels depression (PKS group: n=9, 64.27%, AS group: 
n=20, 69.00%). There were no significant differences in anxiety and depression of 
parents/carers between the groups (p>0.05) (Table 2.13). 
 1
6
8
 
 
Table 2.13: Percentage Displaying Classification26, Median (Inter Quartile Range), for Individuals with PKS and Non-Matched 
individuals with Angelman Syndrome, Cornelia de Lange Syndrome and Fragile X Syndrome Subscales of the Hospital Anxiety and 
Depression Scale with Results for Mann-Whitney U Analysis. 
 
 
                                                        
26 Classification: Normal= 0-7, Borderline=8-10, Abnormal=11-21 (Zigmond and Snaith, 1983) 
 
27 Participants selected from the non-matched AS group, where HADS data was available. Age, Median: 9.60 years, IQR: 5.92-15.95, 69.00% mobile, 
6.9% verbal.  
Raw Scores PKS (n=14) AS (n=29)27 Mann-Whitney U 
N % Median IQR N % Median IQR U P Value 
Anxiety Normal 2 14.29% 10 8-11 12 41.4% 8 5-12 164.50 .316 
Borderline 6 42.85% 7 24.15% 
Abnormal 
 
6 42.85% 10 34.50% 
Depression Normal 9 64.27% 6 2-9 20 69.00% 4 1-8.50 178.50 .524 
Borderline 4 28.57% 5 14.25% 
Abnormal 1 7.15% 4 13.80% 
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Table 2.14: Table displaying Summary Results and Relative Comparisons of the 
Pallister-Killian Syndrome group to the Angelman Syndrome, Cornelia de Lange 
Syndrome and Fragile X Syndrome.28 
 
Behavioural Domain Syndrome Group 
Matched 
Comparison 
Group 
Non-Matched Comparison 
Groups 
PKS AS AS CdLS FXS 
Challenging Behaviour 0 0 N/A N/A N/A 
Mood - + N/A N/A N/A 
Interest and Pleasure - + N/A N/A N/A 
Stereotyped Behaviour 0 0 N/A N/A N/A 
Compulsive Behaviour 0 0 N/A N/A N/A 
Insistence on Sameness 0 0 N/A N/A N/A 
Overactivity - + N/A N/A N/A 
Impulsivity - + N/A N/A N/A 
Autism + - N/A N/A N/A 
Social Communication 0 0 N/A N/A N/A 
Restricted, Repetitive Behaviours and 
Stereotypy 
0 0 N/A N/A N/A 
Reciprocal Social Interaction 0 0 N/A N/A N/A 
Sociability with Familiar others - N/A + 0 0 
Sociability with Unfamiliar others - N/A + 0 0 
Hyposensitivity + N/A - 0 - 
Hypersensitivity 0 N/A 0 0 0 
Sensory-Seeking - N/A + + + 
Parent/Carer Anxiety and Depression 0 N/A 0 N/A N/A 
  
                                                        
28 For PKS group: += Scores higher than another group, 0=scores than same as another group, -
= scores lower than another group. For other groups: += Scores higher than PKS, 0=scores than 
same as PKS, -= scores lower than PKS. 
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Discussion 
This is the first study to our knowledge to explore the behavioural phenotype of 
PKS using a cross syndrome approach, drawing direct comparisons with behaviour 
reported in other genetic syndrome groups with better defined phenotypic behaviour 
patterns using measures with established psychometric properties with a strong history 
of contribution to the understanding of behavioural phenotypes (Tierney, Nwokoro, 
Porter, Freund, Ghuman and Kelley, 2001). Behaviour reported for fourteen individuals 
with PKS was, where possible, compared with that reported for fourteen people with 
Angelman syndrome (AS) matched on age, gender, self-help ability, mobility and 
verbal ability. For other measures, comparisons were made with larger groups of less 
well-matched individuals with AS, Cornelia de Lange syndrome (CdLS), and Fragile X 
syndrome (FXS), due to availability of relevant data and the relatively well-established 
behavioural phenotypes of these groups. This is also the first study to use the well-
established autism screening tool (the SCQ) across a range of low functioning 
individuals with PKS, allowing further understanding of autism symptomology. 
Furthermore, it is also the first study to explore sociability and sensory experiences of 
individuals with PKS, using specific well-established questionnaires with good 
psychometrics.  
A summary of the assessment results and how the PKS group differed to the AS, 
CdLS and FXS group is displayed to ease comparison (Table 2.14).
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The findings indicated that the majority of individuals with PKS had very limited 
abilities, with absent speech and mobility and significant developmental delays 
consistent with the overall phenotype described in the literature (Kosteneka, Close, 
Izumi, Krantz and Pipan, 2012). The majority of participants also had health difficulties, 
and visual and hearing impairments were prevalent in the sample.  
 
Three of the sixteen individuals appeared to display a milder phenotype in terms 
of their ability levels. These three participants (ages: twelve-years, eleven-years and 
thirteen-years old) were verbal, mobile, and displayed higher levels of self help skills. 
Specifically, one participant (ID: 2) was able to feed themself independently, wash and 
dress themself with help, speak in sentences (but chose not to), could read and write a 
little and understand monetary values. Another participant (ID: 9) was able to feed 
themself independently, wash and dress themself with help, speak in sentences, read, 
write and count a little. Also another participant (ID: 12) was able to feed, wash and 
dress themself independently, speak in sentences, read, write and count a little. Two of 
the three with the milder phenotype met criteria for ASD on the SCQ, although one met 
the more stringent criteria for autism and two displayed SIB. One of these participants 
was reported to have normal hearing and vision, one had poor vision and normal 
hearing, and the other had normal vision and poor hearing. Whilst the small N does not 
allow formal comparison of the behaviours shown by the three more able participants 
with those who are less able, the results do suggest a wide behavioural phenotype. 
 
Blyth et al., (2015) argue the higher reported functioning is mostly in individuals 
born after 2000 due to more advanced antenatal imaging detecting abnormalities leading 
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to termination for those more profoundly affected. Kostanecka, Close, Izumi, Krantz 
and Pipan (2012) suggest that extent of the milder phenotype of PKS has not been 
established due to a lack of diagnoses in these individuals.  
 
The current study found higher reported levels of SIB displayed by individuals 
with PKS (46.67%) than has been reported in previous research (25%; Wilkens et al., 
2012), although lower levels of repetitive and stereotyped movements (53.33%) were 
reported than in other studies (75%; Kostanecka, Close, Izumi, Krantz and Pipan, 2012). 
Individuals with PKS generally displayed lower frequencies of destruction of property 
and physical aggression than the matched participants with AS, although the differences 
did not reach statistical significance. Aggressive behaviours are known to be a part of 
the behavioural profile of people with AS, although it should be noted that the AS 
sample studied here displayed a lower frequency of SIB (45.1%) and aggression 
(13.33%) than reported in previous research (73%; Arron, Oliver, Berg, Moss and 
Burbidge, 2011). This may reflect the lower ability selection bias of the sample, 
although research has reported that high impulsitivity, lower scores in social interaction 
and poor communication have been reported as risk markers for aggressive behaviour 
(Arron, Oliver, Moss, Berg and Burbidge, 2011; Cooper et al., 2009). 
 
Individuals with PKS in the current sample displayed lower levels of SIB 
(46.67%) than individuals with CdLS (70.3%) and similar levels to individuals with 
FXS (51.3%; Davis and Oliver, 2016). Furthermore, their frequency of physical 
aggression (2/15; 13%) is lower compared to individuals with CdLS (40.2%) and FXS 
(51.3%). Participants with PKS have lower ability levels than those with CdLS and 
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FXS, which may be a confounding factor when making comparisons. However, 
challenging behaviour can be frequent for those with severe ID (69%; Davis and Oliver, 
2016). It may be that, while nearly half of the sample was reported to display self-
injurious behaviours, SIB is not a specific part of the phenotype of PKS.  
 
Whilst the relatively low levels of some types of challenging behaviour 
displayed in PKS (e.g., physical aggression; disruption and destruction of property) 
might be surprising due to the high level of ID, which is a known risk factor for 
challenging behaviour (Cooper et al., 2009), it might be that limited physical abilities 
restrict the behaviours, which can be displayed. The relatively lower levels of 
stereotyped and repetitive behaviours (in comparison to other syndrome groups29) and 
lower levels of activity are consistent with relatively lower levels of challenging 
behaviours, since increased repetitive and stereotyped behaviours and activity have been 
reported as significant risks markers for challenging behaviours for individuals with 
autism (Richards, Oliver, Nelson and Moss, 2012) and a number of genetic syndromes 
(Oliver, Sloneem, Hall and Arron, 2009).  
 
Individuals with PKS displayed a similar level of restrictive and repetitive 
behaviours to individuals with AS. Individuals with AS have been found to have lower 
levels of repetitive behaviours compared to other genetic syndrome groups (Moss, 
Oliver, Arron, Burbidge and Berg, 2009; Barry, Leitner, Clarke and Enfeld, 2005; 
Bonati et al., 2007; Walz, 2006). Whilst overall scores on the RBQ were comparable, it 
                                                        
29 Percentages of stereotyped behavior in other syndrome groups; CdLS=57% (Hyman, Oliver, 
and Hall, 2002), AS= 9-84% (Summers, Allison, Lynch and Sandler, 1995), FXS= 69.2-74.2%, 
Lowe Syndrome= 85% and SMS= 100% (Smith and Gropman, 2001). 
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may be that different types of RRBs were present for the different groups. However, 
Moss, Oliver, Arron, Burbidge and Berg (2009) reported that individuals with AS were 
less likely to endorse items on the RBQ, which are considered ‘higher level’, that 
require individuals to have a level of ability, for example items which assess tidying up, 
hoarding and organising objects. Yet, individuals were more likely to display hand and 
body stereotypy, which is also similar to the individuals with PKS found in this study.  
 
Participants with PKS were reported to display less impulsivity and overactivity. 
A lack of activity has been described in other research examining individuals with PKS, 
who have sometimes been observed to be lethargic and withdrawn, possibly to poor 
hearing and visual, mobility or sensory difficulties (Kostanecka, Close, Izumi, Krantz 
and Pipan, 2012). The research reported higher levels of over-activity and impulsivity in 
individuals with AS, which is comparable with previous research using TAQ. The 
previous research examining other syndrome groups can also be informally compared to 
the results here, which suggest that the PKS the lowest levels of impulsivity and over-
activity, which are mostly compared to those individuals with Prader-Willi Syndrome 
(PWS) (Oliver, Berg, Burbidge, Arron and Moss, 2011)30.  
 
Unsurprisingly, the study found lower mood and interest and pleasure in 
individuals with PKS in comparison to individuals with AS. This is perhaps due to the 
unique display of laughing, smiling and a happy demeanour which characterises the AS 
                                                        
30 This research: AS (over-activity); mean=18.64, sd=7.47, (impulsivity); mean=14.00, sd=9.11. 
PKS (over-activity); mean=9.53, sd=8.48, (impulsivity); mean=6.30, sd=8.00. Previous 
research: AS (over-activity); mean=19.02, (impulsivity); mean=17.48: FXS (over-activity); 
mean=18.77, (impulsivity); mean=16.21: CdLS (over-activity); mean=14.56, (impulsivity); 
mean=14.75: PWS (over-activity); mean=6.94, (impulsivity); mean=13.00 (Oliver, Berg, 
Burbidge, Arron and Moss, 2011).  
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phenotype (Walz and Benson, 2002). However, previous literature has reported other 
syndrome groups have a similar MIPQ scores to those found in the current study’s AS 
group (Nelson, Moss and Oliver, 2014)31. Thus, indicating the higher mood and interest 
and pleasure in AS is perhaps not magnifying the lower mood and interest seen in the 
PKS group, but rather the low mood may be distinctive to the PKS phenotype. 
However, future research would benefit from directly comparing PKS individuals to 
other matched genetic syndromes using statistical analysis to draw more precise 
conclusions. It is hypothesised that the high levels of health difficulties and autism 
symptomology in the PKS group could be associated with the lower mood and interest 
as these constructs have been noted as risk factors for a lower mood in other genetic 
syndromes (Berg, Arron, Burbidge, Moss and Oliver, 2007; Kim, Szatmari, Bryson, 
Streiner and Wilson, 2000). However, contributing factors could also be physical 
difficulties and reported lack of interaction in their environment reducing their 
opportunity to engage in meaningful activities (Kostanecka, Close, Izumi, Krantz and 
Pipan, 2012).  
 
Interestingly, there was a positive correlation of mood with age, indicating 
higher mood for older participants. This contrasts with the effect seen for some other 
groups (e.g., CdLS; Berney, Ireland and Burn, 1999; Nelson, Moss and Oliver, 2014; 
Oliver, Berg, Moss, Arron and Burbridge, 2011) and Kleefstra Syndrome (unpublished 
data; personal communication, 2016) for whom older age is associated with declining 
mood, interest and pleasure. Whether this is an effect which would also be seen 
                                                        
31 Reported results for individuals <15 years old with CdLS (Mood, median; 20, IQR; 17-21; 
Interest and pleasure; median; 18, IQR; 15-20), FXS (mood; median; 21.00, IQR; 20-23; 
Interest and pleasure; 17, IQR; 14-20) and CdCS (Mood, median; 20, IQR; 18-22; Interest and 
pleasure; median; 19, IQR; 18-21) (Nelson, Moss and Oliver, 2014).  
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longitudinally, indicating improvement with age, remains to be addressed in future 
studies.  
 
A large majority of participants with PKS met criteria for ASD on the SCQ, a 
well-regarded screening tool. More individuals within the PKS group (64.3%) met the 
more stringent criteria for autism, compared to individuals in the AS group (14.3%), 
suggesting the prevalence of autism may be higher in comparison to the prevalence in 
AS syndrome (34%; Richards et al., 2015). However, the autism assessment used was a 
screening measure and therefore is not a diagnostic tool. There is a lack of autism 
descriptions in the PKS literature and this should be a specific focus of further research 
using observation-based diagnostic assessments. However, as noted by Kostanecka, 
Close, Izumi, Krantz and Pipan (2012), there is difficulty using autism assessment 
methods as they are not applicable to the low levels of cognitive functioning and the 
normative data often represents only typically developing children.  
 
The current study is the first to examine the sociability of people with PKS. Data 
indicated that individuals with PKS display greater social interaction with familiar 
adults compared to unfamiliar adults which is consistent with many other genetic 
syndromes (Nelson, Moss, Powis, Waite and Oliver, In press). Furthermore, the results 
demonstrated that individuals with PKS display a lack of sociability in comparison to 
individuals with AS, which is consistent with research describing how individuals with 
AS have a strong interest in social communication (Clayton-Smith, 2001; Williams et 
al., 2006), despite their inappropriate social reciprocity (Smith et al., 1996; Peters, 
Beaudet, Madduri and Bacino, 2004). Furthermore, the results in the current study are 
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consistent with SQID results previously reported for individuals with AS (Nelson, 
Moss, Powis, Waite and Oliver, In press)32.  
 
However, individuals with PKS displayed similar difficulties/avoidance of social 
interactions to individuals with CdLS and FXS, which is also consistent with previous 
SQID analysis for individuals with CdLS and FXS (Nelson, Moss, Powis, Waite and 
Oliver, In press)33. This suggests that individuals with PKS may also display significant 
shyness and social anxiety similar to individuals with CdLS and FXS (Hall, 
DeBarnardis and Reiss, 2006; Richards, Moss, O’Farrell, Kaur and Oliver, 2009). 
Sociability is not thought to be related to adaptive functioning (r=.02-.7; Nelson, Moss, 
Powis, Waite and Oliver, In press), indicating that comparisons between PKS and other 
syndromes such as CdLS and FXS may be valid in this regard. However, considering 
the lack of verbal communication skills in the PKS group, and suggestions that a lack of 
ability possibly also contributes to reduced social interaction for individuals with CdLS 
(Moss, Howlin, Magiati and Oliver, 2012), future research will need to determine if the 
lack of sociability is due to a reduced desire to engage socially/social anxiety or due to a 
lack of ability to do so. This reduced sociability may account for the high percentage of 
individuals with PKS reaching autism criteria. However, further research investigating 
the autism symptomology in PKS is needed. 
 
                                                        
32 AS; n=66, mean age=15.1 years old, unfamiliar score; median=41, IQR=31-48, familiar 
score; median=53, IQR=48-55 (Nelson, Moss, Powis, Waite and Oliver, In press).  
33 CdLS: n=98, mean age=18.8 years old, unfamiliar score; median=26, IQR=13.50-35, familiar 
score; median=41.50, IQR=35-48 
FXS: n=142, mean age=19.8 years old, unfamiliar score; median=15, IQR=11-25, familiar 
score; median=39, IQR=31-44 (Nelson, Moss, Powis, Waite and Oliver, In press).   
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Certain areas of sociability correlated positively with age, indicating that older 
participants may have shown greater levels of certain types of sociability. This is 
intriguing in relation to the aforementioned possible positive association of mood with 
age. A possible decline in sociability with age has been seen in some other syndrome 
groups (e.g., CdLS; Berney, Ireland and Burn, 1999; Nelson, Moss and Oliver, 2014; 
Oliver, Berg, Moss, Arron and Burbridge, 2011) and Kleefstra Syndrome (unpublished 
data).  The pattern observed in the current data should be investigated further in future 
work. 
 
The current study is the first to use a comprehensive assessment to explore 
sensory experiences in individuals with PKS using comparison groups. The results 
found that hypersensitivity and sensory-seeking behaviours mostly fell in the typically 
developing range for people with PKS. However, the data indicated hyposensitivity 
behaviours, across social and non-social contexts. The group specifically displayed less 
difficulties hypersensitivity in olfactory, vestibular, auditory and tactile domains, yet 
increased hypersensitivity in visual domains. Moreover, The PKS group significantly 
displayed the least sensory-seeking behaviours compared to the AS, CdLS and FXS 
groups and significantly more hypo-sensitivity behaviours compared to individuals with 
FXS. This finding is consistent with previous research reporting that individuals with 
AS display sensory-seeking behaviours (Peters, Horowitz, Barbieri-Welge, Taylor and 
Hundley, 2012; Walz and Baranek, 2006) and individuals with FXS display 
hypersensitivity (Hagerman and Hagerman, 2002; Roberts, Weisenfeld, Hatton, Heath 
and Kaufmann, 2007).  
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This finding also supports Kostanecka, Close, Izumi, Krantz and Pipan’s (2012) 
suggestion that individuals with PKS display lethargy and withdrawal due to 
hyposensitivity difficulties and avoidance. It is hypothesised that individuals with PKS 
are passive in their coping strategies and do not attempt to adapt their sensory 
thresholds (Dunn, 1997; 2001). As a result, the sensory difficulties and reduced mobility 
in the PKS group are perhaps associated with individuals’ lack of engagement with the 
environment, which has consequently restricted their learning and independence 
(Baranek et al., 2008; Baranek, Chin, Hess, Yankee, Hatton and Hooper, 2002). 
However, to determine the causal relationship between sensory difficulties and 
development, longitudinal analysis is necessary.  
 
The final finding of the research was the high levels of reported anxiety and 
depression in carers/parents of both individuals with PKS and AS. This distress, 
including clinical symptoms of depression, stress and anger experienced by carers of 
children with autism has been well described in the literature (Lutz, Patterson and Klein, 
2012; Sawyer et al., 2010; Stuart and McGrew, 2009). In addition, Griffith et al., (2011) 
reported that parents of children with AS, CdLS and CdCS experience specific 
difficulties in accessing medical services and general day-to-day living.  
 
Clinical implications 
The findings of the study are important in further defining the behavioural 
phenotype of PKS. The results have clinical implications for the assessment and 
intervention of behavioural difficulties. First, due to the high frequency of autism 
identified by the SCQ, it may be recommended that individuals with PKS undergo 
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autism screening to aid early identification of specific autism symptomology, which is 
fundamental in developing appropriate behavioural and educational programmes (Moss 
and Howlin, 2009).  
 
Second, due to the hypothesis about mobility and hypo-sensitivity difficulties 
leading to reduced engagement in the environment and thus limiting learning 
opportunities, it may be useful to assess whether sensory interventions might mitigate 
some elements of developmental delay. Early sensory-integration interventions 
promoting adaptive approaches to sensory experiences could be implemented to 
encourage individuals to explore their environment. Whilst there is no specific research 
assessing such interventions with individuals with PKS, child-directed sensory 
interventions have been clinically useful for individuals with autism (Case-Smith, 
Weaver and Fristad, 2015). Finally, it is recommended that carer distress is identified 
early to ensure the timing of appropriate interventions (Griffith et al., 2011; Shah, 
Wadoo, Lattoo, 2010).  
 
Limitations  
Firstly, the possible limitations of the statistical analysis and potential Type I 
errors need to be acknowledged. The results and consequent clinical implications need 
to be taken with caution due to the use of the numerous statistical tests employed and 
the small sample size. Specifically, it is possible the conclusions reached were 
incoreectly arrived at due to statistical error and there is perhaps no (or lesser) 
significant difference between individuals with PKS incomparsion to individuals with 
other genetic syndromes. Therefore, the possible behavioural phenotype of PKS 
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discussed may not be valid and reliable, thus parents and clinicians may be misinformed 
by the research and expect individuals with PKS to exhibit certain behaviours shown by 
this research, despite that behaviour not being part of the PKS behavioural phenotype. 
This has multiple clinical and ethical implications of potential parental anxiety, 
misdiagnosis and implementation of non-beneficial treatment plans. It is therefore 
essential the results of the study are replicated to ensure their validity and families and 
clinicans are aware of the studies limitations.  
 
The selection of participants may be a potential limitation to the research as 
participants were only recruited via parent support organisations, which may 
particularly attract families who have a child with particular characteristics. Therefore 
results may not be representative of all individuals with PKS. Additionally, as use of 
multiple fully matched comparison groups was not possible, it needs to be noted that 
different demographic or ability levels may have accounted for the difference in 
behaviours between the PKS group and the other syndrome groups. In addition, some 
differences in comparisons may be due to the characteristics of the AS phenotype and 
not specifically due to a unique PKS phenotype. Whilst the use of comparison groups is 
a strength of the study, the selection of the matched AS sample on characteristics such 
as ability may mean that this group is not representative of AS more generally. As a 
result, the findings should not be taken as a definite phenotype for the PKS group. 
Future research needs to make further direct comparisons between other matched ability 
syndrome groups. Moreover, future research should consider investigating behaviours 
shown by different specific genetic mechanisms in PKS, as this study included all 
individuals with PKS as a group despite differences in specific genetics (Dykens, 1995). 
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As this was a cross-sectional survey study data were available for only one time 
point. This means that possible associations with age should be followed up with future 
longitudinal studies. This is fundamental to assess in future research as behavioural 
phenotypes are not static and this methodology would allow identification of specific 
risk markers such as hyposensitivity, which may contribute to increased difficulties or 
delays as children develop (Nelson, Moss and Oliver, 2014). For example, some 
individuals with FXS display an increase of autism symptomology and social avoidance 
(Hatton et al., 2006) and reduced adaptive functioning (Fisch, Simensen and Schroer, 
2002) with age. 
 
Data are also based on parent report assessments only. Future research would 
benefit from the use of observational to strength the reliability of the results and 
investigate gene-environment interactions. This study was the first to use the SCQ for a 
range of individuals with PKS, including those with a lower cognitive ability. Although 
the SCQ is only recommended for individuals with a mental age of two years or older 
(Rutter, Bailey and Lord, 2003), research has suggested it is suitable for individuals 
who are less able (Lee, David, Rusyniak, Landa and Newschaffer, 2007).  
 
Finally, this identification of a wide spectrum of the phenotype has also been 
reported in other studies, which describe distinct individuals with a high level of 
functioning and ability (Genevieve et al., 2003; Warburton, Anyane-Yeboa, Francke 
and Reynolds, 1987; Wilkens et al., 2003). Differences in presentation may relate to 
genetic factors (Leube, Majewski, Gebauer and Royer-Pokora, 2003). Unfortunately, 
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the current study was limited by lack of direct genetic testing leading to reliance on 
parental report and/or information available via UNIQUE. For two of three most able 
participants, genetic information beyond diagnosis of PKS was not available. Future 
research needs to develop a precise understanding of how the molecular mechanisms 
relate to the full PKS phenotypic spectrum described in the literature (Izumi and Krantz, 
2014).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 184 
 
References 
 
Aman, M., Singh, N., Stewart, A., Field, C. (1985). Psychometric characteristics of the 
Aberrant behaviour checklist. American Journal of Mental Deficiency, 89, 492-502.  
 
Arron, K., Oliver, C., Berg, K., Moss, J., and Burbidge, C. (2011). Prevalence and 
phenomenology of self-injurious and aggressive behaviour in genetic syndromes. 
Journal of Intellectual Disability Research, 55, 109-120.  
 
Baranek, G., Chin, Hess, L., Yankee, J., Hatton, D., and Hooper, S. (2002). Sensory 
processing correlates of occupational performance in children with Fragile X syndrome: 
preliminary findings. American Journal of Occupational Therapy, 56, 538-546.  
 
Baranek, G., Roberts, J., David, F., Sideris, J., Mirrett, P., Hatton, D., and Bailey, D. 
(2008). Developmental trajectories and correlates of sensory processing in young boys 
with fragile X syndrome. Physical and Occupational Therapy in Paediatrics, 28, 79-98.  
 
Barisic, I., Tokic, V., Loane, M., Bianchi, F., Calzolari, E., Garne, E., Wellesley, D., 
and Dolk, H. (2008). Descriptive epidemiology of Cornelia de Lange syndrome in 
Europe. American Journal of Medical Genetics, Part A, 146, 51-59.  
 
Barry, R., Leitner, R., Clarke, A., and Einfeld, S. (2005). Behavioural aspects of 
Angelman syndrome: a case control study. American Journal of Medical Genetics, 132, 
8-12.  
 
 185 
 
Bartsch, O., Loitzsch, A., Kozlowski, P., Mazauric, M., Hickmann, G. (2005). Forty-
two super-numerary marker chromosomes (SMCs) in 43, 273 prenatal samples: 
Chromosomal distribution, clinical findings, and UPD studies. European Journal of 
Human Genetics, 13, 1192-1204.  
 
Basile, E., Villa, L., Selicorni, A., Molyeni, M. (2007). The behavioural phenotype of 
Cornelia de Lange syndrome: A study of 56 individuals. Journal of Intellectual 
Disability Research, 51, 671-681.  
 
Berg, E., Arron, K., Burbidge, C., Moss, J., and Oliver, C. (2007). Carer-reported 
contemporary health problems in people with severe and profound intellectual disability 
and genetic syndromes. Journal of Policy and Practice in Intellectual Disability, 4, 120-
128.  
 
Berney, T., Ireland, M., and Burn, J. (1999). Behavioural phenotype of Cornelia de 
Lange syndrome. Archives of Disease in childhood, 81, 333-336.  
 
Bielanska, M., Khalifa, M., and Duncan, A. (1996). Pallister-Killian syndrome: a mild 
case diagnosed by fluorescence in situ hybridization. Review of the literature and 
expansion of the phenotype. American Journal of Medical Genetics, 65, 104-108.  
 
Blyth, M., Maloney, V., Beal, S., Collinson, M., Huang, S., Crolla, J., Temple, K., and 
Baralle, D. (2015). Pallister-Killian syndrome: a study of 22 British patients. Journal of 
Medical Genetics, 52, 454-564.  
 186 
 
 
Bonati, M., Russo, S., Fineli, P., Valsecchi, M., Cogliati, F., Cavalleri, F., Roberts, W., 
Elia, M., Larizza, L. (2007). Evaluation of autism traits in Angelman syndrome: a 
resource to unfold autism genes. Neurogenetics, 8, 169-178.  
 
Candee, M., Carey, J., Krantz, I., and Filloux, F. (2012). Seizure characteristics in 
Pallister-Killian syndrome. American Journal of Medical Genetics, Part A, 158A, 3026-
3032.  
 
Chaouachi, S., Ben, H., Ennie, I., Chaabouni, M., Sfar, R., Chaabouni, H., and 
Marrakchi, Z. (2010). Journal Medical Tunisie, 88, 614-616.  
 
Clayton-Smith, J. (2001). Angelman syndrome: evaluation of the phenotype in 
adolescents and adults. Developmental and Medical Child Neurology, 43, 476-480.  
 
Clayton-Smith, J., and Laan, L. (2003). Angelman syndrome: a review of the clinical 
and genetic aspects. Journal of Medical Genetics, 40, 87-95.  
 
Coffee, B., Keith, K., Albizual, I., Malone, T., Mowrey, J., Sherman, S., and Warren, S. 
(2009). Incidence of Fragile X syndrome by newborn screening for methylated FMR1 
DNA. American Journal of Medical Genetics, 85, 503-514. 
 
 187 
 
Cook, F. (2009). An investigation of sociability: delineating a behavioural and social 
phenotype for Monosomy 1p36 deletion syndrome. (Unpublished doctoral dissertation). 
University of Birmingham, UK.  
 
Cook, F., and Oliver, C. (2011). A review of defining and measuring sociability in 
children with intellectual disabilities. Research in Developmental Disabilities, 32, 11-
24.  
 
Cooper, S., Smiley, E., Jackson, A., Finlayson, J., Allan, L., Mantry, D., and Morrison, 
J. (2009). Adults with Intellectual Disabilities: prevalence, incidents and remission of 
aggressive behaviours and related factors. Journal of Intellectual Disability Research, 
53, 217-232.  
 
Cunningham, A., and Schreibman, L. (2008). Stereotypy in Autism: The Importance of 
Function. Research in Autism Spectrum, 2, 469-479.  
 
Dan, B., Bouillot, E., Bengoetxea, A. Boyd, S., and Cheron, G. (2001). Distinct multi-
joint control strategies in spastic diplegia associated prematurity or Angelman 
syndrome. Clinical Neurophysiology, 112, 1618-1625.  
 
Davis, L., and Oliver, C. (2016). Self-injury, aggression and destruction in children with 
severe intellectual disability: Incidence, persistence and novel, predictive behavioural 
risk markers. Research in Developmental Disabilities, 49, 291-301.  
 
 188 
 
De Oliveria, A., Ortega, A., and Ciamponi, A. (2006). Pallister-Killian syndrome 
(PKS): clinical case report. Journal of Clinical Pediatric Dentistry, 30, 257-260.  
 
Dunn, W. (1999). Sensory Profile. San Antonio, TX: Psychological Corporation.  
 
Dunn, W. (2001). The sensations of everyday life: Empirical, theoretical and pragmatic 
considerations. American Journal of Occupational Therapy, 55, 608-620. 
 
Dykens, E. (1995). Measuring behavioural phenotypes: provocations from the “new 
genetics”. American Journal of Mental Retardation, 99, 522-532. 
 
Dykens, E., and Hodapp, R. (2001). Research in mental retardation: Towards an 
etiological approach. Journal of Child Psychology and Psychiatry, 42, 49-71.  
 
Filloux, F., Carey, J., Krantz, I., Ekstrand, J., and Candee, M. (2012). Occurrence and 
clinical features of epileptic and non-epileptic paroxysmal events in five children with 
Pallister-Killian syndrome. European Journal of Medical Genetics, 55, 367-373.  
 
Fisch, G., Simensen, R., and Schroer, R. (2002). Longitudinal changes in cognitive and 
adaptive behaviour scores in children and adolescents with the fragile X mutation or 
autism. Journal of Autism and Developmental Disorders, 32, 107-114.  
 
Griffith, G., Hastings, R., Nash, S., Petalas, M., Oliver, C., Howlin, P., Moss, J., Petty, 
J., and Tunnicliffe, P. (2011). “You have to sit and explain it all, and explain yourself.” 
 189 
 
Mothers’ experiences of support services for their offspring with a rare genetic 
intellectual disability syndrome. Journal of Genetic Counselling, 20, 165-177.  
 
Hagerman, R. and Hagerman, P. (2002). Fragile X syndrome: Diagnosis, treatment, and 
research. Baltimore: John Hopkins University Press. 3-109.  
 
Hall, S., Debarnardis, M., and Reiss, A. (2006). Social escape behaviours in children 
with fragile X syndrome. Journal of Autism and Developmental Disorders, 36, 935-947.  
 
Hatton, D., Sideris, J., Skinner, M., Mankowski, J., Bailey, J., Roberts, J., and Mirrett, 
P. (2006). Autistic behaviour in children with fragile X syndrome: Prevalence, stability 
and the impact of FMRP. American Journal of Medical Genetics, 140A, 1804-1813.  
 
Horneff, G., Majewski, F., Hildebrand, B., Voit, T., and Lenard, H. (1993). Pallister-
Killian syndrome in older children and adolescents. Pediatric Neurology, 9, 312-315.  
 
Hyman, P., liver, C., and Hall, S. (2002). Self-injurious behaviour, self-restraint and 
compulsive behaviours in Cornelia de Lange. American Journal of Mental Deficiency, 
107, 146-154.  
 
Izumi, K., and Krantz, I. (2014). Pallister-Killian Syndrome. American Journal of 
Medical Genetics Part C, 166C, 406-413. 
 
 190 
 
Izumi, K., Kellogg, E., Fujiki, K., Kaur, M., Tilon, R., Noon, S., Wilkens, A., Shirahige, 
K., and Krantz, I. (2015). Elevation of insulin-like growth factor binding protein-2 level 
in Pallister-Killian syndrome: Implications for the postnatal growth retardation 
phenotype. American Journal of Medical Genetics, Part A, 167A, 1268-1274.  
 
Jolleff, N., and Ryan, M. (1993). Communication development in Angelman syndrome. 
Archives of Disease in Childhood, 69, 148-150.  
 
Kaufmann, W., and Reiss, A. (1999). Molecular and cellular genetics of Fragile X 
syndrome. American Journal of Medical Genetics, 88, 11-24.  
 
Kerby, D., and Dawson, B. (1994). Autistic features, personality and adaptive behaviour 
in males with Fragile X syndrome and no Autism. American Journal of Mental 
Retardation, 98, 455-462.  
 
Kim, J., Szatmari, P., Bryson, s., Streiner, D., and Wilson, F. (2000). The prevalence of 
anxiety and mood problems among children with autism and Asperger syndrome. 
Autism, 4, 117-132.  
 
Kishino, T., Lalande, M., and Wagstaff, J. (1997). UBE3A/ E6-AP mutations cause 
Angelman syndrome. Nature Genetics, 15, 70-73.  
 
 191 
 
Kostanecka, A., Close, L., Izumi, K., Krantz, I., and Pipan, M. (2012). Developmental 
and Behavioural Characteristics of Individuals with Pallister-Killian Syndrome. 
American Journal of Medical Genetics Part A, 158A, 3018-3025. 
 
Lee, L., David, A., Rusyniak, J., Landa, R., and Newschaffer, C. (2007). Performance 
of the Social Communication Questionnaire in children receiving preschool special 
education services. Research in autism Spectrum Disorders, 1, 126-138.  
 
Leube, B., Majewski, F., Gebauer, J., and Royer-Pokora, B. (2003). Clinical, 
cytogenetic, and molecular observations in a patient with Pallister-Killian syndrome 
with an unusual karyotype. American Journal of Medical Genetics, Part A, 123A, 296-
300.  
 
Liu, J., and Baynam, G. (2010). Cornelia de Lange syndrome. Advances in 
Experimental Medicine and Biology, 685, 111-123.  
 
Lutz, H., Patterson., B., and Klein, J. (2012). Coping with autism: A journey towards 
adaption. Journal of Paediatric Nursing, 27, 206-213.  
 
Mazzocco, M., Pennington, B., and Hagerman, R. (1994). Social cognition skills among 
females with Fragile X syndrome. Journal of Autism and Developmental Disorders, 24, 
473-485.  
 
 192 
 
Moss, J., Oliver, C., Arron, K., Burbidge, C., and Berg, K. (2009). The prevalence and 
phenomenology of repetitive behaviours in genetic syndromes. Journal of Autism and 
Developmental Delay, 39, 572-588.  
 
Moss, H., and Howlin, P. (2009). Autism spectrum disorders in genetic syndromes; 
implications for diagnosis, intervention and understanding the wider autism spectrum 
disorder population. Journal of Intellectual Disability Research, 53, 852-873.  
 
Moss, J., Howlin, P., Magiati, I., Oliver, C. (2012). Characteristics of autism spectrum 
disorder in Cornelia de Lange syndrome. Journal of Child Psychology and Psychiatry, 
53, 883-891.  
 
Nelson, L., Moss, J., and Oliver, C. (2014). A longitudinal follow-up study of affect in 
children and adults with Cornelia de Lange syndrome. American Journal of Intellectual 
and Developmental Disabilities, 119, 235-252.  
 
Nelson, L., Moss, J., Powis, L., Waite, J., and Oliver, C. (In press). A comparative study 
of sociability and selective mutism in autism spectrum disorder, Angelman syndrome, 
Cri du Chat Syndrome, Cornelia de Lange Syndrome, Fragile X Syndrome and 
Rubinstein-Taybi Syndrome. American Journal of Intellectual and Developmental 
Disabilities.   
 
Nyhan, W. (1972). Behavioural phenotypes in organic genetic disease: presidential 
address to the Society for Paediatric Research, May 1. Paediatric Research, 6, 1-9.  
 193 
 
 
Oliver, C., Arron, K., Hall, S., and Sloneem, J. (2008). The behavioural phenotype of 
Cornelia de Lange syndrome. British Journal of Psychiatry, 193, 466-470.  
 
Oliver, C., Berg, K., Moss, J., Arron, K., and Burbidge, C. (2011). Deletion of 
behavioural phenotypes in genetic syndromes: Characteristics of autism spectrum 
disorder, affect and hyperactivity. Journal of Autism and Developmental Disorders, 41, 
1019-1032.  
 
Oliver, C., Horsler, K., Berg, K., Bellamy, G., Dick, K., and Griffiths, E. (2007). 
Genomic imprinting and the expression of affect in Angelman syndrome: What’s in the 
smile? Journal of Child Psychology and Psychiatry, 48, 571-579.  
 
Oliver, C., Sloneem, J., Hall, S., and Arron, K. (2009). Self-injurious behaviour in 
Cornelia de Lange syndrome. 1. Prevalence and phenomenology. Journal of Intellectual 
Disability, 53, 590-603.  
 
Pallister, P., Meisner, L., Elejalde, B., Francke, U., Herrmann, J., Spranger, J., Tiddy, 
W., Inhorn, S., and Opitz, J. (1977). The Pallister mosaic syndrome. Birth Defects 
Original Article Series, 13, 103-110.  
 
Pelc, K., Cheron, G., and Dan, B. (2008). Behaviour and neuropsychiatric 
manifestations in Angelman syndrome. Neuropsychiatric Disease and Treatment, 4, 
577-584.  
 194 
 
 
Peters, S., Beaudet, A., Madduri, N., and Bacino, C. (2004). Autism in Angelman 
syndrome: implications for autism research. Clinical Genetics, 66, 530-536.  
 
Peters, S., Horowitz, L., Barbier-Welge, R., Taylor, J., and Hundey, R. (2012). 
Longitudinal follow-up of autism spectrum features and sensory behaviours in 
Angelman syndrome by deletion class. Journal of Child Psychiatry, 53, 152-159.  
 
Quarrell, O., Hamill, M., and Hughes, H. (1988). Pallister-Killian mosaic syndrome 
with emphasis on the adult phenotype. American Journal of Medical Genetics, 31, 841-
844.  
 
Reynolds, J., Daniel, A., Kelly, T., Gollin, S., Stephan, M., Carey, J., Adkins, W., 
Webb, M., Char, F., and Jimenez, J. (1987). Isochromosome 12p mosaicism (Pallister 
mosaic aneuploidy or Pallister-Killian syndrome): report of 11 cases. American Journal 
of Medical Genetics, 27, 257-274.  
 
Richards, C., Jones, C., Groves, L., Moss, J., and Oliver, C. (2015). Prevalence of 
autism spectrum disorders: a systematic review and meta analysis. The Lancet 
Psychiatry, 10, 909-916.  
 
Richards, C., Moss, J., O’Farrell, L., Kaur, G., and Oliver, C. (2009). Social anxiety in 
Cornelia de Lange syndrome. Journal of Autism and Developmental Disorders, 39, 
1155-1162.  
 195 
 
 
Roberts, J., Weisenfeld, L., Hatton, D., Heath, M., and Kaufmann, W. (2007). Social 
approach and autistic behaviour in children with Fragile X syndrome. Journal of Autism 
and Developmental Disorders, 37, 1748-1760.  
 
Sawyer, M., Bittman, M., Greca, A., Crettenden, A., Harchak, T., and Martin, J. (2010). 
Time demands of caring for children with autism: What are the implications for 
maternal mental health? Journal of Autism and Developmental Disorders, 40, 620-628.  
 
Schaefer, G., Jochar, A., Muneer, R., and Sanger, W. (1997). Clinical variability of 
tetrasomy 12p. Clinical Genetics, 51, 102-108.  
 
Schinzel, A. (1991). Tetrasomy 12p (Pallister-Killian syndrome). Journal of Medical 
Genetics, 28, 122-125.  
 
Shah, A., Wadoo, O., Lattoo, J. (2010). Psychological distress in carers of people with 
mental disorders. British Journal of Medical Practitioners, 3, 327-334.  
 
Sherman, S. (2002). Epidemiology in Hagerman, R., and Hagerman, P. (Eds.). Fragile 
X syndrome: Diagnosis, treatment and research. 136-168. Baltimore, MD: John 
Hopkins University Press.  
 
Smith, A., and Gropman, A. (2001). Smith Magenis Syndrome. In Management of 
Genetics Syndromes. Cassidy, S., and Allanson, J. (Eds). New York: Wiley-Liss, Inc.   
 196 
 
 
Smith, C., Weaver, L., and Fristad, M. (2015). A systematic review of sensory 
processing interventions for children with autism spectrum disorders. Autism, 19, 133-
148.  
 
Smith, A., Wiles, C., Hann, E., McGill, J., Wallace, G., Dixon, J., Selby, R., Colley, A., 
Marks, R., and Trent, R. (1996). Clinical features in 27 patients with Angelman 
syndrome resulting from DNA deletion. Journal of Medical Genetics, 33, 107-112.  
 
Speleman, F., Leroy, J., Van Roy, N., De Paepe, A., Suijkerbuijk, R., Brunner, H., 
Looijenga, L., Verschraegen-Spae, M., and Orye, E. (1991). Pallister-Killian syndrome: 
characterization of the isochromosome 12p by fluorescent in situ hybridization. 
American Journal of Medical Genetics, 41, 381-387.  
 
Stalker, H., Gray, B., Bent-Williams, A., and Zori, R. (2006). High cognitive 
functioning and behavioural phenotype in Pallister-Killian syndrome. American Journal 
of Medical Genetics Part A, 140, 1950-1954.  
 
Summers, J., Allison, D., Lynch, P., and Sandler, L. (1995). Behaviour problems in 
Angelman Syndrome. Journal of Intellectual Disability Research, 39, 97-106.  
 
Symons, F., Butler, M., Sanders, M., Feurer, I., and Thompson, T. (1999). Self-injurious 
behaviour and Prader-Willi syndrome: behavioural forms and body locations. American 
Journal of Mental Retardation, 104, 260-290.  
 197 
 
 
Taylor, L., and Oliver, C. (2008). The behavioural phenotype of Smith-Magenis 
Syndrome: evidence for a gene-environment interaction. Journal of Intellectual 
Disability Research, 52, 830-841.  
 
Teschler-Nicola, M., and Killian, W. (1981). Case report 72: Mental retardation, 
unusual facial appearance, abnormal hair. Syndrome identification, 7, 6-7.  
 
Tierney, E., Nwokoro, N., Porter, F., Freund, L., Ghuman, J., and Kelley, R. (2001). 
Behaviour phenotype in the RHS/ Smith-Lemli-Opitz Syndrome. American Journal of 
Medical Genetics, 98, 191-200.  
 
Tilton, R., Wilkens, A., Krantz, I., and Izumi, K. (2014). Cardiac manifestations of 
Pallister-Killian syndrome. American Journal of Medical Genetics, Part A, 164A, 1130-
1135.  
 
Thompson, R., and Bolton, P. (2003). Case report: Angelman Syndrome in an 
individual with small SMC (15) and paternal uniparental disomy: a case report with 
reference to the assessment of cognitive functioning and Autistic symptomology. 
Journal of Autism and Developmental Disorders, 33, 171-176.  
 
Turk, J., and Cornish, K. (1998). Face recognition and emotion perception in boys with 
Fragile X syndrome. Journal of Intellectual Disability Research, 42, 490-499. 
 
 198 
 
Vogel, I., Lyngbye, T., Nielsen, A., Pedersen, S., and Hertz, J. (2009). Pallister-Killian 
syndrome in a girl with mild developmental delay and mosaicism for hexasomy 12p. 
American Journal of Medical Genetics Part A, 149A, 510-514.  
 
Walz, N. (2006). Parent report of stereotyped behaviours, social interactions and 
developmental disturbances in individuals with Angelman syndrome. Journal of autism 
and Developmental Disorders, 37, 940-947.  
 
Walz, N., and Baranek, G. (2006). Sensory processing patterns in persons with 
Angelman syndrome. The American Journal of Occupational Therapy, 60, 472-479.  
 
Walz, N., and Benson, B. (2005). Behavioural phenotypes in children with down 
syndrome, Prader-Willi syndrome and Angelman syndrome. Journal of Developmental 
and Physical Disabilities, 14, 307-321.  
 
Warburton, D., Anyane-Yeboa, K., and Francke, U. (1987). Mosaic tetrasomy 12p: four 
new cases, and confirmation of the chromosomal origin of the supernumerary 
chromosome in one of the original Pallister-Mosaic syndrome cases. American Journal 
of medical Genetics, 27, 275-283.  
 
Wilkens, A., Liu, H., Park, K., Campbell, L., Jackson, M., Kostanecka, A., Pipan, M., 
Izumi, K., Pallister, P., and Krantz, I. (2012). Novel clinical manifestations in Pallister-
Killian syndrome: comprehensive evaluation of 59 effected individuals and review of 
 199 
 
previously reported cases. American Journal of Medical Genetics, Part A, 158A, 3002-
3017.  
 
Williams, C., Beaudet, A., Clayton-Smith, J., Knoll, J., Kyllerman, M., Laan, L., 
Magenis, R., Monda, A., Schinzel, A., Summers, J., and Wagstaff, J. (2006). Angelman 
syndrome 2005; updates consensus for diagnostic criteria. American Journal of Medical 
Genetics, 140, 413-418.  
 
Williams, C. (2005). Neurological aspects for the Angelman syndrome. Brain and 
Development, 27, 88-94.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 200 
 
CHAPTER 3 
 
Public Dissemination Document: 
 
Exploring Sensory symptoms across Rare Genetic Syndromes and Exploring the 
Behavioural Phenotype of Pallister-Killian Syndrome 
 
 
 
Literature Review: Exploring Sensory symptoms across Rare Genetic Syndromes 
Introduction 
 Autism Spectrum Disorder (ASD) was previously diagnosed by clinicians 
assessing individual’s behaviour, including their social interactions, communication 
skills, imagination and repetitive behaviours. However, national guidance (DSM-5; 
APA, 2013) has changed and clinicians now need to additionally assess individual’s 
sensory symptoms before a diagnosis can be made.  
Individuals with ASD have a range of sensory difficulties across different 
modalities (Schaaf and Lane, 2015). These could be hypo-sensitivity (individuals are 
slower to respond to sensory stimuli), or hyper-sensitivity (individuals experience more 
intense sensory experiences) (Dunn, 2001). In individuals with ASD the difficulties are 
displayed inconsistency across different modalities including, touch, sight, taste, smell 
and hearing (Lane, Dennis and Geraghty, 2011). 
The changes in the diagnostic criteria not only has implications for individuals 
with ASD, but also for individuals with rare genetic syndromes and intellectual 
disability as many individuals with genetic syndromes also have ASD symptoms 
(Richards, Jones, Groves, Moss and Oliver, 2015). Therefore, it is important to assess 
sensory symptoms in a range of genetic syndromes.  
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Method 
 Research databases were searched to identify all published papers that 
investigated sensory symptoms in a range of genetic syndromes. Sixteen papers were 
identified that investigated sensory symptoms in seven syndromes; Angelman syndrome 
(AS), Down syndrome (DS), Fragile X syndrome (FXS), Phelan-Mc Dermid syndrome 
(PHMDS), Smith-Lemli-Opitz syndrome (SLOS), Smith Magensis syndrome (SMS) 
and Williams syndrome (WS). Each paper was evaluated against a number of different 
criteria, which helped determine how well the research was conducted and how reliable 
the results were.  
 
Main Results 
1. All of the syndrome groups displayed a range of sensory difficulties. 
2. Some of the research reviewed was not completed to a high standard, therefore 
the results could not be reliably used to draw conclusions about each syndrome. 
3. The most reliable research showed the individuals with FXS and WS had hyper-
sensitivity difficulties and individuals with AS had hypo-sensitivity difficulties.  
4. Not all genetic syndromes displayed the same sensory difficulties and responded 
to different modalities in different ways.  
 
Conclusion 
 The findings show that the assessment of sensory symptoms in genetic syndromes 
will have implications for co-morbid diagnoses of ASD. Specifically, suggesting that 
some syndromes may be more be more likely to met criteria for a diagnosis of ASD, 
whereas some syndromes will be less likely. The research as a whole had a lack of 
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comparison groups, often only used one method of assessing sensory symptoms and did 
not follow individuals up to determine how their sensory symptoms changed as they 
grew older.  
 
Research Study: Exploring the Behavioural Phenotype of Palllister-Killian 
Syndrome (PKS) 
 
Introduction 
Pallister-Killian syndrome (PKS) is a rare genetic disorder first identified in 
1977 (Pallister et al., 1977). Much of the research into the syndrome has concentrated 
on the their physical health difficulties and the underlying genetics. There has been a 
lack of research describing the ‘behavioural phenotype’ of PKS. A behavioural 
phenotype is a set of behaviours, which are more likely to be displayed by individuals 
with one specific syndrome compared to individuals with different genetic syndromes 
(Dykens, 1995). For example, research has reported that the Angelman Syndrome (AS) 
group behavioural phenotype includes, sensory-seeking, a happy demeanour, excessive 
laughing and a desire to communicate with others (Williams et al., 2006). To date 
previous research investing the behaviour of the syndrome have used less reliable 
assessment measures and not compared individuals with PKS to other individuals with 
other genetic syndromes. Therefore, there is a need to further investigate the 
behavioural phenotype of PKS using more reliable assessments and comparing results 
to other syndrome groups (Nelson, Oliver and Moss, 2014).  
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Method 
Sixteen Parents of individuals with PKS completed online questionnaires 
exploring challenging behaviour, mood, activity, repetitive behaviours, ASD 
symptomology, sensory symptoms and parental anxiety and depression. This data was 
compared against individuals with other genetic syndromes including AS, Fragile X 
syndrome (FXS) and Cornelia de Lange syndrome (CdLS). Some of the individuals in 
the comparison syndrome groups were matched by their age and ability to participants 
with PKS, to be more confident the results found were not due to these factors and more 
likely due to the syndrome difference. Although, it was not possible to match all 
individuals in all syndrome comparison groups.  
 
Main Results 
 
1. Individuals with PKS have developmental delays and are mostly not 
independent mobile and are unable to speak.  
2. Individuals with PKS displayed the same level of challenging 
behaviour as individuals with AS.  
3. Individuals with PKS displayed behaviour which suggested they had a 
lower mood and less interest and pleasures compared to individuals 
with AS.  
4. Individuals with PKS displayed the same level of repetitive behaviours 
as individuals with AS.  
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5. Individuals with PKS were less active and impulsive compared to 
individuals with AS.  
6. More individuals with PKS met screening criteria for Autism than 
individuals with AS.  
7. Individuals with PKS were less sociable compared to individuals with 
AS, but displayed similar sociability to individuals with FXS and 
CdLS.  
8. Individuals with PKS showed more hyposensitivity difficulties 
compared to individuals with AS and FXS and less sensory-seeking 
behaviours compared to individuals with AS, FXS and CdLS.  
9. Parents/carers of individuals with PKS had similar levels of anxiety 
and depression as parents/carers of individuals with AS.  
 
Discussion 
The research suggests that the behavioural phenotype of PKS may include low 
mood, lack of interest and engagement, reduced activity, a lack of sociability, 
hyposensitivity difficulties and autism. However, there were some individuals who 
displayed a less severe phenotype. The results highlight the importance of ASD 
assessments and timely sensory interventions (Griffith et al., 2011).  
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Appendix 1: Criteria and Associated Features with ASD taken from Grzadzinski, 
Huerta and Lord (2013).  
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Appendix 2: The Percentage of ASD Symptomology in a Range of Genetic 
Syndromes Associated with Intellectual Disability. 
 
Syndrome Percentage of ASD comorbidity 
 
Richards (2015)  Zafeirous, Ververi, 
Dafoulis, Kalyva and 
Vargiami (2013) 
Angelman Syndrome 34% 50-61% 
CHARGE Syndrome 30% 28-68% 
Chromosome 22q11.2 Deletion 
Syndrome 
11% - 
Chromosome 2q37 Deletion 
Syndrome 
- 24-50% 
Cohen’s Syndrome 54% 25-93% 
Cornelia de Lange Syndrome 43% 46-67% 
Down Syndrome 16% 16-19% 
Fragile X Syndrome 22% 15-52% 
Klineflter Syndrome - 11-27% 
Neurofibromatisis Type 1 18% 4% (Autism) 
Noonan’s Syndrome 15% - 
Phelan- McDermid Syndrome - 50% 
Potocki-Lupski Syndrome - >65% 
Prader Willi Syndrome - 19-36% 
Rett Syndrome 61%  
Smith-Lemli-Opitz Syndrome - 53-57% 
Smith-Magenis Syndrome - 68.4% 
Soto Syndrome - 68% 
Timothy Syndrome - 80% 
Tuberous Sclerosis Complex 36% 5-61% (~50%) 
Turner Syndrome - 3% (Autism) 
Velocardiofacial Syndrome - 14-50% 
William’s Syndrome 12% 50% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 209 
 
Appendix 3: Explanation of the Development of the Quality Assessment 
Framework 
 
Sensory Assessment 
 
Richards et al., (2015) criteria for ASD assessment was changed to assess sensory 
modulation methods. Methods which have not been validated or used in previous 
studies, lack reliability and validity, specifically, criterion validity due to difficulties in 
overlapping constructs (Gabriel et al., 2008). Therefore, conclusions are limited and 
results can be used only as a screening, exploratory assessment of sensory modulation. 
Assessments, which have been previously used and offer psychometric properties, are 
considered more reliable and valid. However, there is often a lack of consistency 
between parent reports, observation methods and physiological data (Goldberg, Landa, 
Lasker, Cooper and Zee, 2000), thus, a combination of these methods offered the most 
comprehensive assessment (Rogers and Ozonoff, 2005). However, it is noteworthy that 
no sensory assessment has currently been validated for individuals with rare genetic 
syndromes.  
 
As a result, a broad quality criterion of sensory modulation assessments was 
constructed. The sensory assessments used in the research were either ranked ‘red’, 
‘yellow’, ‘orange’ or ‘green’. Red was assigned to studies where no information was 
specified or reported on the type of sensory assessment conducted. A red symbol was 
also assigned to studies where clinician judgement alone was used to assess sensory 
modulation, without reference to any specified tools or diagnostic criteria. A yellow 
symbol was assigned when an assessment method was used, but it had not been 
previously used in other research and thus lacked validation, e.g. SRAF-SSI. A yellow 
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symbol was also given if a validated assessment measure was used, although it had not 
been validated or previously used in individuals with ID or ASD, or was being used for 
participants out of the normative age range.  An orange symbol was assigned for studies 
that employed validated assessment measures, which had been validated or used 
previously for individuals with ID or ASD and was used for participants within the 
normative age range. Finally, a green symbol was assigned if studies used consensus 
from multiple assessments, and that at least one of these assessments would have 
obtained an orange symbol in isolation.  
 
Comparison Group 
The CASP framework (CASP, 2014) questions if control participants are matched and 
discusses the importance of comparison participants, selection methods and eligibility 
criteria. Therefore, comparison to normative data is less comprehensive compared to the 
studies, which have recruited their own participants. Furthermore, Young and Solomon 
(2009) highlight the importance of appropriate comparison groups, suggesting that the 
only difference between groups should be the syndrome diagnosis. This difficulty has 
also been discussed in the sensory modulation literature, specifically; suggesting that 
research needs to include age or IQ matched comparison groups (Ben-Sasson et al., 
2009).  
 
A criterion for comparison groups was developed. The comparison participants/data 
used in the research were ranked from ‘red’, ‘yellow’, ‘orange’ and ‘green’ with a 
symbol of red being assigned to studies where no information was specified or reported 
about comparison groups/data. A symbol of yellow was assigned when a comparison 
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could be made to published normative data or data in other research articles. A symbol 
of orange was assigned for studies that recruited and assessed a comparison group, 
which either contained TD individuals or those with ID, ASD or another genetic 
difficulty or syndrome, which was recruited by the research paper. Finally, a symbol of 
green was assigned if studies recruited and assessed a comparison group, which was 
matched at least on one domain e.g. chronological age or ID, which was recruited by the 
research paper.  
 
Confounding Variables 
The CASP framework (CASP, 2014) questions what confounding factors were 
accounted for and if they were considered in the design and analysis of the study. 
Moreover, Young and Solomon (2009) and von Elm, Altman, Egger, Pocock, Gotzsche 
and Vandenbroucke, (2007) recommend considering if important confounding factors 
were identified and accurately assessed. Confounding variables have also been 
considered in the literature and there is debate regarding the contribution of age, ID, 
repetitive behaviours, attention, social communication and mental health have on 
sensory modulation (e.g. Boyd et al., 2010; Militerni, Bravaccio, Falco, Fico and 
Palermo, 2002; Simonoff, Pickles, Charman, Candler, Locas and Baird, 2008; Watson 
et al., 2011).  
 
Therefore, a criterion for assessment of confounding variables was developed. The 
assessment of confounding variables in the research was ranked ‘red’, ‘yellow’, 
‘orange’ and ‘green’, with a red symbol assigned to studies where no information was 
specified or reported about confounding variables. A symbol of yellow was assigned 
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when at least one known confounding variables were assessed, but only used to describe 
participant sample, e.g. descriptions of age, or IQ, but no analysis was completed. A 
symbol of orange was assigned for studies were at least one known confounding 
variable was assessed and the relationship between constructs were considered e.g. 
correlational analysis between sensory modulation and repetitive behaviour assessment 
or age, functional ability. However, confounding variables were not controlled for in 
sensory analysis. Finally, a symbol of green was assigned if studies assessed known 
confounding variables and they were controlled for in the analysis.  
 
Developmental Changes 
The CASP framework (CASP, 2014) questions if participants were followed up and if 
the length of follow-up was long enough. Moreover, the sensory modulation literature 
suggests that studies use longitudinal methodology to determine how sensory symptoms 
develop and change with age (Schaaf and Lane, 2015).  
 
A criterion for assessment for assessing developmental changes was developed. The 
assessment for developmental changes in the research was ranked ‘red’, ‘yellow’, 
‘orange’ or ‘green’, with a symbol of red assigned to studies where no information was 
specified or reported about age-related changes. A symbol of yellow was assigned when 
retrospective data was collected, e.g. interviewing parents/carers about the development 
and changes in sensory modulation. A symbol of yellow was also given if correlational 
data was analysed between age and sensory modulation. A symbol of orange was 
assigned for studies, which made comparisons between specific age ranges e.g. 
recruiting both younger and older individuals with a syndrome and comparing sensory 
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modulation between the two age groups.  Finally, a symbol of green was assigned if 
studies were longitudinal and assessed the same participants over a length of time.  
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Appendix 4: Participant Invitation, Consent Forms, Information Sheets and 
Background Information Questionnaire. 
 
 
 
                                         
 
April 2016 
    
  
Dear Parent, 
 
We are writing to inform you of a new research project that is being carried out 
at the Cerebra Centre for Neurodevelopmental Disorders at the University of 
Birmingham. We would like to invite you and the person you care for to take 
part in this new research project. Briefly, the research is a questionnaire study 
looking at different behaviours in children and adults with Pallister-Killian 
syndrome that have received minimal attention within the literature.  
 
We have contacted you through Unique. Your personal details will not be known 
to us unless you decide to take part in the study. There is an information sheet 
enclosed that gives you more details about why the research is being carried 
out and what participation will involve. If you feel it is appropriate you may wish 
to discuss the research with the person you care for before a decision is made 
about taking part.  
 
There is an information sheet enclosed that gives you more details about why 
the research is being carried out and what it will involve. If you and your 
child/person you care for would like to take part in the study then please 
complete the enclosed consent form and questionnaire pack and return them in 
the pre-paid envelope provided. 
 
Please read the information sheets before completing the questionnaires 
and if you are unclear about any aspect of the study or have any 
questions then contact Professor Chris Oliver at the address below or on 
  
 
Thank you for your time and we look forward to hearing from you. 
 
Yours sincerely 
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Chris Oliver 
Professor of Neurodevelopmental Disorders 
 
 
Consent Form A :  For individuals who are able to provide consent to 
participate in the study 
 
Understanding behaviour and family adjustment in individuals with 
neurodevelopmental disorders 
 
Study Director: Professor Chris Oliver 
 
SECTION 1:  Please complete this section if you are a person with Pallister-Killian 
syndrome: 
 
1. Has somebody else explained the project to you?   YES/NO 
2. Do you understand what the project is about?     YES/NO 
3. Have you asked all of the questions you want?     YES/NO 
4. Have you had your questions answered in a way you understand?  YES/NO 
5. Do you understand it is OK to stop taking part at any time?   YES/NO 
6. Are you happy to take part?       YES/NO 
 
If any answers are ‘no’ or you don’t want to take part, don’t sign your name! 
 
If you do want to take part, you can write your name below 
 
You can also choose if you want to say ‘yes’ to these questions: 
7. If your Dr asks to see your results from this project is that OK?  YES/NO 
8. Are you happy for us to contact you again in the future?   YES/NO 
 
Your 
name:______________________________________________________________ 
 
Date:_____________________ 
 
The person who explained this project to you needs to sign too. If you are under the age 
of 16, this should be your parent/guardian. 
 
Print name:___________________________ Sign:_________________________ 
Date:__________________ 
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SECTION 2: Please complete this section if you are a parent/carer/guardian of a 
person with PKS  
who has provided their consent to participate in the study.     Please initial box… 
 
1. I confirm that I have read and understood the information sheet for the 
above study. I have had the opportunity to consider the information, ask 
questions and have had these answered satisfactorily. 
 
2. I understand that my participation and that of my child/person I care for is 
voluntary and that I am free to withdraw at any time without giving any 
reason, without my or that of my child’s/person I care for’s medical care or 
legal rights being affected. 
 
3. I understand that relevant sections of my child’s/person I care for’s GP 
medical notes or records confirming genetic diagnosis and health status may 
be looked at by members of the Cerebra Centre for Neurodevelopmental 
Disorders research team at the University of Birmingham, where it is 
relevant to this research project. I give permission for these individuals to 
have access to these records. 
 
4. I agree to my child’s/person I care for’s GP being informed of my 
participation and that of my child/person I care for’s in the study, where 
access to my child’s/person I care for’s medical records is required. 
 
5. I agree to take part in the above study.  
 
Optional clause: The statement below is optional:    
  
 
1. I agree to the University of Birmingham research team sharing my research 
data with any professionals or clinicians working with me and the person I 
care for should they request to see them. 
 
Print Name: ________________________________________  
Telephone number: ______________________________ 
 
Address: ________________________________________________________ 
Email: ___________________________ 
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Relationship to participant: ________________ 
Signature: ________________________ 
Date: _____________________ 
 
SECTION 3: This is optional and allows you to provide consent for us to keep your 
personal details on the Regular Participant Database.  See section titled ‘Regular 
Participant Database’ in the information sheet.      
                                                                                                                                                           
Please initial box… 
1. I have read and understood the section titled ‘Regular Participant Database’ 
and I would like my personal details to be added to the database. 
 
2. I understand that my name and contact details will be kept by the research 
team at the University of Birmingham in accordance with the provisions of 
the Data Protection Act 1998 and I will be contacted by an approved 
member of the team with information about future research that I and the 
person I care for may like to participate in. 
 
3. I understand that if my details are held on the database it will be possible for 
the research team to trace the results of the assessments that I complete in 
this project back to me and my child/person I care for so that they can look 
at changes over time if I take part in future projects. 
 
4. I understand that even after I have agreed for my details to be added to the 
database, I can request that they be removed by contacting Chris Oliver on 
 or by post at the 
School of Psychology, University of Birmingham, Edgbaston, B15 2TT. 
 
5. I understand the Professor Chris Oliver holds ultimate responsibility for the 
database. 
 
Print Name: ____________________Signature: ____________________________Date: 
__________ 
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Consent Form B: For Children under the age of 16 who are not able to provide 
consent. 
 
Understanding behaviour and family adjustment in individuals with 
neurodevelopmental disorders 
 
Study Director: Professor Chris Oliver 
 
SECTION 1: Please complete this section if you are a parent/ guardian of a child 
(under 16 years) with Pallister-Killian syndrome who is not able to provide 
consent. 
           Please initial 
box… 
 
1. I confirm that I have read and understood the information sheet dated 
01.02.2010 for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
2. I understand that my participation and that of my child/person I care for is 
voluntary and that I am free to withdraw at any time without giving any 
reason, without my or that of my child’s/person I care for’s medical care or 
legal rights being affected. 
3. I understand that relevant sections of my child’s/person I care for’s GP 
medical notes or records confirming genetic diagnosis and health status may 
be looked at by members of the Cerebra Centre for Neurodevelopmental 
Disorders research team at the University of Birmingham, where it is 
relevant to this research project. I give permission for these individuals to 
have access to these records. 
4. I agree to my child’s/person I care for’s GP being informed of my 
participation and that of my child/person I care for’s in the study, where 
access to my child’s/person I care for’s medical records is required. 
5. I agree to take part in the above study.  
 
Optional clause: The statement below is optional:      
   
6. I agree to the University of Birmingham research team sharing my 
research data with any professionals or clinicians working with me and 
the person I care for should they request to see them. 
 219 
 
 
Print Name: _____________________Name of person you care 
for___________________________ 
 
Address:_____________________________________Email: 
______________________________ 
 
Telephone number:______________Relationship to participant: 
______________________________  
 
Signature: ________________________Date: __________________ 
SECTION 2: This is optional and allows you to provide consent for us to keep your 
personal details on the Regular Participant Database.  See section titled ‘Regular 
Participant Database’ in the information sheet.  
           
                                                                                                                     Please initial 
box… 
 
6. I have read and understood the section titled ‘Regular Participant Database’ 
and I would like my personal details to be added to the database. 
 
7. I understand that my name and contact details will be kept by the research 
team at the University of Birmingham in accordance with the provisions of 
the Data Protection Act 1998 and I will be contacted by an approved 
member of the team with information about future research that I and the 
person I care for may like to participate in. 
 
8. I understand that if my details are held on the database it will be possible for 
the research team to trace the results of the assessments that I complete in 
this project back to me and my child/person I care for so that they can look 
at changes over time if I take part in future projects. 
 
9. I understand that even after I have agreed for my details to be added to the 
database, I can request that they be removed by contacting Chris Oliver on 
 or by post at the 
School of Psychology, University of Birmingham, Edgbaston, B15 2TT. 
 
10. I understand the Professor Chris Oliver holds ultimate responsibility for the 
database. 
 
 
Print Name: ___________________________Signature: ___________________Date: 
____________ 
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Consent Form C: For individuals over the age of 16 who are not able to provide 
consent. 
 
Understanding behaviour and family adjustment in individuals with 
neurodevelopmental disorders 
 
Study Director: Professor Chris Oliver 
 
SECTION 1: Please read the following statements:     
                Please initial 
box… 
  
1. I (your name)___________________have been consulted about (name of 
participant)_______________’s participation in the above research project. 
I have had the opportunity to ask questions about the study and understand 
what is involved. 
2. In my opinion he/she would have no objection to taking part in the above study. 
3. I understand that I can request he/she is withdrawn from the study at any 
time without giving any reason and without his/her care or legal rights 
being affected. 
4. I understand that relevant sections of his/her GP medical notes or records 
confirming genetic diagnosis and health status may be looked at by 
members of the Cerebra Centre for Neurodevelopmental Disorders research 
team at the University of Birmingham, where it is relevant to this research 
project. I give permission for these individuals to have access to these 
records. 
5. I agree to his/her GP being informed of their participation in the study, 
where access to medical records is required. 
6. I agree to take part in the above study.  
 
 
Optional clause: The statement below is optional:      
   
7. I agree to the University of Birmingham research team sharing his/her 
research data with any professionals or clinicians working with them 
should they request to see them. 
 
 
Print Name: _________________________________ Telephone 
number:_______________________ 
 
Address:______________________________________________________ 
Email: _____________________________ 
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Relationship to participant________________ 
Signature: ________________________Date: _____________________ 
SECTION 3: This is optional and allows you to provide consent for us to keep your 
personal details on the Regular Participant Database.  See section titled ‘Regular 
Participant Database’ in the information sheet.  
           
                                                                                                                                          Please initial 
box… 
 
11. I have read and understood the section titled ‘Regular Participant Database’ and 
I would like my and the person I care for’s personal details to be added to the 
database. 
 
12. I understand that my name and contact details will be kept by the research team 
at the University of Birmingham in accordance with the provisions of the Data 
Protection Act 1998 and I will be contacted by an approved member of the 
team with information about future research that I and the person I care for may 
like to participate in. 
 
13. I understand that if my details are held on the database it will be possible for the 
research team to trace the results of the assessments that I complete in this 
project back to me and the person I care for so that they can look at changes 
over time if we take part in future projects. 
 
14. I understand that even after I have agreed for my details to be added to the 
database, I can request that they be removed by contacting Chris Oliver on 
 or by post at the 
School of Psychology, University of Birmingham, Edgbaston, B15 2TT. 
 
15. I understand the Professor Chris Oliver holds ultimate responsibility for the 
database. 
 
Print Name: ___________________________Signature: ____________________________ 
Date: _______________ 
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Understanding behaviour in Neurodevelopmental Disorders:  Information Sheet  
 
Please read this information carefully before deciding whether you wish to take part in 
the study.  If you have any further questions please contact Professor Chris Oliver on 
   . If you have any 
medical/ other problems which make it difficult for you to read this information, please 
contact Professor Chris Oliver for a verbal explanation of the research. 
 
When you are happy that you have all of the information you need to be able to decide 
whether or not you and the person you care for would like to take part in the study, 
please complete the enclosed consent form and questionnaire pack return them to us 
in the prepaid envelope provided 
 
Background 
We would like to invite you to take part in a questionnaire study being conducted at the 
Centre for Neurodevelopmental Disorders, University of Birmingham. This research 
work, which is led by Professor Chris Oliver, looks at a range of behaviours, skills and 
impairments in individuals with Pallister-Killian syndrome including: Repetitive 
behaviour, Hyperactivity, Mood, Challenging behaviour, Social functioning and Health. 
We will also ask some questions that are related to family well-being and the impact 
that having a child with a disability has on the family.  
 
We hope that this information will enable us to further understand the behaviours, skills 
and impairments associated with Pallister-Killian syndrome including challenging 
behaviour, social functioning, mood, hyperactivity and health and the impact that these 
behaviours have on the family. The more people that take part in this research, the 
more meaningful the results will be. A good response will provide new and valuable 
information about Pallister-Killian syndrome. In the future we hope to follow up the 
progress of the people who take part in this study. However, participation in this stage 
of the project will not mean that you are obliged to participate in further surveys in the 
future. 
 
Aims of the study 
1. To further our understanding of challenging behaviour, repetitive behaviour, 
hyperactivity, mood and social functioning in individuals with Pallister-Killian 
syndrome. 
2. To understand what happens with regard to these behaviours as children and 
adults develop. 
3. To understand what, if any, changes may occur with regard to these behaviours 
when the individuals reach a certain age.  
4. To understand the impact of having a child with a disability has on the family. 
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What will happen if you and your child/the person you care for decide(s) to 
participate? 
 
Where will the research take place? 
The research will involve completing the enclosed questionnaire pack. This can be 
completed by you in your own time. 
 
Who will be involved in collecting the data? 
Members of the research team at the Cerebra Centre for Neurodevelopmental 
disorders including Professor Chris Oliver, Dr Alice Wheelham and Miss Claire 
Edwards 
How long will participation in the study take? 
The questionnaire pack will take approximately 45 minutes to complete. 
 
In the future you may be asked if you would like to complete the questionnaire again so 
that we can start to understand what happens to people with Pallister-Killian syndrome 
across their lifetime. We will only contact you with this invitation if you have previously 
agreed to be contacted by the research team at the University of Birmingham with 
information about research studies conducted by the team. 
 
Sometimes after you have completed the questionnaire, we may need to contact you 
again in order to clarify any information that you have provided or to ask you for further 
information regarding the diagnosis of the person you care for. This helps us to ensure 
that our data is as useful and as accurate as possible. If this happens then we would 
contact you again within 6 months of receiving your questionnaire pack to ask whether 
or not you would be willing to provide us with the extra information.  
 
What will participants be required to do during the study? 
We will ask parents and caregivers to complete the enclosed questionnaire pack and 
return it to us alongside the consent form in the pre-paid envelope provided.  
 
Are there any risks that individuals taking part in the study might face? 
There will not be any risks associated with participation in this study.  
 
What are the potential benefits for participants from taking part? 
You will receive a personalised feedback regarding your child/ the person you care for. 
This study will help us to find out more about the lives of people with Pallister-Killian 
syndrome and the difficulties that these people face.  The results might help us to 
improve things for people with Pallister-Killian syndrome in the future.  
 
Where will data be stored? 
The data collected will be kept in locked or password protected storage at the 
University of Birmingham.  Only members of the research team at the University of 
Birmingham will have access to information that we collect about you.  Information will 
be treated as strictly confidential and handled in accordance with the provisions of the 
Data Protection Act 1998. 
 
If you/ the person you care for decide(s) to participate, what will happen after 
that participation? 
You and your child/ person you care for will receive an individual feedback report 
describing the results of all of the assessments that were carried out during the study.   
If requested, this feedback report will be circulated to other interested individuals.  
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Descriptions of research findings will be published in newsletters of the relevant family 
support groups and educational institutions involved.  Any request for advice 
concerning the person you care for will be referred to Professor Chris Oliver, Clinical 
Psychologist. 
The researchers will publish the findings from the study in scientific journals and will 
present the results at relevant conferences. 
 
What will happen to the data afterwards? 
The information that you provide will be locked in a filing cabinet at the University of 
Birmingham or held on a password protected database. Participants will be identified 
by a unique number so that the information you provide us with cannot be traced to 
your personal details.  You will be able to decide whether or not you want to make your 
research data available to any professionals or clinicians working with you and the 
person you care for should they wish to see it. This is optional and will not affect your 
participation in the current study. If you agree to this, then your research data will only 
be made available to relevant clinicians or professionals should they contact us directly 
and request to see it. If you do not agree to this then research data will not be made 
available to anyone other than the research team at the University of Birmingham. 
 
After 6 months of receiving your questionnaire pack, your personal details will be 
destroyed unless you tell us otherwise.  This means that we would no longer be 
able to trace the results of your assessments back to you.  The section below on ‘The 
Regular Participant Database Information’ gives information about a database that 
we use to store the personal details of some participants.  Please read this section in 
order to decide if you would like to join that database. 
 
 
Regular Participant Database Information: 
 
What is the regular participant database? 
We have a database that we keep in the Cerebra Centre where we store the names 
and contact details of some previous participants.  If you would like us to, we can add 
your details to this database.  We would use this information for two things: 
1) We will contact you with information about future research work to find out 
whether or not you would like to participate. 
2) It is often important to find out how things change over time.  By keeping your 
details we would be able to trace the results of the previous assessments that 
you have done with us back to you.  This means that if you take part in other 
studies with us we would be able to look at how things have changed over time. 
 
Who would have access to my details? 
Only approved members of out research team would have access to your details.  We 
would not share your details with anyone outside the research team. 
 
When would I be contacted? 
You would only be contacted by an approved member of the research team when we 
are starting another study or phase of a study that we think you might like to participate 
in or when we need to clarify some information that you have provided us with from 
participation in a research study.  
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What happens if I decide that I want my details to be added to the database but then I 
change my mind? 
All you would need to do is contact Chris Oliver on  
  at the School of Psychology, University of 
Birmingham, Edgbaston, Birmingham, B15 2TT.  Your details would be removed from 
the database immediately. 
 
Consent 
After having read all of the information and having received appropriate responses to 
any questions that you may have about the study you and the person you care for will 
be asked to give your and your child’s/ person you care for’s consent to participate in 
the study if you decide that you do wish to participate.  The section below on ’Giving 
consent’ will explain this process.  We need to receive consent from/ on behalf of 
potential participants in order for them to participate. 
 
Withdrawal 
Even after consent has been granted, participants can request to be withdrawn from 
the study at any time, without giving a reason. Even after participation has taken place, 
consent can be withdrawn and any data collected will be destroyed.  This will not 
restrict the access of you/ the person you care for to other services and will not affect 
their right to treatment. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. Please contact Chris 
Oliver on   in the first 
instance. If you remain unhappy and wish to complain formally, you can contact: 
Professor Chris Miall; Head of School; School of Psychology, University of 
Birmingham, Birmingham, B15 2TT, by email: hos.psychology@contacts.bham.ac.uk  
or by phone on 0121 414 4931 
 
Confidentiality                  
The confidentiality of participants will be ensured.  If published, information on the 
participant will be presented without reference to their name or any other identifying 
information.  All personal details will be kept separately from the information collected 
so that it will only be possible to connect results to individuals via a special code.  This 
will ensure that results are kept anonymous.  In the unlikely event of any evidence of 
abuse being identified, this information will be disclosed by the research workers. 
 
Review 
The study has been approved by Coventry NHS Research Ethics Committee. For any 
queries or concerns regarding the ethical approval of this study please contact Pauline 
Pittaway on 02476967529 quoting study reference number: 10/H1210/1. 
 
Further information 
If you would like any more information about the study please contact Professor Chris 
Oliver on    Or write to 
Chris Oliver, School of Psychology, University of Birmingham, Edgbaston, Birmingham, 
B15 2TT.  
 
 226 
 
IMPORTANT: 
You need to decide whether your child/the person you care for is able to 
understand enough about the study to make an ‘informed’ decision independently 
about whether or not they would like to participate and to communicate this 
decision to you.  If you are unsure whether or not your child/person you care for is 
able to understand enough to make a decision independently then we can provide 
you with some guidelines to help you to assess this A symbol information sheet can 
also be made available to you if this would be of help. Please contact Professor 
Chris Oliver     request a 
copy of this.  
 
 
 
 
 
 
Giving consent 
Now it is up to you whether you decide that you and your child/the person you care for 
would like to participate.  The decision about whether or not to take part in the study 
must be ‘informed’.  This means that anyone making the decision must understand 
exactly what is involved in the study, what will be required from participants and why.   
 
Please choose from one of the following options: 
 
1. My child/ the person I care for is able to understand what is 
involved in the study and what will be required from them if 
they participate and has communicated their decision to me: 
 
If you think that the person is able to understand enough about the study in order to 
make an ‘informed’  
decision and they decide that they would like to participate then please ensure that 
they complete Section 1 of Consent Form A coloured YELLOW enclosed, or that 
you complete it with them, on their behalf.  A parent/carer will need to complete 
Section 2 of Consent From A coloured YELLOW in order to indicate that they also 
agree to participate in the study. A symbol information sheet can be made available in 
order to support your child/person you care for in making this decision if it would be of 
help. Please contact the research team if you would like a copy of the symbol consent 
form or if you need us to adapt this information further, in order to suit your child’s 
needs. Please return the consent form along with the questionnaire pack to us in the 
prepaid envelope provided.  
 
 
2. My child/ the person I care for is unable to understand what 
is involved in the study and what will be required from them 
if they participate (either because they are too young to 
understand or because they are unable to understand) and 
cannot communicate their decision to me: 
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If you are reading this information on behalf of someone you care for who is under the 
age of 16 years and you decide that the person is not able to make an ‘informed’ and 
independent decision about whether or not they would like to participate, then we 
would like to ask you to decide whether or not you think that it is in your child’s best 
interests for them to participate in the study and whether you would like to provide your 
consent to participation on their behalf. If you would like your child/person you care for 
to participate in this study, please complete Consent Form B coloured PURPLE 
enclosed. Please return the consent form along with the questionnaire pack to us in the 
prepaid envelope provided.  
 
  
      
  
 
 
Understanding behaviour in Neurodevelopmental Disorders:  Information Sheet  
 
Please read this information carefully before deciding whether you wish to take part in 
the study.  If you have any further questions please contact Professor Chris Oliver on 
   . If you have any 
medical/ other problems which make it difficult for you to read this information, please 
contact Professor Chris Oliver for a verbal explanation of the research. 
 
When you are happy that you have all of the information you need to be able to decide 
whether or not you and the person you care for would like to take part in the study, 
please complete the enclosed consent form and questionnaire pack return them to us 
in the prepaid envelope provided 
 
Background 
We would like to invite you to take part in a questionnaire study being conducted at the 
Centre for Neurodevelopmental Disorders, University of Birmingham. This research 
work, which is led by Professor Chris Oliver, looks at a range of behaviours, skills and 
impairments in individuals with Pallister-Killian syndrome including: Repetitive 
behaviour, Hyperactivity, Mood, Challenging behaviour, Social functioning and Health. 
We will also ask some questions that are related to family well-being and the impact 
that having a child with a disability has on the family.  
 
We hope that this information will enable us to further understand the behaviours, skills 
and impairments associated with Pallister-Killian syndrome including challenging 
behaviour, social functioning, mood, hyperactivity and health and the impact that these 
behaviours have on the family. The more people that take part in this research, the 
more meaningful the results will be. A good response will provide new and valuable 
information about Pallister-Killian syndrome. In the future we hope to follow up the 
progress of the people who take part in this study. However, participation in this stage 
of the project will not mean that you are obliged to participate in further surveys in the 
future. 
 
Aims of the study 
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5. To further our understanding of challenging behaviour, repetitive behaviour, 
hyperactivity, mood and social functioning in individuals with Pallister-Killian 
syndrome. 
6. To understand what happens with regard to these behaviours as children and 
adults develop. 
7. To understand what, if any, changes may occur with regard to these behaviours 
when the individuals reach a certain age.  
8. To understand the impact of having a child with a disability has on the family. 
 
What will happen if you and your child/the person you care for decide(s) to 
participate? 
 
Where will the research take place? 
The research will involve completing the enclosed questionnaire pack. This can be 
completed by you in your own time. 
 
Who will be involved in collecting the data? 
Members of the research team at the Cerebra Centre for Neurodevelopmental 
disorders including Professor Chris Oliver and Dr Alice Wheelham and Miss Claire 
Edwards.  
 
How long will participation in the study take? 
The questionnaire pack will take approximately 45 minutes to complete. 
 
In the future you may be asked if you would like to complete the questionnaire again so 
that we can start to understand what happens to people with Pallister-Killian syndrome 
across their lifetime. We will only contact you with this invitation if you have previously 
agreed to be contacted by the research team at the University of Birmingham with 
information about research studies conducted by the team. 
 
Sometimes after you have completed the questionnaire, we may need to contact you 
again in order to clarify any information that you have provided or to ask you for further 
information regarding the diagnosis of the person you care for. This helps us to ensure 
that our data is as useful and as accurate as possible. If this happens then we would 
contact you again within 6 months of receiving your questionnaire pack to ask whether 
or not you would be willing to provide us with the extra information.  
 
What will participants be required to do during the study? 
We will ask parents and caregivers to complete the enclosed questionnaire pack and 
return it to us alongside the consent form in the pre-paid envelope provided.  
 
Are there any risks that individuals taking part in the study might face? 
There will not be any risks associated with participation in this study.  
 
What are the potential benefits for participants from taking part? 
You will receive a personalised feedback regarding your child/ the person you care for. 
This study will help us to find out more about the lives of people with Pallister-Killian 
syndrome and the difficulties that these people face.  The results might help us to 
improve things for people with Pallister-Killian syndrome in the future.  
 
Where will data be stored? 
The data collected will be kept in locked or password protected storage at the 
University of Birmingham.  Only members of the research team at the University of 
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Birmingham will have access to information that we collect about you.  Information will 
be treated as strictly confidential and handled in accordance with the provisions of the 
Data Protection Act 1998. 
 
If you/ the person you care for decide(s) to participate, what will happen after 
that participation? 
You and your child/ person you care for will receive an individual feedback report 
describing the results of all of the assessments that were carried out during the study.   
If requested, this feedback report will be circulated to other interested individuals.  
Descriptions of research findings will be published in newsletters of the relevant family 
support groups and educational institutions involved.  Any request for advice 
concerning the person you care for will be referred to Professor Chris Oliver, Clinical 
Psychologist. 
The researchers will publish the findings from the study in scientific journals and will 
present the results at relevant conferences. 
 
 
What will happen to the data afterwards? 
The information that you provide will be locked in a filing cabinet at the University of 
Birmingham or held on a password protected database. Participants will be identified 
by a unique number so that the information you provide us with cannot be traced to 
your personal details.  You will be able to decide whether or not you want to make your 
research data available to any professionals or clinicians working with you and the 
person you care for should they wish to see it. This is optional and will not affect your 
participation in the current study. If you agree to this, then your research data will only 
be made available to relevant clinicians or professionals should they contact us directly 
and request to see it. If you do not agree to this then research data will not be made 
available to anyone other than the research team at the University of Birmingham. 
 
After 6 months of receiving your questionnaire pack, your personal details will be 
destroyed unless you tell us otherwise.  This means that we would no longer be 
able to trace the results of your assessments back to you.  The section below on ‘The 
Regular Participant Database Information’ gives information about a database that 
we use to store the personal details of some participants.  Please read this section in 
order to decide if you would like to join that database.  
 
 
Regular Participant Database Information: 
 
What is the regular participant database? 
We have a database that we keep in the Centre where we store the names and contact 
details of some previous participants.  If you would like then we can add your details to 
this database.  We would use this information for two things: 
3) We will contact you with information about future research work to find out 
whether or not you would like to participate. 
4) It is often important to find out how things change over time.  By keeping your 
details we would be able to trace the results of the previous assessments that 
you have done with us back to you.  This means that if you take part in other 
studies with us we would be able to look at how things have changed over time. 
 
Who would have access to my details? 
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Only approved members of out research team would have access to your details.  We 
would not share your details with anyone outside the research team. 
 
When would I be contacted? 
You would only be contacted by an approved member of the research team when we 
are starting another study or phase of a study that we think you might like to participate 
in or when we need to clarify some information that you have provided us with from 
participation in a research study.  
 
What happens if I decide that I want my details to be added to the database but then I 
change my mind? 
All you would need to do is contact Chris Oliver on  
 or at the School of Psychology, University of 
Birmingham, Edgbaston, Birmingham, B15 2TT.  Your details would be removed from 
the database immediately. 
 
Consent 
After having read all of the information and having received appropriate responses to 
any questions that you may have about the study you and the person you care for will 
be asked to give your and your child’s/ person you care for’s consent to participate in 
the study if you decide that you do wish to participate.  The section below on ’Giving 
consent’ will explain this process.  We need to receive consent from/ on behalf of 
potential participants in order for them to participate. 
 
Withdrawal 
Even after consent has been granted, participants can request to be withdrawn from 
the study at any time, without giving a reason. Even after participation has taken place, 
consent can be withdrawn and any data collected will be destroyed.  This will not 
restrict the access of you/ the person you care for to other services and will not affect 
their right to treatment. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. Please contact Chris 
Oliver on   in the first 
instance. If you remain unhappy and wish to complain formally, you can contact: 
Professor Chris Miall; Head of School; School of Psychology, University of 
Birmingham, Birmingham, B15 2TT, by email: hos.psychology@contacts.bham.ac.uk  
or by phone on 0121 414 4931 
 
Confidentiality                  
The confidentiality of participants will be ensured.  If published, information on the 
participant will be presented without reference to their name or any other identifying 
information.  All personal details will be kept separately from the information collected 
so that it will only be possible to connect results to individuals via a special code.  This 
will ensure that results are kept anonymous.  In the unlikely event of any evidence of 
abuse being identified, this information will be disclosed by the research workers. 
Review 
The study has been approved by Coventry NHS Research Ethics Committee. Ref: 
10/H1210/01. Tel: 01527 587688 
 
Further information 
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IMPORTANT: 
You need to decide whether your child/the person you care for is able to 
understand enough about the study to make an ‘informed’ decision 
independently about whether or not they would like to participate and to 
communicate this decision to you.  If you are unsure whether or not your 
child/person you care for is able to understand enough to make a decision 
independently then we can provide you with some guidelines to help you to assess 
this A symbol information sheet can also be made available to you if this would be 
of help.  
 
Please contact Professor Chris Oliver 0121 414 7206 or cndd-
enquiries@contacts.bham.ac.uk  to request a copy of this.  
If you would like any more information about the study please contact Professor Chris 
Oliver on    Or write to 
Chris Oliver, School of Psychology, University of Birmingham, Edgbaston, Birmingham, 
B15 2TT.  
 
Giving consent 
Now it is up to you whether you decide that you and your child/the person you care for 
would like to participate.  The decision about whether or not to take part in the study 
must be ‘informed’.  This means that anyone making the decision must understand 
exactly what is involved in the study, what will be required from participants and why.   
 
Ple se choose fr m one of the following options: 
 
3. My child/ the person I care for is able to understand what is 
involved in the study and what will be required from them if 
they participate and has communicated their decision to me: 
If you think that the person is able to understand enough about the study in order to 
make an ‘informed’ decision and they decide that they would like to participate then 
please ensure that they complete Section 1 of Consent Form A coloured YELLOW 
enclosed, or that you complete it with them, on their behalf.  A parent/carer will need to 
complete Section 2 of Consent From A coloured YELLOW in order to indicate that 
they also agree to participate in the study. A symbol information sheet can be made 
available in order to support your child/person you care for in making this decision if it 
would be of help. Please contact the research team if you would like a copy of the 
symbol consent form or if you need us to adapt this information further, in order to suit 
your child’s needs. Please return the consent form along with the questionnaire pack to 
us in the prepaid envelope provided.  
 
4. My child/ the person I care for is over the age of 16 and 
cannot understand what is involved in the study or cannot 
communicate their decision to me: 
If you are reading this information on behalf of someone you care for who is over the 
age of 16 and you decide that the person is not able to make an ‘informed’ decision 
about whether or not they would like to participate, then we would like to invite you to 
act as a ‘personal consultee’ (or ‘nominated consultee’ where an unpaid carer e.g. 
parent, legal guardian etc is not able to act as a ‘personal consultee’) for that person.  
Please read the enclosed ‘Personal and Nominated Consultee Information Sheet’ 
coloured PINK.  Once you have finished reading the ‘Personal and Nominated 
Consultee Information Sheet’ please decide whether or not you feel able to act as a 
personal or nominated consultee for the person you care for. 
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If you feel able to act as a personal or nominated consultee for the person you care for 
please think about whether the person would decide to participate if they were able to 
make an ‘informed’ decision themselves about whether or not to participate.  If you 
decide that the person would decide to participate, please complete Consent Form C 
coloured BLUE enclosed and return it to us alongside the questionnaire pack in the 
prepaid envelope provided. 
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ID____________ 
 
BACKGROUND INFORMATION 
 
 
1. Today’s date: ________________________ 
 
2. Gender:     Male    Female  
 
3. Date of Birth: ___/___/____  Age:______________  
 
4. Is the person you care for verbal? (i.e. more than 30 signs/words in their vocabulary)  
 
  Yes/No (delete as appropriate) 
 
5. Is the person you care for able to walk unaided? 
 
  Yes/No (delete as appropriate) 
 
6. Has the person you care for been diagnosed with a syndrome?  Yes/No (delete as 
appropriate)  
 
 If yes, please indicate which syndrome in 5a. and answer questions 6 to 8.  If no, please 
move on to question 9 
  
6.a Cornelia de Lange syndrome  Cri du Chat syndrome  
  
  Prader-Willi syndrome   Rubinstein Taybi syndrome 
  
  Fragile X syndrome   Down syndrome    
  Lowe syndrome    Soto Syndrome   
  
Rubinstein-Taybi syndrome                       9q34 deletion 
8p23deletion     Tuberous Sclerosis 
Pallister-Killian Syndrome                
Other _____________________________ 
 
7. What is the genetic mechanism causing the syndrome in the person you care for? 
  
  Uni-parental disomy    Sequence repetition 
  Deletion     Translocation 
  Unknown     
Other __________________________________ 
 
8. When was the person you care for diagnosed? ____________________________________ 
 
9. Who diagnosed the person you care for?     
  
  Paediatrician       Clinical Geneticist 
  GP        
 Other ____________________________ 
Please tick or write your response to these questions concerning background 
details: 
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10.   Has the person you care for had any medical/health difficulties in the last six months? If 
yes, please give details:                      
__________________________________________________________________________
__________________________________________________________________________
__ 
 
In the information sheet and consent form we informed you that we may need to contact your 
child’s/person you care for’s GP in order to clarify any information regarding your child’s health 
and diagnostic status (see consent form and information sheet for more information). If you have 
already indicated on the consent form that you are happy for us to do this, please complete the 
relevant details below: 
 
11. Name of your child’s/person you care for’s  
GP_________________________________________________________ 
GPAddress_______________________________________________________________________
_______________________________________________________________ 
GP Telephone number_______________________________ 
 
 
1. Are you male or female? Male            Female    
 
2. What was your age in years on your last birthday? _____________ years 
  
3. Please tick the highest level of your educational qualifications.  
     
No formal educational qualifications............................................................................    
Fewer than 5 GCSE’s or O Level’s (grades A-C), NVQ 1, or BTEC First Diploma…   
5 or more GCSE’s or O Level’s (grades A-C), NVQ 2, or equivalent……….……..   
3 or more ‘A’ Levels, NVQ 3, BTEC National, or equivalent......................................   
Polytechnic/University degree, NVQ 4, or equivalent...................................................   
Masters/Doctoral degree, NVQ 5, or equivalent…………............................................   
 
4. What is your relationship to your child with a genetic syndrome (e.g. mother, 
father, stepmother, grandmother, adoptive parent)? 
______________________________ 
 
 
5. In total how many people currently live in your home? ________  Adults  _______  
Children 
 
6. Does your child with a genetic syndrome normally live with you? Yes   No     
 
If no, then where do they live?______________________________________________ 
 
     The following questions ask for background information about you and your family. 
Please tick the appropriate boxes or write in the spaces provided. 
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7. What is your current marital status? 
 
Married, and living with spouse...................................................................   
 
Living with partner.......................................................................................   
  
Divorced/Separated/Widowed/Single and NOT living with a partner.........   
 
If living with partner/spouse, please answer the following questions, if not, please go to 
question 12. 
 
8. Is your partner male or female?                 Male            Female       
 
9. What was their age in years on their last birthday? _____________ years 
 
10. Please tick the highest level of your partner/spouse’s educational qualifications.  
            No formal educational qualifications........................................................................  
Fewer than 5 GCSE or O Level (grades A-C), NVQ 1, or BTEC First Diploma.....   
5 or more GCSE or O Level (grades A-C), NVQ 2, or equivalent…………..…  
3 or more ‘A’ Levels, NVQ 3, BTEC National, or equivalent.................................   
 Polytechnic/University degree, NVQ 4, or equivalent.............................................  
Masters/Doctoral degree, NVQ 5, or equivalent…………......................................  
 11. What is your partner/spouse’s relationship to your child with a genetic 
syndrome (e.g., mother, father, stepmother, adoptive 
parent)?______________________________ 
 
12. Recent data from research with families of children with special needs has shown 
that a family’s financial resources are important in understanding family member’s 
views and experiences. With this in mind, we would be very grateful if you could 
answer the additional question below. We are not interested in exactly what your family 
income is, but we would like to be able to look at whether those with high versus lower 
levels of financial resources have different experiences.  
What is your current total annual family income? Please include a rough estimate 
of total salaries and other income (including benefits) before tax and national 
insurance/pensions. Please tick one box only: 
Less than £15,000…………………………………………………………………….…………..… 
 
£15,001 to £25,000……………………………………………………………………...………….  
 
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£25,001 to £35,000………………………………………………………………..…….……….      
 
£35,001 to £45,000………………………………………………………………….…..…………   
 
£45,001 to £55,000……………………………………………………………..…………….……   
 
£55,001 to £65,000…………………………………………………….………………….…..          
 
£65,001 or more……………….………………………………….…                                               
 
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Appendix 5: Ethical Approval Letter.  
 
Coventry Research Ethics Committee 
2nd floor West Wing 
University Hospital 
Clifford Bridge Road 
Coventry 
CV2 2DX 
22 February 2010 
Telephone: 024 7696 7529  
Facsimile: 024 7696 5033 
Professor Chris Oliver 
School of Psychology 
University of Birmingham 
Birmingham  
B15 2TT 
 
 
Dear Professor Oliver 
 
Study title: Understanding Behaviour and Family Adjustment in 
Individuals with Neurodevelopmental Disorders. 
REC reference: 10/H1210/1 
Protocol Number: Version 1 
 
Thank you for your letter of 02 February 2010 responding to the Committee’s request for 
further information on the above research and submitting revised documentation. Please 
accept my sincere apologies for the delay in writing to you the IT problem with the 
Research Ethics Database has only been fixed today. 
 
The further information has been considered on behalf of the Committee by the Chairman. 
 
Mental Capacity Act 2005 
 
The members of the committee present approved the supplementary application on the 
basis described in the documentation submitted.  I confirm that the committee has 
approved this research project for the purposes of the Mental Capacity Act 2005.  The 
committee is satisfied that the requirements of section 31 of the Act will be met in relation 
to research carried out as part of this project on, or in relation to, a person who lacks 
capacity to consent to taking part in the project. 
 
Confirmation of ethical opinion 
 
The research continues to have a favourable opinion from this committee.  It should 
continue to be conducted on the basis previously approved by the committee, as amended 
by this supplementary application.  The conditions of approval issued with the 
committee's original favourable opinion continue to apply. 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
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Document    Version    Date      
Covering Letter  Prof C 
Oliver  
14 December 
2009  
  
REC application  IRAS  11 December 
2009  
  
Protocol  Version 1  01 December 
2009  
  
Copy REC letter    06 November 
2009  
  
Investigator CV  C Oliver  10 December 
2009  
  
Letter of invitation to participant  Version 1 
A31 Letter 
Unknown 
new 
research 
project  
10 December 
2009  
  
Letter of invitation to participant  Version 1 
A31 Letter 
Known new 
phase of 
research  
10 December 
2009  
  
Questionnaire: Instructions & Background Information  Version 1  10 December 
2009  
  
Questionnaire: Wessex          
Questionnaire: Social Communication         
Questionnaire: Activity         
Questionnaire: Sociability for People with Intellectual 
Disabilities  
       
Questionnaire: Health         
Questionnaire: Mood Interest & Pleasure         
Questionnaire: The CBQ         
Questionnaire: Parenting & the Family         
Questionnaire: Your feelings & emotions         
Questionnaire: Nisonger Scale         
Questionnaire: Brief-P         
Questionnaire: The RBQ         
Questionnaire: Food Related Problems         
Questionnaire: Routines Inventory         
Questionnaire: The GRQ         
Questionnaire: NCCPC-R Pain Checklist         
Questionnaire: Social Resources         
Letter of invitation to participant  Continue 
Project 
version 1 
A31 Letter  
10 December 
2009  
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The Fragile X Society syndrome group letter of support    01 June 2009    
Participant Information Sheet: A31 Consultee   Version 1  10 December 
2009  
  
Participant Information Sheet: Symbol  Version 1  10 December 
2009  
  
Participant Consent Form: Access to Medical Records  Version 1  10 December 
2009  
  
Assessment of Capacity Protocol  Version 1  10 December 
2009  
  
Interview Schedules/Topic Guides  Vineland-II 
Adaptive 
Behaviour 
Scales 2nd 
Edition  
     
Interview Schedules/Topic Guides  Challenging 
Behaviour 
Interview  
     
Evidence of insurance or indemnity  UMAL 
Certificate 
of 
University 
of 
Birmingha
m 
Professiona
l Indemnity   
01 August 2009    
Covering Letter  C Oliver & J 
Moss  
02 February 2010    
Participant Consent Form: A31 Consent Known Form B  Version 2  01 February 2010    
Participant Consent Form: A31 Consent Unknown Form A  Version 2  01 February 2010    
Participant Consent Form: A31 Consent Form Unknown Form 
B  
Version 2  01 February 2010    
Participant Consent Form: A31 Consent Unknown Form C 
Consultee  
Version 2  01 February 2010    
Participant Consent Form: A31 Confirm Known Form A   Version 2  01 February 2010    
Response to Request for Further Information         
Participant Information Sheet: A31 Infor fu 16+  Version 2  01 February 2010    
Participant Information Sheet: A31 Info Unknown 16+  Version 2  01 February 2010    
Participant Information Sheet: A31 infor Fu <16  Version 2  01 February 2010    
Participant Information Sheet: A31 Info Unknown <16  Version 2  01 February 2010    
Participant Consent Form: A31 Consent Known Form C  Version 2  01 February 2010    
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
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Feedback on the application process 
 
Now that you have completed the application process you are invited to give your view of 
the service you received from the National Research Ethics Service.  If you wish to make 
your views known please use the feedback form available on the NRES website at: 
 
https://www.nationalres.org.uk/AppForm/Modules/Feedback/EthicalReview.asp
x 
 
We value your views and comments and will use them to inform the operational 
process and further improve our service.  
 
10/H1210/1    Please quote this number on all 
correspondence 
 
With the Committee’s best wishes for the success of this project 
 
Yours sincerely 
 
 
 
 
Stephen Keay 
Chairman 
 
E-mail: pauline.pittaway@uhcw.nhs.uk 
 
 
Copy to: Dr Brendan Laverty, University of Birmingham 
 
Coventry Research Ethics Committee 
 
Attendance at Chair's Actions meeting on 02 February 2010 
 
 
Mr Stephen Keay Consultant in Reproductive Medicine  Chairman & 
Expert 
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Appendix 6: Assessments.  
WESSEX Questionnaire 
 
These items refer to the person you care for. For each question (A, B, C, D etc …), 
please enter the appropriate code in each box. 
 
(Frequently = more than once a week) 
 
A) Wetting (nights)  1 = frequently  2 = occasionally     3 = never   
B) Soiling (nights)  1 = frequently  2 = occasionally     3 = never 
C) Wetting (days) 1 = frequently  2 = occasionally     3 = never 
D) Soiling (days) 1 = frequently  2 = occasionally     3 = never 
E) Walk with help 1 = not at all  2 = not up stairs     3 = up stairs  
                    and elsewhere 
 
(note: if this person walks by himself upstairs and elsewhere, please also code ‘3’ for 
‘walk with help’) 
 
F) Walk by himself    1 = not at all  2 = not up stairs  3 = up stairs and 
                                         elsewhere  
G) Feed himself         1 = not at all  2 = with help      3 = without help 
H) Wash himself        1 = not at all  2 = with help      3 = without help 
I)   Dress himself        1 = not at all  2 = with help      3 = without help 
 
J) Vision                   1 = blind or almost   2 = poor        3 = normal   
K) Hearing          1 = deaf or almost     2 = poor      3 = normal 
 
L) Speech         1 = never a word        2 = odd words only 
          3 = sentences and normal    4 = can talk but doesn’t  
 
If this person talks in sentences, is his/her speech: 
1 = Difficult to understand even by acquaintances, impossible for strangers? 
2 = Easily understood for acquaintances, difficult for strangers? 
3 = Clear enough to be understood by anyone? 
M) Reads 1 = nothing 2 = a little 3 = newspapers and/or books 
N) Writes 1 = nothing 2 = a little 3 = own correspondence 
O) Counts 1 = nothing 2 = a little 3 = understands money values 
Please check your answers and go on to the next questionnaire. 
 242 
 
THE MOOD, INTEREST AND PLEASURE QUESTIONNAIRE –  
SHORT FORM (MIPQ-S) 
 
 
Instructions for completing the MIPQ-S 
 
This questionnaire contains 12 questions – you should complete all 12 questions.  Each 
question will ask for your opinion about particular behaviours, which you have observed in 
the last 2 weeks.  For every question you should circle the most appropriate response e.g. 
 
6) In the last two weeks, how interested did the person appear to be in his/her 
surroundings? 
 
interested all interested 
most 
interested 
about 
interested some never 
of the time of the time half of the 
time 
of the time interested 
 
 
 
 
 
The Mood, Interest and Pleasure Questionnaire - Short Form 
 
1) In the last two weeks, did the person seem… 
 
sad all of sad most sad about half sad some never sad 
the time of the time of the time of the time  
 
Please comment if anything has happened in the last two weeks which you feel might explain 
sadness if it has been observed (e.g. a bereavement): 
 
 
2) In the last two weeks, how often did you hear positive vocalizations* when the 
person was engaged in activities*? 
 
all of the most of the about half of some of the never 
time the time the time time  
 
*positive vocalizations: e.g. laughing, giggling, “excited sounds” etc. 
*engaged in activities: i.e. when someone is actively involved in any activity such as a 
mealtime, a social interaction, a self-care task or social outing etc. 
 
3) In the last two weeks, do you think the facial expression of the person looked 
“flat”*… 
 
all of the most of the about half of some of the never 
time the time the time time  
 
*flat expression: expression seems lifeless; lacks emotional expression; seems 
unresponsive. 
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4) In the last two weeks, would you say the person… 
 
cried every cried nearly cried 3-4 times cried once or cried less than 
day every day each week twice each 
week 
once each 
week 
 
 
5) In the last two weeks, how interested did the person appear to be in his/her 
surroundings? 
 
interested all interested 
most 
interested 
about 
interested 
some 
never 
of the time of the time half of the time of the time interested 
 
6) In the last two weeks, did the person seem to have been enjoying life… 
 
all of the most of the about half of some of the never 
time the time the time time  
 
Please comment if there are any reasons why this person might not have been enjoying him/herself 
e.g. illness, being in pain, experiencing a loss etc.: 
 
 
7) In the last two weeks, would you say the person smiled… 
 
at least once at least once 3-4 times  once or  twice less than once 
every day nearly every 
day 
each week each week each week 
 
8) In the last two weeks, how disinterested did the person seem to be in his/her 
surroundings? 
 
disinterested disinterested disinterested 
about  
disinterested never 
all of the 
time 
most of the 
time 
half of the time some of the 
time 
disinterested 
 
9) In the last two weeks, when the person was engaged in activities*, to what 
extent did his/her facial expressions* suggest that s/he was interested in the 
activity? 
 
interested all interested 
most 
interested 
about 
interested 
some 
never 
of the time of the time half of the time of the time interested 
         
*engaged in activities: i.e. when someone is actively involved in any activity such as a 
mealtime, social interaction, self-care task or social outing etc. 
*facial expressions: interest might be indicated by the degree to which the person’s gaze 
is being directed at the person/things involved in an activity. 
 
10) In the last two weeks, would you say that the person… 
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laughed laughed 
nearly 
laughed 3-4 laughed once 
or 
laughed less 
than 
every day every day times each 
week 
twice each 
week 
once each week 
 
11) In the last two weeks, how often did you see gestures which appeared to 
demonstrate enjoyment* when the person was engaged in activities*? 
 
all of the most of the about half of some of the never 
time the time the time time  
 
*gestures which appear to demonstrate enjoyment: e.g. clapping, waving hands in 
excitement etc. 
*engaged in activities: i.e. when someone is actively involved in any activity such as a 
meal time, social interaction, self-care task or social outing etc. 
 
12) In the last two weeks, did the person’s vocalizations* sound distressed… 
 
all of the most of the about half of some of the never 
time the time the time time  
 
*vocalizations: any words, noises or utterances. 
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THE RBQ  
 
INSTRUCTIONS 
 
1. The questionnaire asks about 19 different behaviours. 
 
2. Each behaviour is accompanied by a brief definition and examples. The examples 
given for each behaviour are not necessarily a complete list but may help you to 
understand the definitions more fully. 
 
3. Please read the definitions and examples carefully and circle the appropriate number 
on the scale to indicate how frequently the person you care for has engaged in each 
of the behaviours within the last month. 
 
4. If a particular behaviour does not apply to the person you care for because they are 
not mobile or verbal please circle the number 0 on the scale 
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1. Object stereotypy: repetitive, seemingly purposeless movement 
of objects in an unusual way E.g. twirling or twiddling objects, twisting 
or shaking objects, banging or slapping objects. 
 
0 1 2 3 4 
2. Body stereotypy:  repetitive, seemingly purposeless movement of 
whole body or part of body (other than hands) in an unusual way. E.g. 
body rocking, or swaying ,or  spinning, bouncing, head shaking, body 
posturing.. Does not include self-injurious behaviour. 
 
0 1 2 3 4 
3. Hand stereotypy: repetitive, seemingly purposeless movement of 
hands in an unusual way. E.g. finger twiddling, hand flapping, wigging 
or flicking fingers, hand posturing. Does not include self-injurious 
behaviour. 
 
0 1 2 3 4 
4. Cleaning: Excessive cleaning, washing or polishing of objects or 
parts of the body         E.g. polishes windows and surfaces excessively, 
washes hands and face excessively,  
 
0 1 2 3 4 
5. Tidying up:  Tidying away any objects that have been left out. This 
may occur in situations when it is inappropriate to put the objects 
away. Objects may be put away into inappropriate places. E.g. putting 
cutlery left out for dinner in the bin, removes all objects from surfaces. 
  
0 1 2 3 4 
6. Hoarding: Collecting, storing or hiding objects to excess, including 
rubbish, bits of paper, and pieces of string or any other unusual items. 
 
0 1 2 3 4 
7. Organising objects: Organising objects into categories according 
to various characteristics such as colour, size, or function. E.g. ordering 
magazines according to size, ordering toy cars according to colour, 
ordering books according to topic.  
 
0 1 2 3 4 
8. Attachment to particular people: Continually asking to see, 
speak or contact a particular ‘favourite’ person. E.g. continually asks to 
0 1 2 3 4 
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see or speak to particular friend, carer, babysitter or schoolteacher. 
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9. Repetitive questions: Asking specific questions over and over. 
E.g. always asking people what their favourite colour is, asking who is 
taking them to school the next day over and over 
 
0 1 2 3 4 
10. Attachment to objects: Strong preference for a particular 
object to be present at all times. E.g. Carrying a particular piece of 
string everywhere, taking a particular red toy car everywhere, 
attachment to soft toy or particular blanket. 
 
0 1 2 3 4 
11.  Repetitive phrases/signing: Repeating particular sounds, 
phrases or signs that are unrelated to the situation over and over. E.g. 
repeatedly signing the word ‘telephone’.  
 
0 1 2 3 4 
12. Rituals: carrying out a sequence of unusual or bizarre actions 
before, during or after a task. The sequence will always be carried out 
when performing this task and will always occur in the same way. E.g. 
turning round three times before sitting down, turning lights on and off 
twice before leaving a room, tapping door frame twice when passing 
through it.  
 
0 1 2 3 4 
13. Restricted conversation: Repeatedly talks about specific, 
unusual topics in great detail. E.g. conversation restricted to: trains, 
buses, dinosaurs, particular film, country, or sport. 
 
0 1 2 3 4 
14. Echolalia: Repetition of speech that has either just been heard or 
has been heard more than a minute earlier. E.g.: Mum:‘ Jack don’t do 
that’  Jack: ‘Jack don’t do that’.         
 
0 1 2 3 4 
15. Preference for routine: Insist on having the same household, 
school or work schedule everyday. E.g. likes to have the same activities 
on the same day at the same time each week, prefers to eat lunch at 
exactly the same time every day, wearing the same jumper everyday. 
 
0 1 2 3 4 
16. Lining up or arranging objects:  Arrangement of objects into 
lines or patterns E.g. placing toy cars in a symmetrical pattern, precisely 
lining up story books,  
 
0 1 2 3 4 
17. Just right behaviour: Strong insistence that objects, furniture 
and toys always remain in the same place. E.g. all chairs, pictures and 
toys have a very specific place that cannot be changed. 
 
0 1 2 3 4 
18. Completing behaviour: Insists on having objects or activities 
‘complete’ or ‘whole’ E.g. Must have doors open or closed not in 
between,  story must be read from beginning to end, not left halfway 
through. 
 
0 1 2 3 4 
19. Spotless behaviour: Removing small, almost unnoticeable 0 1 2 3 4 
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pieces of lint, fluff, crumbs or dirt from surfaces, clothes and objects. 
E.g.  Picking fluff off a jumper, removing crumbs from the kitchen table. 
 
 248 
 
THE ACTIVITY QUESTIONNAIRE 
                  Instructions: 
 Please read each item carefully and circle the appropriate number on the scale, for the 
person you care for. 
 Please ensure that you indicate a response for every item.  If the particular behaviour 
does not apply, 
for example, if the person is not verbal or not mobile, please circle 0 on the scale. 
 
 
 
 
 
 
 
 
 
 
 
Never
/ 
almost 
never 
 
 
 
Some 
of the 
time 
 
 
 
 
Half of 
the time 
 
 
 
 
A lot 
of the 
time 
 
 
 
 
Always/ 
almost all 
the time 
 
 
1. Does the person wriggle or squirm about when 
seated  or lying down? 
 
0 1 2 3 4 
2. Does the person fidget or play with their hands 
and/or  feet when seated or lying down? 
 
0 1 2 3 4 
3. Does the person find it difficult holding still? 0 1 2 3 4 
4. Does the person find it difficult to remain in their 
seat  even when in situations where it would be 
expected? 
0 1 2 3 4 
5. Does the person prefer to be moving around or
 becomes    
        frustrated if left in one position for too long? 
 
0 1 2 3 4 
6. When the person is involved in a leisure activity 
(e.g.  watching TV, playing a game etc.) do they make a 
lot  of noise? 
 
0 1 2 3 4 
7. When the person is involved in an activity, are 
they  boisterous and/or rough? 
 
0 1 2 3 4 
8. Does the person act as if they are “driven by a 
motor”  (i.e. often very active)? 
 
0 1 2 3 4 
9. Does the person seem like they need very little 
rest to  recharge their battery? 
 
0 1 2 3 4 
10. Does the person often talk excessively? 
 
0 1 2 3 4 
11. Does the person’s behaviour seem difficult to 
 manage/contain whilst out and about (e.g. in 
town, in  supermarkets etc.)? 
 
0 1 2 3 4 
12. Do you feel that you need to “keep an eye” on the  
         person at all times? 
 
0 1 2 3 4 
13. Does the person you care for seem to act/do things  
         without stopping to think first? 
 
0 1 2 3 4 
14. Does the person blurt out answers before 
questions  have been completed? 
 
0 1 2 3 4 
15. Does the person start to respond to instructions 
before  they have been fully given or without seeming 
to  understand them? 
 
0 1 2 3 4 
16. Does the person want things immediately? 
 
0 1 2 3 4 
17. Does the person find it difficult to wait? 
 
0 1 2 3 4 
18. Does the person disturb others because they have 
 difficulty waiting for things or waiting their turn? 
 
0 1 2 3 4 
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SOCIAL COMMUNICATION QUESTIONNAIRE © Rutter et al 2003          
  
1.  Is she/he now able to talk using short phrases or sentences? If no, skip to question 8.  Yes      No 
  
2.  Can you have a to and fro “conversation” with her/him that involves taking turns or 
building on what you have said?        
Yes      No 
  
3. Has she/he ever used odd phrases or said the same thing over and over in almost exactly 
the same way (either phrases that she/he has heard other people use or ones that she/he 
has made up?  
Yes      No 
  
4.  Has she/he ever used socially inappropriate questions or statements?  For example, has 
she/he ever regularly asked personal questions or made personal comments at awkward 
times? 
Yes      No 
  
5.   Has she/he ever got her/his pronouns mixed up (e.g., saying you or she/he for I)? 
 
Yes      No 
  
6.  Has she/he ever used words that she/he seemed to have invented or made up her/himself; 
put  things in odd, indirect ways; or used metaphorical ways of saying things (e.g., saying 
hot rain for steam)? 
 
Yes      No 
  
7.  Has she/he ever said the same thing over and over in exactly the same way or insisted that 
you say the same thing over and over again? 
Yes      No 
  
8.  Has she/he ever had things that she/he seemed to have to do in a very particular way or 
order or rituals that she/he insisted that you go through?  
Yes      No 
  
9.   Has her/his facial expression usually seemed appropriate to the particular situation, as far 
as you could tell? 
Yes      No 
  
10. Has she/he ever used your hand like a tool or as if it were part of her/his own body (e.g., 
pointing with your finger, putting your hand on a doorknob to get you to open the door)?
     
Yes      No 
  
11. Has she/he ever had any interests that preoccupy her/him and might seem odd to other 
people (e.g., traffic lights, drainpipes, or timetables)? 
Yes      No 
  
12. Has she/he ever seemed to be more interested in parts of a toy or an object (e.g., spinning 
the wheels of a car), rather than using the object as it was intended? 
Yes      No 
  
13. Has she/he ever had any special interests that were unusual in their intensity but 
otherwise appropriate for her/his age and peer group (e.g., trains, dinosaurs)? 
Yes      No 
  
14. Has she/he ever seemed to be unusually interested in the sight, feel, sound, taste, or smell 
of things or people? 
Yes      No 
  
15. Has she/he ever had any mannerisms or odd ways of moving her/his hands or fingers, 
such as flapping or moving her/his fingers in front of her/his eyes? 
Yes      No 
  
16. Has she/he ever had any complicated movements of her/his whole body, such as spinning 
or repeatedly bouncing up and down?  
Yes      No 
Please circle ‘yes’ if any one of the following behaviours is present.  Although you may 
be uncertain about whether some behaviours are  present or not, please do answer ‘yes’ 
or ‘no’ to every question on the basis of what you think. 
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17. Has she/he ever injured her/himself deliberately, such as by biting her/his arm or banging 
her/his head? 
Yes      No 
  
18. Has she/he ever had any objects (other than a soft toy or comfort blanket) that she/he had 
to carry around? 
Yes      No 
  
19. Does she/he have any particular friends or a best friend? Yes      No 
  
20. When she/he was 4 to 5, did she/he ever talk with you just to be friendly (rather than to 
get something)? 
Yes      No 
  
21. When she/he was 4 to 5, did she/he ever spontaneously copy you (or other people) or 
what you were doing (such as vacuuming, gardening, or mending things)? 
 
Yes      No 
  
22. When she/he was 4 to 5, did she/he ever spontaneously point at things around her/him 
just to show you things (not because she/he wanted them)? 
Yes      No 
  
23. When she/he was 4 to 5, did she/he ever use gestures, other than pointing or pulling your 
hand, to let you know what she/he wanted 
Yes      No 
  
24. When she/he was 4 to 5, did she/he nod her/his head to mean yes? Yes      No 
  
25. When she/he was 4 to 5, did she/he shake her/his head to mean no? Yes      No 
  
26. When she/he was 4 to 5, did she/he usually look at you directly in the face when doing 
things with you or talking with you? 
Yes      No 
  
27. When she/he was 4 to 5, did she/he smile back if someone smiled at her/him? Yes      No 
  
28. When she/he was 4 to 5, did she/he ever show you things that interested her/him to 
engage your attention? 
Yes      No 
  
29. When she/he was 4 to 5, did she/he ever offer to share things other than food with you? Yes      No 
  
30. When she/he was 4 to 5, did she/he ever seem to want you to join in her/his enjoyment of 
something? 
Yes      No 
  
31. When she/he was 4 to 5, did she/he ever try to comfort you if you were sad or hurt? Yes      No 
  
32. When she/he was 4 to 5, when she/he wanted something or wanted help, did she/he look 
at you and use gestures with sounds or words to get your attention? 
Yes      No 
  
33. When she/he was 4 to 5, did she/he show a normal range of facial expressions? Yes      No 
  
34. When she/he was 4 to 5, did she/he ever spontaneously join in and try to copy the actions 
in social games, such as The Mulberry Bush or London Bridge Is Falling Down? 
Yes      No 
  
35. When she/he was 4 to 5, did she/he play any pretend or make-believe games? Yes      No 
  
36. When she/he was 4 to 5, did she/he seem interested in other children of approximately 
the same age whom she/he did not know? 
Yes      No 
  
37. When she/he was 4 to 5, did she/he respond positively when another child approached 
her/him? 
Yes      No 
  
38. When she/he was 4 to 5, if you came into a room and started talking to her/him without 
calling her/his name, did she/he usually look up and pay attention to you? 
Yes      No 
  
39. When she/he was 4 to 5, did she/he ever play imaginative games with another child in 
such a way that you could tell that they each understood what the other was pretending? 
Yes      No 
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40. When she/he was 4 to 5, did she/he play cooperatively in games that required joining in 
with a group of other children, such as hide-and-seek or ball games? 
Yes      No 
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Hospital Anxiety and Depression Scale (Zigmond & Smaith, 1983) 
This questionnaire focuses on how you feel about things. Please read each item and circle the reply underneath the item which 
comes closest to how you have been feeling in the past week. Do not take too long over your replies; your immediate reaction to 
each item will probably be more accurate than a long thought-out response.  
1. I feel tense or “wound up” 
Most of the time A lot of the time  Occasionally,  
from time to time 
Not at all 
2. I still enjoy the things I used to enjoy 
Definitely as much Not quite so much Only a little Hardly at all 
 
3. I get a sort of frightened feeling as if something awful is about to happen 
Very definitely and quite  
Badly 
Yes, but not too badly A little, but it  
doesn’t worry me 
 Not at all 
 
4. I can laugh and see the funny side of things  
As much as I always  
Could 
Not quite so much now Definitely not so 
much now 
Not at all. 
 
5. Worrying thoughts go through my mind 
A great deal of the  
Time 
A lot of the time From time to time 
but not too often 
Only  
occasionally 
 
6. I feel cheerful 
Not at all Not often Sometimes Most of the  
time 
7. I can sit at ease and feel relaxed 
Definitely Usually Not often Not at all 
 
8. I feel as if I am slowed down 
Nearly all the time Very often Sometimes Not at all 
 
9. I get a sort of frightened feeling like “butterflies” in the stomach 
Not at all Occasionally Quite often Very often 
 
10. I have lost interest in my appearance 
Definitely I don’t take as much care 
as I should 
 I may not take 
quite as much care 
I take just as 
much care as 
ever 
11. I feel restless as if I have to be on the move 
Very much indeed Quite a lot Not very much Not at all 
 
12. I look forward with enjoyment to things 
As much as I ever did Rather less than I used to Definitely less than 
 I used to 
Hardly at all 
13. I get sudden feelings of panic 
Very often indeed Quite often Not very often Not at all 
 
14. I can enjoy a good book, radio or TV programme 
Often Sometimes Not often Very seldom 
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Health Questionnaire 
PART A 
Instructions: 
 Have these problems EVER affected your child or person you care for?   
 Please rate as 0 – if  the problem has never affected the person you care for, 1 – if it has 
been a mild problem, 2  - if the problem has been moderately serious, or 3 – if the problem 
has been severe.   
 If the person you care for has had these problems please state whether any treatment has 
been implemented by circling yes or no.                   
 Never Mild Moderat
e 
Severe 
1a. Eye Problems (e.g. glaucoma / blocked tear duct/s)....................................................... 0 1 2 3 
1b. Corrective surgery / medication / treatment:  yes / no       
     
2a. Ear Problems (e.g. infections, glue ear) ......................................................................... 0 1 2 3 
2b. Corrective surgery / medication / treatment (e.g. grommets):  yes / no       
     
3a. Dental Problems (e.g. toothache / gum problems / mouth ulcers / delayed         
      eruption of teeth)............................................................................................................. 
 
0 
 
1 
 
2 
 
3 
3b.Dental surgery / treatment (e.g. teeth removal): yes / no       
     
4a. Cleft Palate...................................................................................................................... 0 1 2 3 
4b. Repaired: yes / no       
     
5a. Gastrointestinal Difficulties (e.g. reflux / stomach problems)........................................ 0 1 2 3 
5b. Corrective surgery / medication / treatment (e.g. nissen fundoplication):  yes / 
no   
    
     
6a. Bowel Problems (e.g. obstruction).................................................................................. 0 1 2 3 
6b. Corrective surgery / treatment:  yes / no        
     
7a. Heart Abnormalities or Circulatory Problems  (e.g. congenital heart lesions or  
      murmur)........................................................................................................................... 
 
0 
 
1 
 
2 
 
3 
7b. Corrective surgery / medication / treatment:  yes / no        
     
8a. Problems with Genitalia (e.g. prostate/ testicular problems i.e. undescended      
      testes) ………………………………………………………………………………….. 
 
0 
 
1 
 
2 
 
3 
8b. Corrective surgery / treatment:  yes / no       
     
9a. Hernia (e.g. inguinal or hiatal)........................................................................................ 0 1 2 3 
9b. Repair / treatment:  yes / no        
     
10. Limb Abnormalities (e.g. malformed arm)..................................................................... 0 1 2 3 
     
11a. Epilepsy / Seizures / Neurological Referrals................................................................ 0 1 2 3 
11b. Medication:  yes / no        
     
12a. Lung or Respiratory Problems (asthma/bronchitis)...................................................... 0 1 2 3 
12b. Corrective surgery / medication / treatment:  yes / no        
     
13a. Liver or Kidney Problems............................................................................................. 0 1 2 3 
13b. Corrective surgery / medication / treatment:  yes / no       
     
14a. Diabetes or Thyroid Function Problems....................................................................... 0 1 2 3 
14b. Corrective surgery / medication / treatment:  yes / no        
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15a. Skin Problems (e.g. tinea, eczema, psoriasis, dry skin)………………........................ 0 1 2 3 
15b. Medication / treatment:  yes / no       
     
16a. Other (please specify problem, severity from 0-3)....................................................... 0 1 2 3 
16b. Corrective surgery / medication / treatment:  yes / no       
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PART B 
 
Instructions: 
 Have these medical problems affected the person you care for in the past MONTH 
 
 Please rate as 0 – if your child has not been affected by this problem in the past month, 1 - 
if they have been mildly affected, 2 – if the problem has moderately affected your child and 
3 - if your child has been severely affected by the problem. 
 
 No Mild Moderat
e 
Severe 
17. Eye Problems (e.g. glaucoma /  blocked tear duct/s)...................................................... 0 1 2 3 
     
18. Ear Problems (e.g. infections, glue ear)......................................................................... 0 1 2 3 
     
19. Dental Problems (e.g. toothache / gum problems / mouth ulcers / delayed 
eruption of teeth)...................................................................................................................................... 
 
0 
 
1 
 
2 
 
3 
     
20. Cleft Palate...................................................................................................................... 0 1 2 3 
     
21. Gastrointestinal Difficulties (e.g. reflux / stomach problems)........................................ 0 1 2 3 
     
22. Bowel Problems (e.g. obstruction).................................................................................. 0 1 2 3 
     
23. Heart Abnormalities or Circulatory Problems (e.g. congenital heart lesions or   
      murmur)………………………………………………………………………………... 
 
0 
 
1 
 
2 
 
3 
     
24. Problems with Genitalia (e.g. prostate / testicular problems i.e. undescended 
testes).... 
0 1 2 3 
     
25. Hernia (e.g. inguinal or hiatal)........................................................................................ 0 1 2 3 
     
26.  Limb Abnormalities (e.g. malformed arm).................................................................... 0 1 2 3 
     
27. Epilepsy / Seizures / Neurological Referrals.................................................................. 0 1 2 3 
     
28. Lung or Respiratory Problems (asthma / bronchitis)...................................................... 0 1 2 3 
     
29. Liver or Kidney Problems............................................................................................... 0 1 2 3 
     
30. Diabetes or Thyroid Function Problems......................................................................... 0 1 2 3 
     
31. Skin Problems (e.g. tinea, eczema, psoriasis, dry skin).................................................. 0 1 2 3 
     
32. Other  (please specify problem and severity from 0-3) ……………………………….. 0 1 2 3 
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Appendix 7: Health Difficulties in Individuals with Pallister-Killian Syndrome. 
 
 
Never/ No  
n (%) 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
Corrective surgery/ 
Treatment? n (%) 
Eye Problems Lifetime 9 (56.3%) 3 (18.8%) 3 (18.8%) 1 (6.3%) 4 (25%) 
Last Month 14 (87.5%) 2 (12.5%) - - 
Ear Problems Lifetime 2 (12.5%) 5 (31.3%) 6 (37.5%) 3 (18.8%) 11 (68.8%) 
Last Month 10 (62.5%) 4 (25%) 1 (6.3%) 1 (6.3%) 
Dental Problems Lifetime 3 (18.8%) 5 (31.3%) 5 (31.3%) 3 (18.8%) 4 (25%) 
Last Month 10 (62.5%) 4 (25%) - 2 (12.5%) 
Cleft Palate Lifetime 11 (68.8%) 1 (6.3%) 4 (25%) - 3 (18.8%) 
Last Month 13 (81.3%) 1 (6.3%) 2 (12.5%) - 
Gastrointestinal Problems Lifetime 8 (50%) 2 (12.5%) 4 (25%) 2 (12.5%) 4 (25%) 
Last Month 11 (68.8%) 4 (25%) 1 (6.3%) - 
Bowel Problems Lifetime 9 (56.3%) 2 (12.5%) 3 (18.8%) 2 (12.5%) 3 (18.8%) 
Last Month 11 (68.8%) 3 (18.8%) 1 (6.3%) 1 (6.3%) 
Heart Abnormalities or Circulatory Problems Lifetime 10 (62.5%) 5 (31.3%) - 1 (6.3%) 2 (12.5%) 
Last Month 16 (100%) - - - 
Problems with Genitalia Lifetime 10 (62.5%) 5 (31.3%) 1 (6.3%) - 4 (25%) 
Last Month 14 (87.5%) 2 (12.5%) - - 
Hernia Lifetime 10 (62.5%) 2 (12.5%) 1 (6.3%) 3 (18.8%) 5 (31.3%) 
Last Month 14 (87.5%) 2 (12.5%) - - 
Limb Abnormalities Lifetime 14 (87.5%) - 2 (12.5%) - - 
Last Month 14 (87.5%) 1 (6.3%) 1 (6.3%) - 
Epilepsy/ Seizures Lifetime 5 (31.3%) 4 (25%) 5 (31.3%) 2 (12.5%) 7 (43.8%) 
Last Month 9 (56.3%) 4 (25%) 2 (12.5%) 1 (6.3%) 
Lung or Respiratory Problems Lifetime 11 (68.8%) 1 (6.3%) 2 (12.5%) 2 (12.5%) 4 (25%) 
Last Month 13 (81.3%) 3 (18.8%) - - 
Liver or Kidney Problems Lifetime 13 (81.3%) 1 (6.3%) 2 (12.5%) - 3 (18.8%) 
Last Month 15 (93.8%) - 1 (6.3%) - 
Diabetes or Thyroid Function Problems Lifetime 15 (93.8%) - - 1 (6.3%) 1 (6.3%) 
Last Month 15 (93.6%) - 1 (6.3%) - 
Skin Problems Lifetime 6 (37.5%) 8 (50%) 2 (12.5%) - 8 (50%) 
 Last Month 8 (50.0%) 6 (37.5%) 1 (6.3%) 1 (6.3%)  
 257 
 
 
